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Basigin (BSG), a member of the immunoglobulin superfamily, is a transmembrane 
glycoprotein expressed in many cell types.  It is involved in neurological processes, lymphocyte 
migration, angiogenesis, tissue remodeling and lactate transport. Our data show that Bsg is 
expressed in the reproductive tract and is important for fertility in both males and females. I 
hypothesized that loss of Bsg expression in the uterus reduces fertility in female mice by altering 
implantation, decidualization, lactate transporters and angiogenesis. In mice, global ablation of 
Bsg is embryonic lethal, which complicates the studies on the role of BSG in reproduction. To 
overcome the embryonic lethality, we generated a progesterone receptor (PR)-Cre Bsg conditional 
knockout (cKO) mouse model and used this animal model to test this hypothesis. The aims of the 
present study were 1) to validate the Bsg cKO animal model and investigate the fertility phenotype 
associated with this animal model; 2) to investigate whether BSG is required for luminal epithelial 
cell and basement membrane integrity at the time of implantation; 3) to examine whether BSG 
regulates decidualization process in vivo and in vitro; and 4) to investigate whether loss of BSG 
affects angiogenesis and lactate transport. 
Successful deletion of uterine Bsg was confirmed by quantitative real-time PCR (qRT-
PCR), immunohistochemistry (IHC) and immunofluorescence (IF) staining. qRT-PCR indicated 
much lower Bsg mRNA levels in the cKO uteri compared to the controls. BSG was expressed in 
the luminal epithelial and stromal cells in the control mouse uteri. In the cKO mouse uteri, Bsg 
expression was lost in these PR positive cells, and only presented in PR negative cells such as 
immune cells and endothelial cells. BSG expression in the kidney was not affected, indicating it 
was PR-positive cell specific. Breeding study results showed that the cKO females had 
significantly reduced fertility about 40% compared to the controls. They had much smaller litter 
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size and litter frequency. The fertility of the cKO mice decreased more severely as they aged 
compared to the controls. Ovulation, progesterone production, fertilization and early embryo 
development were not affected in the cKO mice, suggesting that dysfunction occurred primarily 
in the uterus.  
Day 5 pregnant uteri were collected to analyze implantation. The results showed that about 
70% cKO mice did not show signs of implantation. In these animals the luminal epithelial cells 
still showed E-cadherin and cytokeratin at the site of implantation, indicating an intact luminal 
epithelial cell layer. In contrast, E-cadherin and cytokeratin in the control uteri were lost at the site 
of implantation, and only presented at the regions of luminal epithelium far from the embryo. The 
luminal epithelium basement membrane in the cKO mice was intact, not disrupted as in the 
controls. Many embryos in the cKO mice were restrained in a continuous layer of luminal 
epithelium, not able to break down the epithelium and penetrate the basement membrane.  
To investigate whether BSG regulates decidualization, an artificially induced 
decidualization experiment was performed. I found that the cKO mice had reduced response to the 
artificial stimulus compared to a robust response in the controls. The decidua size was also 
significantly smaller in the cKO mice. qRT-PCR results showed that decidual genes Cebpβ and 
Bmp2 were significantly downregulated in the cKO decidua. IHC results showed that CEBPβ and 
HAND2 protein expression were lower in the induced decidua and day 5 pregnant uteri in the cKO 
mice. Mouse endometrial stromal cell (MESC) culture experiments showed there was no 
difference in cell proliferation, but qRT-PCR results showed that Prl8a2, Cebpβ, Bmp2 and Hand2 
were significantly downregulated in the cKO MESCs. These results suggest that BSG is required 
for proper decidualization in vivo and in vitro. 
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BSG is involved in angiogenesis. To test whether loss of BSG leads to abnormal 
angiogenesis, day 6 pregnant uteri were stained with the angiogenic marker CD31. There was 
significantly lower abundance of CD31 in the cKO mouse uteri compared to the controls. BSG is 
a chaperone protein for the lactate transporter MCT1/4. The abundance and localization of MCT1 
were altered in the cKO mouse uteri in vivo. A lactate assay of medium from MESCs collected 
from both genotypes showed that the cKO MESCs secreted less lactate than the controls. These 
data indicate that loss of BSG leads to reduction in angiogenesis and lactate transport. Collectively, 
data in this dissertation suggest that uterine expression of BSG is required for proper implantation, 
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Introduction and Rationale 
 
Infertility is one of the most common reproductive health diseases in humans and affects about 
10-15% of reproductive aged couples worldwide (Ramathal et al. 2010). Only 50-60% of all 
conceptions advance beyond 20 weeks of gestation and implantation failure is the major cause of 
early pregnancy loss, reaching about 75% (Norwitz, Schust, and Fisher 2001). Assisted 
reproductive technologies (ART) have helped millions of couples with fertility issues (Sharkey 
and Smith 2003). Despite the significant developments in culture medium and embryo quality, the 
success rate of ART remains very low mainly due to implantation failure (H. Wang et al. 2013). 
Therefore, it is imperative to gain a comprehensive understanding of the mechanism underlying 
implantation in order to address this global clinical issue. Many studies have identified molecules 
and proteins that are critical during embryo implantation, but the mechanisms regulating 
implantation are not fully understood. Thus, it is important to further investigate this process to 
advance the field of reproduction and fertility. 
Basigin (BSG), a member of the immunoglobulin superfamily encoded by Bsg gene, has been 
identified as one of the key molecule regulating early pregnancy by our laboratory and others (L. 
Chen et al. 2007; T Igakura et al. 1998). BSG is a highly glycosylated transmembrane protein 
expressed in many cell and tissue types including the reproductive organs in both human and mice 
(K. Li and Nowak 2019). In mice, BSG is expressed in the luminal and glandular epithelium on 
day 1 and 2 of pregnancy, and starting on day 3 and 4, its expression appears in the stromal cells. 
After implantation, BSG is expressed in the secondary decidual zone on day 5, then in the deep 
undifferentiated stromal zone (L. Chen, Belton, and Nowak 2009). Previous studies using human 
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cell lines have suggested BSG plays a role in implantation and decidualization and Bsg null 
females are profoundly infertile (T Igakura et al. 1998). However, global deletion of Bsg in mice 
results in high embryonic lethality, making it impractical as an animal model to study Bsg 
(Muramatsu and Miyauchi 2003). Thus, we generated a uterine tissue Bsg conditional knockout 
(cKO) mouse model to help us investigate its role in early pregnancy. My central hypothesis is 
that cKO of Bsg in the uterus reduces fertility in female mice. The overall goal of this project 
is to elucidate the roles of BSG in implantation and early pregnancy. To complete my 
dissertation work and test this hypothesis, I completed the following specific aims: 
 
Specific Aim 1: Validating the uterine specific Bsg cKO animal model and investigating the 
fertility phenotype in the cKO animals. 
To complete this aim, I crossed our Bsg floxed mice with a progesterone receptor (PR)-Cre 
mouse line to generate the cKO mice and their littermate controls. The mice were euthanized on 
day 1, day 4, and day 6 of gestation for tissue collection. Tissue samples were subjected to 
immunohistochemistry (IHC) and immunofluorescence (IF) staining for BSG and quantitative 
real-time PCR (qRT-PCR) to confirm successful deletion of BSG in the uterus. Then, a six-month 
fertility study was carried out to determine whether the cKO females experienced subfertility or 
infertility. The timing of pregnancy loss was investigated by euthanizing mice at different 
gestational stages. The location of pregnancy issues was limited to the uterus after assessing 
ovulation, fertilization, ovarian hormone levels and embryo development. These data are presented 




Specific Aim 2: Investigating luminal epithelial cell status and basement membrane integrity 
in the Bsg cKO females. 
 To complete this aim, mice of both genotypes were euthanized on day 5 of pregnancy at 
different times. Uterine tissues were collected and processed for histological analysis. Slides of 
cross sections of the implantation sites from both genotypes were stained for epithelial marker E-
cadherin and cytokeratin by IHC and IF. Additional slides were stained with Jones’ silver stain to 
evaluate basement membrane integrity on day 5 evening of pregnancy. These data are presented 
in Chapter 4. 
 
Specific Aim 3: Investigating post-implantation defects in decidualization, angiogenesis and 
lactate transporter expression in the Bsg cKO females in vivo. 
 To complete this aim, animals of both genotypes were euthanized and collected at different 
days of pregnancy post-implantation. Samples were subjected to RNA isolation and histology. 
IHC and IF staining against Monocarboxylate transport 1 (MCT1) and CD31 were carried out to 
investigate lactate transporter expression and angiogenesis. Animals of both genotypes were 
ovariectomized to artificially induce decidualization. Uterine samples were collected and analyzed 
for decidualization. qRT-PCR on several decidualization-marker genes were analyzed. IHC and 
IF staining for CCAAT enhancer-binding protein beta (CEBPβ) and Heart and neural crest 
derivatives-expressed protein 2 (HAND2) were performed on the decidual tissue from artificial 
decidualization as well as day 5 evening pregnant uteri from both genotypes. These data are 




Specific Aim 4: Investigating in vitro decidualization and lactate secretion in the primary 
endometrial stromal cells of the cKO females. 
To complete this aim, primary mouse endometrial stromal cells (MESC) of both genotypes 
were isolated and cultured to induce decidualization in vitro. Cells were cultured for 3-5 days under 
either normoxic or hypoxic conditions. Culture medium was collected to quantify lactate 
concentration secreted by the cells using a lactate assay. The cells were harvested to isolate RNA 
for qRT-PCR for expression of decidualization markers. These data are presented in Chapter 5.  
 
In summary, Chapter 1 describes the overview of this dissertation. Chapter 2 provides a 
detailed review of A) BSG and B) implantation and decidualization in the current literature. 
Chapter 3 presents the data on validation of the cKO mouse model as well as the fertility phenotype 
associated with the cKO females. In Chapter 4, I describe the data on altered implantation, 
decidualization, lactate transporter localization and angiogenesis in the cKO females in vivo. 
Chapter 5 presents the in vitro data on decidualization and lactate assay under either normoxic or 
hypoxic conditions. Finally, Chapter 6 summarizes the findings presented in the entire dissertation 
work and suggests directions for future study. The appendix contains lists of abbreviations, 
antibodies used, primer sequences for all the genes analyzed, as well as detailed protocols on the 
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Background on basigin, a member of the Ig superfamily 
Basigin was discovered in the 1980s in the laboratory of Dr. C. Biswas, where investigators 
co-cultured rabbit fibroblasts with mouse tumor cells of epithelial origin and found that these 
showed increased collagenase production when compared to fibroblasts cultured alone (C Biswas 
1982). The tumor cell lines were found to secrete a protein(s) that stimulates collagenase 
production by human fibroblasts (C Biswas 1984; Chitra Biswas and Nugent 1987) This protein 
was purified from human lung carcinoma cells and first named tumor cell collagenase-stimulatory 
factor (TCSF). TCSF was later renamed extracellular matrix metalloproteinase inducer 
(EMMPRIN) to indicate its role in extracellular matrix metalloproteinase induction in normal, as 
well as pathological, cellular interactions (Ellis, Nabeshima, and Biswas 1989; Kataoka et al. 1993; 
C. Biswas et al. 1995). Several different labs independently identified this protein in a number of 
different species. Thus EMMPRIN is also known as CD147 and M6 in human, basigin and GP42 
in mice, HT7 and neurothelin in chicken and OX-47, MC31 and CE9 in the rat (Nehme, Fayost, 
and Bartlest 1995; Sameshima et al. 2000; Schlosshauer and Herzog 1990; Seulberger, Unger, and 
Risau 1992; Wakayama et al. 2000; Ellis, Nabeshima, and Biswas 1989; Kataoka et al. 1993). In 
this review, the protein will be referred to as basigin. 
Basigin is a highly glycosylated, type-1 transmembrane protein belonging to the 
immunoglobulin (Ig) superfamily (Fossum, Mallett, and Neil Barclay 1991) as shown in Figure 
2.1. The molecular weight of basigin ranges from 43-66 kDa depending on different glycosylation 
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status and the non-glycosylated molecular weight is 27 kDa (Bai et al. 2014). Different 
glycosylation patterns are found in different cell types and contribute to its multiple physiological 
functions (J. Sun and Hemler 2001). The full length form of human basigin is 269 amino acids 
(Agrawal and Yong 2011) and its structure consists of a heavily glycosylated extracellular domain, 
a transmembrane domain, and a short cytoplasmic domain (J. N. Hahn, Kaushik, and Yong 2015). 
The most abundant isoform is basigin-2, where the extracellular domain is 176 amino acids in 
length, with 77 amino acids forming the extracellular Ig-like domain 1 (EC1) and 95 residues 
forming the extracellular Ig-like domain 2 (EC2) (Hiraishi et al. 2003). These two Ig-like loops 
are held together by disulfide bonds. The extracellular region contains three N-linked glycosylation 
sites at Asn residues and is important for metalloproteinase (MMP) stimulation (H. M. Guo et al. 
1997; Hanna et al. 2003;  wei Tang et al. 2004; Ku et al. 2007). The single transmembrane domain 
is highly conserved among species, as human, mouse, rat and chicken show almost identical amino 
acid sequence in this region. It contains a glutamic acid residue and a leucine zipper in the middle, 
which is important for association with other transmembrane molecules (Muramatsu and Miyauchi 
2003; Miyauchi, Masuzawa, and Muramatsu 1991). The short cytoplasmic tail is about 40 amino 
acid residues in length and has been shown to be involved in the initiation of various signaling 
pathways (Muramatsu 2016).  
There are four different isoforms of basigin in humans, namely basigin-1, -2, -3,and -4, 
resulting from alternative splicing. The only difference among them is in the extracellular domain 
(Grass and Bryan 2016). Basigin isoform 1 has three Ig-like domains in its extracellular portion 
and is specifically expressed in the retinal epithelium (Redzic et al. 2011; Hanna et al. 2003).  
Basigin-2 is the most predominant splice variant, encoding two Ig like extracellular domains. It is 
expressed in most tumor and fibroblast cells and is the only isoform that is secreted. It is also 
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expressed in the reproductive tissues and is the isoform we are focusing on in this review. Basigin-
3 and basigin-4 are short isoforms encoding only one Ig-like domain in the extracellular domain. 
These two isoforms are less abundant and were originally identified in human endometrial stromal 
cells and cervical carcinoma cells (L. Chen, Belton, and Nowak 2009). Basigin-3 serves as an 
endogenous inhibitor of basigin-2 via hetero-oligomerization (Liao et al. 2011). Basigin-4 is 
overexpressed in cervical cancer and promote proliferation of cervical cancer cells (Zhao et al. 
2013).  
Basigin is unusual compared with other plasma membrane glycoproteins in terms of its 
relative level of glycosylation as basigin contains 15-25 kDa of glycans, which is far greater than 
what is  typically observed in a plasma membrane glycoprotein with three N-glycosylation sites.  
( wei Tang et al. 2004). Highly glycosylated forms of basigin have frequently been reported and 
are functionally relevant (J. Sun and Hemler 2001). The first Ig domain of basigin (ECI) and the 
N-glycosylation of its extracellular domains are critical for the MMP-stimulating activity of 
basigin (Nabeshima et al. 2006). Evidence to support this comes from several studies. 
Recombinant basigin produced in a bacteria expression system is not glycosylated and of much 
smaller molecular weight.  This non-glycosylated form was unable to stimulate MMP production 
whereas a highly glycosylated form of basigin isolated from Chinese hamster ovary cells did 
stimulate production of MMPs-1, -2, and -3 from fibroblasts (H. M. Guo et al. 1997). Belton and 
colleagues reported that a soluble, non-glycosylated form of recombinant basigin, expressed in the 
periplasm of bacteria was able to increase MMP-1, -2 and -3 expression in uterine fibroblasts by 
binding in a homophilic manner to basigin-2 in the cell membrane and activating the ERK1/2 
signaling pathway (Belton et al. 2008). Periplasmic expression of the protein exposes the protein 
to an oxidative environment allowing for the formation of intramolecular disulfide bonds during 
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translocation into the periplasm, suggesting that the biological activity of basigin depends on the 
tertiary and quaternary structure of the protein.  A third study demonstrated that a synthetic ECI 
of basigin carrying GlcNAc1-2 was able to stimulate MMP-2 production from fibroblasts but the 
basigin ECI alone had no such activity (Hojo et al. 2003).  
One mechanism of regulation of basigin glycosylation status is through caveolin-1, which 
is a central component of plasma membrane caveolae ( wei Tang et al. 2004). Mutagenesis 
experiments demonstrated that the basigin extra cellular domain II (ECII), but not glycosylation, 
was required for caveolin-1 interaction (W. Tang and Hemler 2004). Caveolin-1 inhibits the 
conversion of the low glycosylated form of basigin into the highly glycosylated form and also 
blocks the MMP inducing activity of basigin ( wei Tang et al. 2004; W. Tang and Hemler 2004). 
In addition to the plasma membrane-bound form, basigin also exists in a soluble form 
(Guindolet and Gabison Eric 2019), a conclusion supported by the finding that basigin-expressing 
tumor cells upregulate MMP production by stromal cells located in or around the tumor 
(Nabeshima et al. 2004). Two main mechanisms for generating a soluble form of basigin have 
been reported. Soluble basigin is generated by proteolysis of basigin, removing the carboxyl 
terminus. (Y. Tang et al. 2004). Second is the release of full-length basigin through microvesicle 
shedding reported in tumor cells and uterine cells (Sukhvinder S. Sidhu et al. 2004; Braundmeier 
et al. 2012; Burnett et al. 2012; Grass and Bryan 2016). The shedding of basigin within 
microvesicles is a regulated process (Emilova 2012). These soluble forms of basigin retain the 
ability to induce MMP production and  stimulate angiogenesis, suggesting that basigin can exert 
its effect on cells in a paracrine manner or at distant sites (Sukhvinder S. Sidhu et al. 2004; 
Millimaggi et al. 2007; Gabison et al. 2005). 
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Role of basigin in cancer: major functions in angiogenesis, energy metabolism and immune 
function.  
Basigin has many physiological functions but is best known for its 1) involvement in tissue 
remodeling through regulation of matrix metalloproteinases (MMPs) (Seulberger, Unger, and 
Risau 1992; Wakayama et al. 2000; Saxena and Toshimori 2004; Naruhashi et al. 1997; 
Schlosshauer and Herzog 1990; Zhou et al. 2005; Ochrietor and Linser 2004); 2) stimulation of 
angiogenesis (Alcazar et al. 2009; Kirk et al. 2000; Halestrap and Price 1999; Philp et al. 2003; 
Pistol et al. 2007; Koch et al. 1999); 3) role in glycolytic energy metabolism through shuttling of 
monocarboxylate transporters (MCTs) to the cell surface membrane (Woodhead et al. 2000; Y. 
Tang et al. 2004; Amit-Cohen, Rahat, and Rahat 2013; Faten Bougatef et al. 2010; F. Bougatef et 
al. 2009); and 4) stimulatory effects on lymphocyte and macrophage activation (Ke et al. 2012; 
Su, Chen, and Kanekura 2009; Renaud Le Floch et al. 2011). (Figure 2.2) 
Since its discovery three decades ago, basigin has been shown by many investigators to be 
a major inducer of MMPs in a variety of cell types (Grass and Bryan 2016). Its ECI domain 
interacts with MMPs and it has been shown to mediate the expression and activity of MMP-1, -2, 
-3 and -9, and MT1-MMP and MT2-MMP (J. Sun and Hemler 2001; Weidle et al. 2010; Xiong, 
Edwards, and Zhou 2014; Nabeshima et al. 2006; Braundmeier et al. 2006; L. Chen, Belton, and 
Nowak 2009). Studies in breast cancer cell lines have indicated that homophilic basigin 
interactions play a pivotal role in MMP-1 and MMP-2 production and facilitate tumor invasion. 
This induction of MMP-1 and MMP-2 by basigin is dependent on proper glycosylation of the core 
protein since deglycosylated basigin fails to stimulate their production (J. Sun and Hemler 2001). 
A study on squamous cell carcinomas of the uterine cervix in humans reported that MMP-9 
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expression is stimulated by basigin and is strongly correlated to tumor invasion and metastasis 
(Weiwei et al. 2009). 
Studies have also shown that basigin is important in promoting tumor progression by 
stimulating angiogenesis (Muramatsu 2016). Changes in basigin expression affect vascular 
endothelial growth factor (VEGF) production at both the protein and RNA levels in human breast 
cancer cells. VEGF expression is increased when basigin is over-expressed and is inhibited when 
basigin is suppressed. In vivo, basigin overexpression promotes tumor angiogenesis and growth by 
inducing VEGF and MMPs expression in both human and mouse (Y. Tang et al. 2005). In another 
study, investigators showed that increased expression of basigin may enhance angiogenesis in both 
stromal fibroblasts and gastric carcinoma cells by upregulating MMPs and VEGF (H.-C. Zheng et 
al. 2006). 
In human glioblastoma U251 cells, downregulation of basigin resulted in reducing 
secretions of MMP2, MMP9 as well as VEGF, indicating a role of basigin in cancer cell 
angiogenesis and invasion (Liang et al. 2005). In human umbilical vein endothelial cells 
(HUVEC), basigin acts on stromal and tumor cell MMP production to stimulate angiogenesis 
(Caudroy et al. 2002). Studies also show that in endothelial cells, basigin upregulate hypoxia 
inducible factor-2α, VEGF2-2 and soluble forms of VEGF to directly regulate angiogenic process 
(F. Bougatef et al. 2009). Szubert et al also showed in the epithelial ovarian cancer patients, basigin 
and VEGF expression are both higher than the benign ovarian tumors and normal ovaries (Szubert 
et al. 2014). 
Another class of binding partners of basigin are the monocarboxylate transporters (MCTs). 
MCTs are a family of transporters involved in shuttling lactate, pyruvate and ketone across the 
plasma membrane and play an important role in metabolic homeostasis in diverse tissue and cell 
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types (Halestrap 2012). There are four isoforms of MCTs (MCT1-MCT4), each with distinct 
affinities for basigin. Studies have confirmed that basigin is a chaperone protein for MCT1 and 
MCT4 and is responsible for shuttling these MCTs to the cell membrane where they remain tightly 
bound to one another (Woodhead et al. 2000; Amit-Cohen, Rahat, and Rahat 2013; Gallagher et 
al. 2007). MCT1 and basigin co-localize and likely form a heterodimer. MCT1 preferentially binds 
to basigin; however, when basigin is absent, MCT1 can also bind to embigin, the founding member 
of this immunoglobulin family (Halestrap 2012). The association of basigin and MCT through the 
transmembrane domain is important in cells with a high glycolytic rate under hypoxic conditions, 
which leads to excessive lactic acid production such as in highly invasive tumors (F. Bougatef et 
al. 2009; L. Chen, Belton, and Nowak 2009). Such increase in glycolytic flux are also critical for 
rapidly proliferating cells in normal physiological processes such as embryo implantation and 
placental development. 
In addition to the MCTs, basigin also interacts with CD98 through its heavy chain. CD98 
directly associates with large neutral amino acid transporter 1 (LAT1) (K. Mori et al. 2004). 
Together with basigin, it forms a basigin-CD98-LAT1 supercomplex and is involved in regulating 
adhesion, amino acid transport and energy metabolism (D. Xu and Hemler 2005). Furthermore, 
the structure of basigin allows it to interact with other proteins for signal transduction and 
regulation of physiological functions. These proteins include integrin α3-β1 (Xin et al. 2016) and 
α6-β1 (J. Dai et al. 2009), caveolin-1 ( wei Tang et al. 2004) and cyclophilin A (Seizer, Gawaz, 
and May 2014).   
Mechanism of action of basigin   
Basigin acts through several different signaling pathways that tend to be cell type specific. 
Several studies have demonstrated that basigin acts through the MAP kinase pathway to activated 
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extracellular signal-regulated kinase (ERK)1/2 signaling (Boulos et al. 2006; Q.-Q. Li et al. 2007).  
For example, Belton et al. reported that basigin activated the ERK1/2 signaling pathway in uterine 
fibroblast cells leading to increased expression of MMPs-1, -2, and -3.  Knockdown of basigin 
expression using siRNA markedly reduced ERK signaling (Belton et al. 2008). The ERK signaling 
pathway is also involved in basigin mediated proliferation and invasion of gastric cancers (Xiong, 
Edwards, and Zhou 2014). 
Basigin also serves as a cell surface receptor for cyclophilin A (CyP-A) and is an essential 
component in the CyP-A-initiated signaling cascade that culminates in ERK activation 
(Vyacheslav Yurchenko et al. 2002). CyP-A is a ubiquitously expressed intracellular protein of the 
immunophilin family and plays a role in protein folding. Although initially discovered as a 
intracellular protein, CyP-A recently is found to be secreted from cells and functions in chemotaxis 
and cell signaling through its cellular receptor basigin (M. Li et al. 2006). Binding of CyP-A to 
basigin results in a pro-inflammatory response and agents targeting either basigin or CyP-A reduce 
the inflammation. Extracellular CyP-A and CyP-B stimulate ERK1/2 phosphorylation 
(Vyacheslav Yurchenko et al. 2001; V. Yurchenko et al. 2010).  
In addition, studies show that basigin is involved in the mitogen-activated protein kinases 
(MAPK) pathway (Sukhvinder S. Sidhu et al. 2004; Huang et al. 2008). Davidson et al reported 
that in metastatic serous ovarian carcinoma patients, basigin expression correlate strongly with 
MMP-1,-2, and -9 as well as p38, suggesting a link between MAPK signaling, MMP expression 
and basigin expression in vivo (Davidson, Givant-Horwitz, et al. 2003; Davidson, Goldberg, et al. 
2003). Basigin shed from lung carcinoma cell microvesicles utilizes the MAPK pathway to 
promote extracellular matrix degradation (Sukhvinder S. Sidhu et al. 2004). Studies have shown 
that basigin stimulates the production of MMP-1 through p38 MAP kinase in human lung 
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fibroblasts. Blocking p38 with an inhibitor significantly decreased the production of MMP-1 
induced by basigin (M. Lim et al. 1998).  
A number of reports have also confirmed that basigin may act via the phosphoinositide 3-
kinase (PI3K)-Akt signaling pathway (Yuan Wang et al. 2015; Y. Tang et al. 2006). In Kaposi’s 
sarcoma (KS), basigin is induced when treated with KS herpesvirus, which activates PI3K/Akt 
dependent secretion of VEGF (L. Dai et al. 2012). Overexpression of basigin in breast cancer cells 
stimulated phosphorylation of Akt and inhibition of basigin expression resulted in suppressed Akt 
phosphorylation (Y. Tang et al. 2006). Treatment of  lung fibroblast cells with recombinant basigin 
(rBASIGIN) resulted in phosphorylation of Akt kinase and an increase in VEGF production (J. 
Tang et al. 2008; Y. Tang et al. 2006). Both the activation of Akt kinase and the induction of VEGF 
were specifically inhibited with a neutralizing antibody to basigin. The PI3K-specific inhibitors 
Wortmannin and LY294002 also inhibited VEGF production by basigin-overexpressing cells in a 
dose- and time-dependent manner (J. Tang et al. 2008; L. Dai et al. 2012). 
  Basigin also forms complexes with α3β1 and α6β1 integrins promoting cell-cell 
interactions (Berditchevski et al. 1997). In cancer cells, this basigin-integrin interaction activates 
the focal adhesion kinase (FAK)-PI3K signaling pathway. This cooperates with Src family kinase 
activation and stimulates production of MMPs which promote cancer invasiveness (J. Tang et al. 
2008; Yuan Wang et al. 2015). β1 integrins also form complexes with basigin and CD98 and play 
a role in MMP production (Grass and Bryan 2016). 
Several studies have also shown that basigin is involved in the Wnt/β-catenin signaling 
pathway (Hasaneen et al. 2016; Knutti, Huber, and Friedrich 2019). Increasing basigin levels in 
lung tumor epithelial cells led to an increase in the metastatic potential of lung cancer cells through 
upregulation of Wnt/β-catenin signaling (S S Sidhu et al. 2010). Moreover, silencing of basigin 
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using shRNA significantly blocked this signaling pathway and inhibited cell migration, 
proliferation and tumor growth (S S Sidhu et al. 2010). Furthermore, overexpression of basigin 
also increases cell proliferation and migration in lung fibroblasts and promotes resistance to 
apoptosis by activating β-catenin/canonical Wnt signaling pathway (Hasaneen et al. 2016). In 
MCF-7 breast carcinoma cells, basigin promotes cancer cells proliferation by stimulating the 
Wnt/β-catenin  target protein MMP-14 (Knutti, Kuepper, and Friedrich 2015). Basigin also 
influences the malignancy-related properties of the breast cancer cells through both Wnt/β-catenin 
and JAK/STAT pathways (Knutti, Huber, and Friedrich 2019). 
Basigin also regulates nuclear factor kappa-light-chain-enhancer of activated B cells 
(NFκB) pathways (C. Wang et al. 2017; R. Jin et al. 2017). In mouse testis and spermatocyte cell 
line, basigin reduces apoptosis in spermatocytes by modulating the NFκB pathway. Knockout of 
basigin leads to apoptosis through extrinsic apoptotic pathway, suppression of canonical NFκB 
signaling and downregulation of TRAF2 and results in infertility in mice (C. Wang et al. 2016). In 
human cytomegalovirus infection, knockdown of basigin significantly downregulate NFκB and 
IFN-β pathways (J. Chen et al. 2017). 
Overall, basigin plays important roles in inducing production of MMPs and VEGF, which 
promotes cell proliferation and survival, stimulate tissue remodeling and angiogenesis through the 
PI3K, ERK/AKT, FAK, Wnt/β-catenin and NFκB pathways. 
Role in Female Reproduction 
a) Basigin in the ovary 
Expression of basigin in the ovary was confirmed in several earlier papers with somewhat 
conflicting findings.  Kuno et al. (1998) determined that expression of Bsg mRNA was present in 
the cumulus granulosa cells and at a low level in the corpora lutea and ovarian stroma in mice. We 
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observed similar expression patterns in cycling mice, with basigin being expressed only in the 
endothelial cells of the corpora lutea (L. Chen et al. 2010b). Chang and coworkers (2004) reported 
that basigin was expressed in the corpora lutea during early gestation (days 1-3) but subsequently 
disappeared thereafter in Kunming White outbred mice.  Smedts and colleagues ( 2006) carried 
out a more detailed analysis of expression patterns in the rat ovary during specific functional stages 
of follicular development, follicular rupture and corpus luteum formation.  They reported that Bsg 
expression was present in developing follicles from 1-48 hours after eCG stimulation in the theca 
and granulosa cells.  Expression persisted following ovulation in the pseudopregnant females in 
the functional corpora lutea but declined as luteal regression occurred. In cycling rats, Bsg mRNA 
was localized to the theca cells of preovulatory follicles and newly forming corpora lutea in cycling 
rats. Expression of basigin was also assessed in human ovaries (Smedts et al. 2006).  Basigin 
mRNA and protein were detected in granulosa cells in follicles at all stages of development and in 
the corpora lutea.  Basigin expression does not appear to be estrogen dependent in the mouse ovary 
as expression is not altered in estrogen receptor-α or estrogen receptor-β knockout mice (L. Chen 
et al. 2010b). 
While expression of basigin has been confirmed in the ovaries of several species, a specific 
function for basigin in the ovary has not yet been identified.  The original publications reporting 
the phenotypic effects of loss of basigin expression on reproductive function in female mice noted 
that  although loss of basigin appeared to greatly impact embryo implantation, ovarian morphology 
and function appeared to be normal (Tadahiko Igakura et al. 1998; Kuno et al. 1998) Similar 





b) Basigin in the endometrium: importance in implantation 
Basigin is expressed in the uterus and appears to play an important role during embryo 
implantation. Very interestingly, both embryonic and uterine expression of basigin are needed for 
successful implantation. Igakura et al. (1998) and Kuno et al. (1998) first reported that Bsg null 
mutant embryos develop normally to the blastocyst stage, but very few of these blastocysts implant 
successfully in the uterus of heterozygous mothers. The vast majority of null mutant embryos are 
lost between days 4.5 and 7.5 of gestation with only 1-3% of Bsg null embryos born as viable pups.  
In vitro trophoblast outgrowth assays with Bsg null mutant blastocysts determined that these 
blastocysts undergo outgrowth comparable to wild type blastocysts (Tadahiko Igakura et al. 1998).  
This suggests that Bsg null embryos may have defects in activation or attachment. 
Adult female Bsg null mice are infertile, and the cause of the infertility appears to be a 
uterine endometrium that is not permissive for embryo implantation (Tadahiko Igakura et al. 1998; 
Kuno et al. 1998).  Embryo transfer experiments in wild type and Bsg null mutant adult female 
mice demonstrated that when wild type embryos were transferred into the uteri of Bsg null mutant 
females, less than 5% were successfully born as pups, compared to over 40% for embryos 
transferred into wild type females.  Due to the high rate of embryonic lethality in Bsg null mutant 
embryos, very few reach adulthood and are available for fertility studies.  This has made 
investigation of the role of basigin in endometrial remodeling and decidualization quite difficult.  
Studies in the mouse have shown that basigin is expressed in the uterus during the estrous 
cycle and early pregnancy and expression is regulated by ovarian steroid hormones (Xiao et al. 
2002; L. Chen, Belton, and Nowak 2009). Basigin expression in the uterine epithelium is 
dependent on estrogen and estrogen receptor α (L. Chen et al. 2010b). Basigin is strongly expressed 
within the luminal and glandular epithelial cells on days 1 and 2 of gestation, but levels decline 
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over the following two days. Expression in the uterine stromal cells is upregulated by progesterone, 
becoming detectable on day 3 of gestation and rapidly increasing at day 4 (Tadahiko Igakura et al. 
1998; Xiao et al. 2002; L. Chen, Belton, and Nowak 2009). On day 5, when the stromal cells 
surrounding the invading embryo begin to undergo decidualization, intense basigin expression is 
evident. On day 6, basigin expression disappears in the secondary decidual zone, but strong basigin 
expression is still detected in the deep undifferentiated stromal cells. By days 7 and 8, as the 
number of decidual cells increases, basigin expression is reduced (L. Chen, Belton, and Nowak 
2009).  
Basigin is also present in the human endometrium where its expression is menstrual-cycle 
dependent (Noguchi et al. 2003; Braundmeier, Fazleabas, and Nowak 2010). 
Immunohistochemical analysis of basigin protein expression showed that uterine epithelial cells 
and stromal fibroblasts display significantly different patterns of expression throughout the 
menstrual cycle. Basigin protein levels in uterine epithelial cells was strongest during the 
proliferative phase, when estrogen and progesterone receptors are maximally expressed in these 
cells. Basigin expression then decreased in epithelial cells during the secretory and menstrual 
phases in parallel with a loss of estrogen and progesterone receptor expression. The expression 
pattern in stromal fibroblast cells was more complicated, showing a slow spread of basigin 
expression from the luminal toward the basal layers of the endometrium during the secretory phase. 
At menstruation, there was a high level of immunoreactivity for basigin throughout the entire 
endometrial stroma. Thus, in contrast to uterine epithelial cells, fibroblasts show increased 
expression of basigin during the secretory phase when progesterone and progesterone receptor 
levels are high (Braundmeier et al. 2006).  Noguchi et al. (Noguchi et al. 2003)  did not detect any 
immunoreactivity for basigin in luminal epithelial cells at any time throughout the menstrual cycle 
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but this may be due to differences in antibody sensitivity between the different studies.  Basigin 
expression has also been confirmed in the endometrium of baboons (Braundmeier, Fazleabas, and 
Nowak 2010) and in both the caruncular and intercaruncular endometrium of pregnant cows 
(Mishra et al. 2012).  A recent report from Turgut et al. (Turgut et al. 2014) determined that 
expression of basigin was significantly lower during the luteal phase in the uterine endometrium 
of women experiencing multiple implantation failures after IVF in comparison to women with 
normal fertility.  These results also support an important role for basigin during embryonic 
implantation. 
Several in vitro studies have investigated the functional role of basigin in endometrial cells. 
Treatment of human uterine stromal cell cultures with recombinant basigin protein stimulated 
production of specific MMPs, including MMPs-1, -2, and-3 in human cells (Braundmeier et al. 
2006; Belton et al. 2008; Braundmeier et al. 2012) and MMPs-3 and -9 in mouse stromal cells (L. 
Chen, Belton, and Nowak 2009).  Belton et al. (Belton et al. 2008) reported that basigin stimulated 
secretion of MMPs by human uterine stromal cells through homophilic binding of recombinant 
basigin protein with basigin protein in the plasma membrane.  This homophilic binding led to 
activation of the ERK1/2 signaling pathway. Basigin is shed by human uterine epithelial cells in 
microvesicles (Braundmeier et al. 2012) and thus one can envision local regulation of MMP 
production within the endometrium through paracrine communication between endometrial 
epithelial and stromal cells (Braundmeier et al. 2012). 
c) Basigin in the developing conceptus and placenta 
Basigin is expressed in preimplantation mouse and human embryos as early as the 2-cell 
stage of development and is expressed in both the inner cell mass and trophectoderm of mouse 
blastocysts (Tadahiko Igakura et al. 1998; Ding, He, and Yang 2002; L. Chen et al. 2007; Hérubel 
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et al. 2002). Expression of basigin mRNA is highest in the oocyte, morula and blastocyst stages 
(Ding, He, and Yang 2002). A very recent study by Lindgren et al. (Lindgren et al. 2018) reported 
that human preimplantation embryos secrete basigin and that embryos that developed into 
blastocysts secreted more basigin than arrested embryos. Most Bsg KO mouse embryos are lost 
before day 6 of gestation with only about 1-2% of null mutant embryos surviving to birth (Kuno 
et al. 1998; Tadahiko Igakura et al. 1998). Basigin expression in the embryo is therefore critical 
for successful implantation and may play a role in embryo metabolism through its effects on MCTs 
or on embryo attachment to the uterine epithelium. 
Basigin expression in placental trophoblast cells was first confirmed in human term 
placenta (W. Li, Alfaidy, and Challis 2004; Yong-qing Wang et al. 2006) and expression was 
found to be lower in placentas of patients with preeclampsia (Yong-qing Wang et al. 2006).  More 
recent studies reported that basigin is expressed in placental trophoblast and endothelial cells 
throughout gestation in the mouse (Nagai et al. 2010) and rat (Dang et al. 2013).  An elegant study 
by Lee et al. (C. L. Lee et al. 2013) examined expression of basigin in the human placenta during 
the first trimester and performed a number of functional studies using human primary 
cytotrophoblast cells and the BeWo choriocarcinoma cell line to investigate the function of basigin 
in the placenta.  Basigin expression was evident in all the first trimester placental samples. 
Functional studies using a siRNA knockdown approach determined that loss of basigin expression 
reduced trophoblast-endometrial cell interaction, trophoblast cell invasion and syncytialization, 
and suppressed production of MMPs -2 and -9 and urokinase plasminogen activator by trophoblast 
cells. Thus basigin regulates several important physiological functions during placental 
development and differentiation.   
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Trophoblast cells as well as other cells of the placenta are known to shed microparticles 
(now referred to as extracellular vesicles or EVs) that consist of both microvesicles and exosomes 
throughout pregnancy (VanWijk, Svedas, et al. 2002; VanWijk, Boer, et al. 2002; Meziani et al. 
2006; Shomer et al. 2013). These EVs, isolated from the blood of pregnant women, are increased 
in women with preeclampsia (VanWijk, Svedas, et al. 2002; Meziani et al. 2006). Several groups 
have reported that EVs from blood plasma of pregnant women with preeclampsia have marked 
negative impacts on vascular endothelial cells and trophoblast cell function when compared to EVs 
isolated from plasma of women with normal healthy pregnancies (VanWijk, Svedas, et al. 2002; 
VanWijk, Boer, et al. 2002; Meziani et al. 2006; Shomer et al. 2013). EVs from preeclamptic 
pregnancies increased trophoblast cell apoptosis and inhibited migration, suppressed endothelial 
cell migration and tube formation, and negatively affected vascular contractility (VanWijk, Boer, 
et al. 2002; Meziani et al. 2006; Shomer et al. 2013). Romao et al. recently reported that basigin 
levels were higher in the blood of women diagnosed with preeclampsia compared to women with 
normal healthy pregnancies (Romão et al. 2014).  Basigin is shed in microvesicles by tumor cells 
(Sukhvinder S. Sidhu et al. 2004) and uterine cells (Braundmeier et al. 2012; Burnett et al. 2012). 
Whether basigin is shed in EVs by cell of the placenta and how it may contribute to the regulation 
of trophoblast cell and vascular function during pregnancy is not currently known but deserves 
further investigation. 
Basigin is also expressed in the extraembryonic membranes particularly in the amniotic 
epithelium. Significantly elevated expression of basigin was noted in the amnion of patients with 
premature rupture of membranes at term labor along with higher levels of MMPs (Sukhikh et al. 




d) Basigin in uterine reproductive diseases 
In the normal, healthy uterus basigin is expressed both in the endometrium and in the 
myometrium.  Several studies have investigated whether basigin expression is altered in two 
common uterine diseases in women, uterine leiomyomas and endometriosis. Reports from Ozler 
et al., (Ozler et al. 2014) and Kefeli et al. (Kefeli et al. 2016) confirmed that basigin is expressed 
in the smooth muscle cells of most leiomyoma tumors and expression is positively correlated with 
Ki67 expression and mitotic index.  Interestingly, malignant leiomyosarcomas showed much 
higher expression than leiomyomas suggesting that basigin may be a useful prognostic marker for 
patients with leiomyosarcoma.  Cell culture studies using primary cultures of leiomyoma-derived 
smooth muscle cells showed that the progesterone receptor modulator asoprisnil (CDB-2914) 
induced expression of basigin in smooth muscle cells leading to increased production of MMPs 
and a reduction in collagen synthesis (Q. Xu et al. 2008; Akira et al. 2008).  These effects of 
asoprisnil were not observed in cultured myometrial smooth muscle cells but may be due to the 
differential responsiveness of the two smooth muscle cell types to progesterone receptor 
modulators. 
Expression of basigin is upregulated in endometriotic lesions in women (Braundmeier et 
al. 2006; Smedts et al. 2006; A. Jin et al. 2014) and also in baboons (Braundmeier, Fazleabas, and 
Nowak 2010).  Levels of expression were highest in lesions of baboons at early stages of the 
disease (1-3 months) and decreased in later stages of disease progression (9-15 months).  Cell 
culture studies with immortalized endometriotic cell lines determined that basigin is an important 
anti-apoptotic factor, protecting endometriotic cells from apoptosis through upregulation of Bcl-2 
via the ERK signaling pathway (A. Jin et al. 2014; C. Wang et al. 2015).  Inhibition of basigin 
expression in endometriotic cells markedly reduced migration as well.  The increased levels of 
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basigin expression in endometriotic lesions appear to be regulated through increases in 
prostaglandin E2 production.  Treatment of cultured immortalized endometriotic cells with 
specific inhibitors of the prostaglandin E receptors EP2 and EP4 reduced basigin expression in 




In mammalian species, a new life begins at fertilization when an egg meets a sperm 
(Wassarman 1999). The zygote then undergoes a few rounds of cell division to form a blastocyst, 
which is composed of two cell types: the trophectoderm and the inner cell mass (Rossant 2016). 
After hatching from the zona pellucida, the blastocyst will attach to the uterine endometrium, then 
invade into the stroma and establish the placenta. This process is known as implantation and it is 
a dynamic event that involves a series of physical and physiological interactions between the 
implanting blastocyst and the receptive uterus (H. Wang and Dey 2006). Implantation requires a 
complex two-way cross talk between the embryo and the maternal endometrium, and a variety of 
genes and molecules have been identified to play a role in this process. These genes and molecules 
include steroid hormones, cytokines, homeobox transcription factors and developmental genes 
(Tranguch et al. 2005; Dimitriadis et al. 2005a; Benson and et al. 1996; B C Paria et al. 2001). 
There are three processes during implantation: uterine receptivity, blastocyst attachment and 
invasion, and decidualization (H. Wang et al. 2013). In this chapter, a detailed literature review 
on these three processes, as well as hormonal profile in early pregnancy and important signaling 
pathways will be provided. Proper implantation is critical for successful pregnancy, and 
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perturbations can generate adverse outcomes for subsequent development and lead to loss of the 
pregnancy (Q. Chen et al. 2011).  
 
Hormonal Profile in Early Pregnancy and Uterine Receptivity 
In most mammals, implantation occurs in a fixed interval of time after ovulation (Finn and 
Martin 1974). In humans, it is during the luteal phases; in mice, it is in the diestrus of the estrous 
cycle. It is well known that estrogen and progesterone are the main hormones in this process 
(Hantak, Bagchi, and Bagchi 2014). Similar to humans, the uterine tissue of mice consists of three 
major layers, the outer myometrial layer, the inner luminal epithelium and the stromal layer in 
between (H. Wang and Dey 2006). During the pre-implantation period, the uterus needs to undergo 
a series of changes to prepare for the attaching embryo. The hormonal profile of both species has 
been well studied and the estrogen and progesterone act in concert to orchestrate these changes 
(Pawar et al. 2014).   
The hormonal profile and the physiological changes in the uterus in early pregnancy in 
mice are shown in Figure 2.3. Estrogen levels increase in mice starting on day 1 of pregnancy and 
stimulate extensive proliferation of the luminal epithelium. This is mediated by stromal estrogen 
receptor α (ERα) (Winuthayanon et al. 2010). As pregnancy progresses, progesterone levels begin 
to rise and lead to a cessation of epithelial proliferation. On day 4 of pregnancy, the uterus enters 
the pre-receptive stage, where the uterine epithelial cells lose polarity and the plasma membranes 
of the epithelial cells become smooth and flattened to be receptive to the blastocyst (Tranguch et 
al. 2005). In mice, nidatory estrogen activation of uterine receptivity opens the implantation 
window and starts the implantation process (Yamada et al. 2014). Without this estrogen surge, the 
embryo will be dormant and free-floating in the uterus. At the same time, the underlying stromal 
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cells begin to proliferate under the influence of rising progesterone produced by the newly formed 
corpora lutea under a hypoxic condition (Harvey 2007). The uterus is only receptive to the 
blastocyst during a restricted period when its environment is favorable for implantation. This 
narrow receptive time is referred to as the implantation window. In mice, it is limited to the 
afternoon of day 4 of pregnancy (H. Wang and Dey 2006). In the pre-receptive stage (day 1-3), 
the uterus cannot initiate implantation before this time. After the receptive stage (day 5 and 
onward), the uterus enters a refractory stage spontaneously and the uterine environment is not 
receptive for blastocyst attachment (Carson et al. 2000b). In humans, the proliferative phase is 
under the influence of rising estrogen from growing antral follicles, resulting in proliferation of 
the epithelium, stroma and vascular endothelium to regenerate the endometrium. At midcycle, a 
surge of luteinizing hormone leads to ovulation on day 14. In secretory phase, the endometrium 
thickens and the corpus luteum forms and secretes progesterone in preparation for implantation. 
At this time, glands become secretory and stromal cells differentiate to decidual cells (Cha, Sun, 
and Dey 2012). In humans, the implantation window is between days 6 to 10 after ovulation (Bruce 
A. Lessey 2011). To some extent, the implantation window is flexible and can be modified by 
hormones. In mice, for example, with progesterone supplementation, blastocysts are able to initiate 
the attachment reaction in the non-receptive uterus when transferred on day 5 of pseudo-pregnancy 
(Song, Han, and Lim 2007) 
In addition to steroid hormones, many genes are required for normal implantation, such as 
cytokines, homeobox transcription factors and developmental genes. The IL-6 family of cytokines 
is of great importance during embryo implantation (Dimitriadis et al. 2005a). The IL-6 family 
includes cytokines such as LIF, IL-6, and IL-11 that all signal through gp130 and mediate the 
activation of STAT3 (Pawar et al. 2013). LIF deficient mice experience implantation failure and 
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supplementation with LIF rescues this defect (J. R. Chen et al. 2000). The importance of LIF 
signaling in implantation is supported by studies that blocking its downstream targets gp130 and 
STAT3 also leads to implantation failure (Menkhorst et al. 2011). IL-6 is also required for normal 
implantation as studies show mice lacking IL-6 failed to undergo implantation (Dimitriadis et al. 
2005b).  
Homeobox genes are a group of conserved transcription regulators that are important for 
embryonic morphogenesis and development (Kwon and Taylor 2004). Homeobox A genes 
Hoxa10 and Hoxa 11 are expressed in uterine stromal cells during receptivity and decidualization 
in mice (Bagot, Kliman, and Taylor 2001). Studies have shown that both Hoxa10 and Hoxa11 
mutant mice are infertile due to failed implantation (Rahman et al. 2006; HS Taylor 1999). Non-
classical Hox genes may also play a role during implantation as deletion of H6 homeobox in mice 
causes implantation defects (Weidong Wang, Van De Water, and Lufkin 1998). Another 
homeobox gene, Msx1, is transiently expressed in the luminal and glandular epithelium during the 
implantation window but is downregulated after the completion of receptivity. Conditional 
knocking out of uterine Msx1 leads to compromised implantation and the double knockout of 
Msx1 and Msx2 leads to complete implantation failure  and infertility (Nallasamy et al. 2012; 
Daikoku 2011).  
There are also developmental genes that are critical for uterine receptivity and 
implantation, and some examples are Indian hedgehog (IHH), bone morphogenetic proteins 
(BMPs), Wingless-type MMTV integration site family members (WNTs) and their receptors (B C 
Paria et al. 2001). IHH is part of the hedgehog family which controls cell proliferation, 
differentiation and cell to cell interactions in many biological processes (Q Wei 2010). In the 
uterus, IHH is expressed in the luminal epithelium under the influence of progesterone, and its 
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effectors are expressed in the stroma (H Matsumoto 2002). Conditional deletion of IHH in the 
uterus results in failed implantation because the mice lack progesterone-facilitated stromal cell 
proliferation (Franco et al. 2010). BMPs are morphogens belonging to the transforming growth 
factor-β (TGF-β) superfamily and several BMPs are expressed in the uteri of mice (Ying and Zhao 
2000; Zamani and Brown 2011). BMP2 is responsive to progesterone and knockout out of BMP2 
or its mediator proprotein convertase 6 (PC6) leads to infertility in mice due to defects in 
implantation and decidualization (K. Y. Lee et al. 2007; Q. Li et al. 2007). WNT4, a downstream 
target of BMP2, is expressed mainly in the luminal epithelium before implantation and in the 
stromal cells later surrounding the implanting embryo (Hayashi et al. 2009). Conditional knockout 
of WNT4 in the uterus causes subfertility in mice due to compromised implantation and 
subsequently impaired decidualization (Franco et al. n.d.). 
 
Blastocyst Attachment and Invasion 
During embryo implantation, a series of physical and physiological interactions happen 
between the blastocyst trophectoderm and endometrial cells such as luminal and glandular 
epithelial cells and stromal cells (H. J. Lim, Dey, and Lim 2009). The embryo goes through three 
stages during implantation: apposition, adhesion/attachment, and penetration (Schlafke, Welsh, 
and Enders 1985).  During apposition, the trophectoderm comes into close proximity with the 
luminal epithelium. Upon uterine lumen closure, firm attachment between the trophectoderm and 
luminal epithelium is initiated through adhesion molecules. After the attachment reaction, the 
embryo initiates penetration through the luminal epithelium and invades into the underlying 
stromal cells (Carson et al. 2000a). This process also involves breakdown of the epithelium and 
the basement membrane, which is mediated by MMPs (Rashid et al. 2011). 
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In mice, uterine luminal fluid serves as a medium for transporting the preimplantation 
embryos into the uterine horn, and then on day 4 of pregnancy, the uterine luminal fluid is 
absorbed. This leads to luminal closure, which assists the blastocyst to position in the uterine cavity 
in intimate contact with the luminal epithelium (H. Wang et al. 2013).  Ovarian estrogen stimulates 
fluid secretion, while progesterone triggers fluid absorption before implantation, and these actions 
occur through two ion channels, the cystic fibrosis transmembrane conductance regulator (CFTR) 
and the epithelial Na+ channel (ENaC) (Salleh et al. 2005). CFTR is a cAMP-activated Cl- channel 
expressed in the apical membrane of endometrial epithelial cells. ENaC is expressed in the stromal 
cells (Chan et al. 2002). Estrogen stimulates CFTR expression and represses ENaC expression, 
which leads to fluid accumulation in the uterine lumen. On the other hand, progesterone induces 
ENaC expression and inhibits CFTR expression, which results in absorption of the luminal fluid 
and luminal closure (Nobuzane, Tashiro, and Kudo 2008; X.-Y. Zheng, Chen, and Wang 2004). 
Studies have shown that in mice, inflammation-induced upregulated expression of CFTR results 
in abnormal uterine fluid accumulation and implantation failure (He et al. 2010). The blastocyst at 
the time of invasion can release trypsin to activate ENaC and a study found activation of ENaC is 
required for normal uterine fluid absorption and implantation (Ruan et al. 2012). Thus CFTR and 
ENaC provide a mechanism explaining how uterine fluid absorption is achieved to assist in uterine 
closure and blastocyst apposition. 
Blastocyst attachment is essentially the interaction between the trophectoderm and the 
uterine epithelium, and adhesion molecules are involved in this process. Studies have identified 
that certain adhesion molecules, such as integrins, selectins and cadherins play important roles in 
blastocyst attachment (Armant 2011; Kimber and Spanswick 2000; H. Singh and Aplin 2009a). 
Integrins are a group of adhesion molecules that bind to the arginine-glycine-aspartic acid (RGD) 
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sequences of the extracellular matrix components such as fibronectin, osteopontin and vitronectin 
(Campbell et al. 1995). Many integrins play a role in implantation, including α1β1, α3β1, α6β1, 
αvβ1, αvβ3, αvβ5 and αvβ6 (H. Singh and Aplin 2009b). Among these integrins, the β3 subunit is 
most broadly studied in mice and human. Integrin αvβ3 is expressed in mice in luminal epithelium 
during implantation, and injection of neutralizing antibody against the αv or β3 subunit reduces 
the implantation rate, suggesting its role in facilitating trophectoderm and luminal epithelium 
interaction (Illera et al. 2000). Similarly in human, the β3 subunit is strongly expressed in the 
luminal and glandular epithelium during the mid-secretory phase and abnormal expression of β3 
integrins leads to recurrent pregnancy loss and infertility (B. A. Lessey et al. 1995).  
L-selectin is a carbohydrate-binding protein and is thought to mediate the adhesion of the 
blastocyst to the luminal epithelium in human (B. Wang et al. 2008). L-selectin is expressed in the 
human trophoblast and blocking of L-selectin with specific neutralizing antibodies results in 
defective adhesion of trophoblasts to the epithelium (Genbacev 2003). The expression of L-
selectin ligand in the endometrium is significantly lower in infertile patients compared to fertile 
women, and reduced expression of L-selectin ligands lowers implantation success rates (Margarit 
et al. 2009; Shamonki et al. 2006). E-cadherin is a Ca2+-dependent transmembrane protein that 
forms adhesion junctions between cells (Wesseling, Van Der Valk, and Hilkens 1996). On the 
embryo side, E-cadherin is required for blastocyst formation as blastocysts deficient in E-cadherin 
fail to form adhesion junctions in the trophectoderm and die before implantation (de Vries et al. 
2004). On the maternal side, E-cadherin is expressed in the luminal epithelium prior to 
implantation, but expression is lost during implantation and transiently appears in the stromal cells, 
suggesting the importance of luminal epithelial cell remodeling to assist in blastocyst attachment 
and invasion into the stroma (Bibhash C. Paria et al. 1999; Q. Li et al. 2002). Persistent expression 
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of E-cadherin results in implantation failure due to impaired epithelial cell remodeling to support 
the blastocyst (Nallasamy et al. 2012). Mice lacking E-cadherin in the uterus also have failed 
implantation and decidualization because they cannot form adhesion junctions and tight junctions 
in the luminal epithelium (Reardon et al. 2012). Together, these data suggest embryonic and 
endometrial E-cadherin is critical for normal implantation. 
 
Decidualization and Associated Signals 
Decidualization is a unique process in human and rodents. During decidualization, the 
uterine stromal cells surrounding the implanting blastocyst undergo a dramatic transformation to 
form decidua to support embryo growth and maintain early pregnancy (Ramathal et al. 2010). 
Similar to humans, the stromal cells at the implantation site undergo extensive proliferation and 
then differentiation into large, multinucleated decidual cells in response to implantation in mice 
(Ramathal et al. 2010; H. J. Lim and Wang 2010). The differentiating stromal cells form an 
avascular primary decidual zone (PDZ) that first encases the embryo on day 5 of pregnancy (X. 
Wang et al. 2004). Then the adjacent stromal cells continue to proliferate and differentiate into a 
well-vascularized secondary decidual zone (SDZ). Decidualization is precisely controlled by 
hormones, epithelial cell secreted factors, cell cycle regulators and immune cells (Conneely, 
Mulac-Jericevic, and Lydon 2003; Wetendorf and DeMayo 2012; Das 2009; Croy et al. 2012). 
Studies have suggested important functions of decidualization including providing nutrition to the 
developing embryo, establishing a barrier for uncontrolled trophoblast invasion, protecting the 
embryo from the maternal immune system, and synthesizing hormones prior to the formation of a 
functional placenta. It is widely accepted that a fully developed decidua is a prerequisite for 
successful implantation (Peng et al. 2008; X. Wang et al. 2004; Welsh and Enders 1987).  
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During implantation, luminal epithelial cells undergo apoptosis at the site of embryo 
attachment and assist embryo invasion to access the maternal blood supply (Pampfer and Donnay 
1999). At the same time, the luminal epithelial cells also secrete signals to facilitate 
decidualization. For example, KLF5 is a transcription factor containing a zinc finger that is 
expressed in the luminal epithelium during implantation (Ema et al. 2008). Knockout of KLF5 in 
mice leads to implantation failure and defective decidualization (X. Sun et al. 2012). IHH is 
expressed in the luminal epithelium and IHH null mice are infertile due to failed implantation as 
well as failed decidualization in response to an artificial stimulus (K. Lee et al. 2006). Mice with 
deletion of IHH’s receptor Ptch1 and downstream effector Gli1-3 and COUP-TFII in the stromal 
cells also have decidualization failure (K. Lee et al. 2006; Kurihara et al. 2007). These data suggest 
the epithelial cells produce important paracrine factors to act on the stromal cells for normal 
implantation and decidualization. 
One of the characteristics of decidualization is the formation of polyploid cells and this 
requires the action of cell cycle regulators (Dey et al. 2004). Cyclin D3 is important for stromal 
cells proliferation, differentiation and polyploidy and knockout of cyclin D3 leads to failed 
decidualization in mice (Das 2009). Moreover, mice deficient in Hoxa10, a cyclin D3 effector, 
exhibits defective decidualization (Rahman et al. 2006). Knocking out of the upstream regulator 
of Hoxa10, basic transcription element-binding protein 1 (BTEB1), also results in decidualization 
failure and subfertility in mice (Simmen et al. 2004). Death effector domain-containing protein 
(DEDD) stabilizes cyclin D3 and ablation of DEDD  leads to attenuated polyploidy and impaired 
decidualization (M. Mori et al. 2011). These results together support cyclin D3’s central role in 
the process of decidualization. In addition to cyclin D3, other cell cycle related genes have been 
shown to regulate the decidual response. For instance, stromal cells in mice lacking hepatoma 
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upregulated protein (Hurp) are unable to decidualize and this results in infertility (Tsou et al. 2003). 
Transcription factor CCAAT enhancer-binding protein beta (CEBPβ) is expressed at high levels 
in the stromal cells surrounding the implanted blastocyst during decidualization and is involved in 
the Cyclin E-cdk2 and STAT3 pathway. When CEBPβ is ablated in the uterus, mice completely 
fail decidualization and are infertile (Bagchi et al. 2006; Ramathal et al. 2011). 
The decidua serves as an immune privileged site for the implanted blastocyst because it is 
genetically foreign to the maternal immune system. The primary decidual zone is avascular and 
composed of layers of semi-epithelialized stromal cells to set a physical barrier for the maternal 
immune components (X. Wang et al. 2004). A number of genes have been identified to participate 
in immune tolerance during decidualization to protect the embryo (Yoshinaga 2012; Taglauer, 
Adams Waldorf, and Petroff 2010). For instance, programmed death ligand 1 (PDL1) is an 
inhibitory T cell costimulatory protein that is important in regulating the immune response in many 
systems (Khoury and Sayegh 2004). Expression of PDL1 is restricted to the decidua basalis, 
suggesting PDL1’s role in the maternal alloimmune response (Guleria et al. 2005). Blocking of 
PDL1 signaling with antibody results in significantly higher T cell-dependent fetal rejection. 
Female mice with PDL1 ablation also have a much lower rate of allogeneic fetal survival (Guleria 
and Sayegh 2007). Galectins (Gal) are a member of the β-galactoside-binding lectin family and 
play a role in immune response by regulating the proliferation and survival of T cells (Rabinovich 
et al. 2007). Gal1 is expressed in the mouse uterus during implantation and can induce cell death 
of T cells (Hirota et al. 2012). Female mice that lack Gal1 have a higher rate of fetal loss on 
gestational day 13 when mated with allogeneic males (Blois et al. 2007). Ablation of Gal1’s 
upstream regulator FK506 binding protein 4 (Fkbp52) in mice also results in a higher rate of fetal 
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resorption (Hirota et al. 2012). Collectively, these results suggest the importance of immune-
regulating genes in supporting normal decidualization and pregnancy. 
 
Steroid Hormones, Receptors and Related Signaling Pathways 
Ovarian estradiol and progesterone are the principal hormones regulating implantation. 
Progesterone is essential for implantation and maintenance of pregnancy in all mammals studied, 
thus it is also called the “pregnancy hormone”, whereas the requirement for estrogen is species 
specific (Dey et al. 2004). The uterine effects of estrogen and progesterone are carried out though 
their nuclear receptors ERα, ERβ, PRα and PRβ. Many studies have focused on the role of these 
receptors in implantation and have revealed that ERα null uteri are unable to support implantation, 
whereas ERβ null uteri still allow normal implantation to occur (Red-Horse et al. 2004). 
Progesterone administration is sufficient to induce decidualization in ERα null mice, indicating 
that ERα may be essential for blastocyst attachment, but not for later decidualization (Curtis et al. 
1999). Mice that lack PRα and PRβ have shown many defects in reproductive functions, but these 
functions are all normal in mice lacking only PRβ, which indicates that progesterone actions are 
primarily mediated by PRα (Mulac-Jericevic et al. 2000). Mice lacking PR exclusively in the 
epithelium are infertile and show persistent proliferation of the luminal epithelium (Franco et al. 
2012). Another study demonstrated a role of PR in the transition of the uterine epithelium from a 
proliferative to receptive state (Hamatani et al. 2004). Estrogen and progesterone coordinate 
uterine functions through multiple paracrine, juxtacrine and autocrine factors in a spatiotemporal 
manner (Cha, Sun, and Dey 2012). This requires a signaling network that involves cytokines, 
homeotic proteins, morphogens and transcription factors (Xie 2007). Some examples of signals 
communicating between the epithelial cells and stromal cells are reviewed here.  
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Leukemia inhibitory factor (LIF) is a very well characterized paracrine factor of epithelial 
cell origin that regulates implantation (Hamatani et al. 2004). It is a secreted cytokine belonging 
to the interleukin (IL-6) family. LIF binds to cell surface LIF receptor, triggers its interaction with 
the signal transducer glycoprotein 130 (GP130, which then activates Janus Kinase (JAK), and 
mediates the phosphorylation and activation of the transcription factor signal transducer and 
activator of transcription 3 (STAT3) (Yang et al. 1995). LIF is expressed predominantly in the 
glandular epithelium on day 4 of pregnancy and LIF null mice are infertile due to impaired 
implantation and decidualization (Bhatt, Brunet, and Stewart 1991). In the absence of LIF, the 
transactivation and nuclear localization of STAT3 is lost, which is required for implantation 
(Catalano et al. 2005). Loss of LIF-STAT3 signaling leads to undifferentiated uterine luminal 
epithelium that is not receptive to the embryo (Pawar et al. 2013). Studies have shown that PR 
interacts directly with STAT3 during the peri-implantation phase and PR and STAT3 act in concert 
to regulate a subset of progesterone responsive genes that are critical for decidualization (Jae Hee 
Lee et al. 2013).  In summary, LIF is produced by the glandular epithelium under estrogen 
stimulation, and acts on luminal epithelium to activate JAK-STAT signaling pathway to mediate 
the shift from the proliferative state to differentiated state. LIF also drives stromal proliferation 
through regulation of the EGF signaling pathway.  
Indian hedgehog (IHH) is a member of the hedgehog family and once it binds to its 
receptor, it recruits and activates downstream transducer to activate the transcription factors Gli 
and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) which regulates 
cell proliferation and differentiation (McMahon 2000). IHH is expressed in the uterus on day3 and 
day4, and then declines on day 5. Deletion of IHH in the uterus leads to infertility due to 
implantation defects and failure of progesterone –induced decidualization (K. Lee et al. 2006; 
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Takamoto et al. 2002). PRKO mouse model studies have shown that IHH is a progesterone 
regulated genes (H Matsumoto 2002). IHH-COUP-TFII signaling controls luminal epithelium 
remodeling necessary for implantation and IHH is also important for decidualization through 
COUP-TFII mediated induction of BMP2 (D. K. Lee et al. 2010). Bone morphogenetic protein 2 
(BMP2) is a member of the BMP family of morphogens. Its expression is observed in the uterine 
stroma near the site of attachment and persists through early phases of decidualization (B C Paria 
et al. 2001). BMP2 is downstream of the IHH-COUP-TFII signaling pathway and BMP2 
expression is lost in the stroma of COUP-TFII knockout uteri (Ying and Zhao 2000). BMP2 
knockout studies have shown that the blastocysts are able to attach to the luminal epithelium, but 
not able to penetrate the uterine epithelium and induce decidualization (K. Y. Lee et al. 2007). In 
vitro studies have shown that knock down of Bmp2 expression in human endometrial stromal cells 
prevents hormone induced decidualization (Q. Li et al. 2007). 
Wingless-type MMTV integration site family member 4 belongs to the WNT family and 
expresses in the adult uterus under regulation of progesterone (J. W. Jeong et al. 2009). Its primary 
expression appears in the uterine stroma at day 4.5 in primary decidual zone and persists into the 
secondary decidual zone (Hayashi et al. 2009).  Wnt4 conditional knockout studies reported 
normal attachment of the blastocyst, but failed invasion through the epithelium and failed 
induction of the decidual response. Wnt4 is an important regulator of decidualization by mediating 
progesterone actions to promote both stromal cell differentiation and survival. 
Insulin-like growth factor 1 (IGF1) is a peptide hormone that promotes cell growth (Baker 
et al. 1996). Studies have shown that IGF1 expression is detected in both uterine epithelial cells 
and stromal cells on day 4 of pregnancy and is limited to the stroma underlying the implanting 
embryo on day 5. IGF receptors are expressed in all uterine cell types (Kapur et al. 1992). Estrogen 
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stimulates IGF1 expression in the uterine stroma and more modestly in the luminal epithelium (L. 
Zhu and Pollard 2007). IGF1 also appears to be a direct target of ERα. There are several proposed 
mechanisms of action and one of them is that IGF1 acts through IGF1 receptor in the epithelium 
to stimulate activation of the PI3K/AKT pathway, that phosphorylates and inactivates GSK3β to 
allow cell cycle progression (Walker et al. 2010). These studies indicate the important role of IGF1 
in executing estrogen-induced epithelial proliferation in a paracrine manner.  
Heart and neural crest derivatives-expressed protein 2 (HAND2) is a basic helix-loop-helix 
transcription factor and has a critical role in the uterine stroma to regulate epithelial function (Wu 
and Howard 2002). Progesterone regulates HAND2 because HAND2 expression is induced by 
progesterone administration in ovariectomized mice and blocked by the PR antagonist RU486 (Q. 
Li, Yamagishi, et al. 2011). Beginning at day 3 of pregnancy, HAND2 expression is robust in the 
uterine stroma but not evident in the epithelium. Stromal expression persists through implantation 
and is present until day 8.5, suggesting a role for HAND2 during decidualization (DV Huyen 
2011). Deletion of HAND2 in the uterus results in infertility due to a defect in implantation and 
Hand2 conditional knockout mice show persistent epithelial proliferation on day 4 of pregnancy, 
which indicates that HAND is important for uterine receptivity (Q. Li, Yamagishi, et al. 2011). 
HAND2 also inhibits the expression of stromal FGFs that induce luminal epithelial proliferation 
through the ERK1/2 pathway. Thus, progesterone induces stromal expression of HAND2 and 
inhibits epithelial proliferation to promote implantation. 
Other transcription factors regulated by progesterone that play an important role in 
implantation and decidualization include but are not limited to Homeobox 10 (Hoxa10), 
CCAAT/Enhancer binding protein β (C/EBP β), and muscle segment homeobox gene 1 and 2 
(MSX1 and MSX2). Ablation of these genes leads to failed implantation and decidualization 
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(Bagchi et al. 2006; H Lim 1999; Daikoku 2011). A model figure adopted from S.K. Dey’s review 
(Cha, Sun, and Dey 2012) on signaling network in decidualization is illustrated in Figure 2.4.  
In summary, implantation is a complex process that requires synchronized development of 
the maternal endometrium and the mature blastocyst. There is constant communication between 
the mother and the embryo. Steroid hormones play vital roles during this crosstalk. Other important 
genes involved in implantation include cytokines, homeobox transcription factors, developmental 
genes, cell cycle regulators, and adhesion molecules. Although studies in the past have established 
the role of various signaling pathways, we are not clear whether theses pathways function 
independently or converge into a larger network that need to be explored. Mouse models are still 
important as functional tools to study embryo-uterine interaction, as more Cre models need to be 
made to study the role of novel genes, such as basigin, in a specific cell type. It is clear that basigin 
is a critically important protein for successful reproduction in both males and females. While much 
has been learned regarding the specific functions of basigin in uterus, many questions regarding 
the role of basigin in implantation remain.  Progress has been hampered by the lack of availability 
of conditional KO mouse models and the lack of a reliable commercial source of the recombinant 
protein.  Basigin is a glycosylated plasma membrane protein that serves as the center of a molecular 
hub within the cell membrane, interacting with a number of other proteins that are important for 
adhesion, cell metabolism, and angiogenesis. A better understanding of the physiological and 








Figure 2.1 Schematic representation of basigin structure and binding partners.  
Basigin is composed of two Ig-like extracellular domains (ECI and ECII), a transmembrane 
domain and a short cytoplasmic domain. Each EC is held together by disulfide bonds. Three 
conserved Asparagine residues serve as glycosylation sites. Glycosylation is marked by curved 
lines on ECI and ECII. A conserved Glutamic Acid residue in the transmembrane domain is 
thought to be important for interacting with certain molecules. A hypoxia inducible factor binding 









Figure 2.2 Schematic overview of basigin-associated proteins and the signaling pathways 
involved. From left to right: Basigin binds MCT1/4 and shuttles them to the cell membrane for 
lactate transport across the cell; Basigin forms a supercomplex by interacting with MCT, CD98, 
ASC2 and LAT to aid amino acid transport; Basigin forms a homodimer to induce MMP 
production and activates PI3K/AKT pathway; Basigin binds to α3/6-β1 integrins and activates 
FAK pathway; Basigin binds CD98 and α4β1 integrin for cell adhesion; Basigin binds cyclophilin 
A in the ECII to activate MAPK and ERK pathways; Basigin binds WNT4 and Frizzled to activate 
the Wnt/β-catenin pathway; Basigin is also present and shed in extracellular vesicles. In the 








Figure 2.3 Hormonal profile and uterine changes during early pregnancy in mice. Top panel: 
Steroid hormone patterns are illustrated during indicated days of pregnancy. Estrogen (red dotted 
line) secretion is high after ovulation. Progesterone (yellow solid line) starts to rise from day 3 and 
onward due to secretion from newly formed corpora luteum after mating. On day 4, a small spike 
of nidatory estrogen opens implantation window. Embryo implantation occurs at midnight of day 
4. After implantation, high level of progesterone is required for proper decidualization, 
placentation and completion of pregnancy. Bottom panel: Diagrams of cross-sections of the 
preimplantation uterus (day1, day4) and implantation sites (day5, day8). On day 1, the luminal 
epithelium of the non-receptive uterus is highly proliferative and branched. On day 4, the luminal 
epithelium ceases proliferation and is receptive to the incoming blastocyst. The stroma starts to 
proliferate. On day 5, the trophectoderm of the blastocyst attaches to the antimesometrial luminal 
epithelium. The stromal cells at the implantation site undergo proliferation and differentiation to 
form an avascular primary decidual zone on day 5. The stromal cells next to the PDZ continues to 
proliferate and differentiate into a vascularized secondary decidual zone (SDZ) by day 8. M, 
mesometrial side; AM, antimesometrial side; LE, luminal epithelium; GE, glandular epithelium; 






Figure 2.4 Signaling networks in decidualization. Key molecules for decidualization are 
depicted in this hybrid cartoon as gathered from mouse and human studies. The decidua is 
composed of differentiated stromal (decidual) cells, many of which are terminally differentiated 
(polyploid). Decidualization involves coordination of several processes, including polyploidy, and 
several types of molecules, such as cytokine receptors, enzymes, morphogens, hormones and 
transcription factors. ADM, adrenomedullin; BV, blood vessel; DEDD, death effector domain– 
containing protein; IL-11Rα, interleukin 11 receptor α; mTORC1, mammalian target of rapamycin 
complex 1; SGK1, serum- and glucocorticoid-inducible kinase 1; Sphk1/2, sphingosine kinase 1/2. 
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Basigin Conditional Knockout Mouse Model and Fertility Phenotypes 
 
Abstract  
Basigin (BSG) is a transmembrane glycoprotein expressed in many cell types and is involved in 
cell proliferation, induction of MMPs, stimulation of angiogenesis, and tissue remodeling. BSG 
has been shown to be important in male and female reproduction and global knockout of Bsg leads 
to infertility. Studies of the role of BSG in the uterus have been complicated because most Bsg 
null mutants are embryonic lethal. I hypothesized that uterine expression of BSG is required for 
normal fertility in mice. To investigate this hypothesis, we generated a conditional knockout (cKO) 
mouse model to ablate uterine BSG expression using the PR-Cre and LoxP method. The aims of 
this study were to 1) validate the Bsg cKO mouse model and 2) to investigate the fertility 
phenotype of the cKO females. Knockout of BSG was confirmed by qRT-PCR and histology. 
Results from a six-month fertility study showed that cKO females had significantly reduced 
fertility compared to controls. The average litter size and litter frequency in the cKO females were 
significantly lower than the controls. The litter size of the cKO decreased more severely as parity 
increased compared to controls. Ovarian functions including ovulation and progesterone 
production were assessed in the cKO mice and were not different from controls. Ovarian histology 
appeared similar between the cKO and the controls, as they both possessed follicles of different 
stages and corpora lutea. Both genotypes responded to ovarian superstimulation by ovulating the 
same number of oocytes. The cKO mice produced comparable numbers of embryos and had 
similar progesterone levels as the controls on day 4 of pregnancy. Data from pregnancy day 6-15 
showed there were fewer implantation sites and abnormal embryo spacing in the uteri of the cKO 
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females. In addition to impaired implantation and reduced litter size and frequency, I also observed 
an increased incidence of dystocia and neonatal death in the cKO females. Overall, the cKO 
females have a higher rate of implantation failure and pregnancy abnormalities compared to 




Infertility has become a  common health concern in humans and affects about 10-15% of 
couples worldwide (Ramathal et al. 2010). Studies have shown that only 50-60% of pregnancies 
advance beyond 20 weeks of gestation, while the rest are lost in early stages (Norwitz, Schust, and 
Fisher 2001). Among all the early pregnancy losses, implantation failure is the major cause. With 
the advancement of assisted reproductive technologies, such as in vitro fertilization, many couples 
with fertility issues are able to have children. However, the success rate of assisted reproductive 
technologies remains low due to implantation failure (Wang et al. 2013; Sharkey and Smith 2003). 
This suggests that implantation is a significant hurdle for human pregnancy, and it is critical to 
understand the mechanisms regulating implantation in order to improve fertility rates.  
Implantation is the process in mammals where the hatched blastocyst attaches to the 
maternal endometrium, invades into the stromal cells and establishes the placenta (Cha, Sun, and 
Dey 2012). This complicated event is tightly regulated by steroid hormones estrogen and 
progesterone. It requires synchronized development of the embryo and the uterus. During this 
process, there is constantly a reciprocal and intricate communication between the embryo and the 
maternal endometrium. In addition, many genes and molecules have been identified to play key 
roles in regulating implantation and pregnancy. These genes include cytokines, adhesion 
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molecules, homeobox transcription factors, developmental genes, and cell cycle regulators etc. 
(Cha, Sun, and Dey 2012; Hantak, Bagchi, and Bagchi 2014). 
BSG is a transmembrane glycoprotein that belongs to the immunoglobulin superfamily 
(Xin et al. 2016). It is expressed in many cell and tissue types and is involved in different 
physiological functions (Li and Nowak 2019). BSG is also expressed in the reproductive organs 
of humans and mice and is essential for successful fertility in both males and females (Braundmeier 
et al. 2012; Chen et al. 2007; Bi et al. 2013). In female mice, BSG is expressed in the embryo, 
ovary and the uterus. On day 1 of pregnancy, it is expressed in the luminal and glandular 
epithelium, and on day 4 of pregnancy, it is expressed in the stromal cells. Following implantation, 
BSG is expressed in the secondary decidual zone and eventually in the undifferentiated stromal 
cells (Chen et al. 2007; Chen, Belton, and Nowak 2009). Igakura and colleagues first showed that 
BSG expression both in the embryo and the mother is crucial for successful pregnancy (Tadahiko 
Igakura et al. 1998).  Limited global knockout studies have shown that female mice lacking BSG 
are profoundly infertile, likely due to failed fertilization and implantation (Tadahiko Igakura et al. 
1998; Kuno et al. 1998). However, global knockout of Bsg is highly embryonic lethal, making it 
difficult to study the role of BSG in reproduction since so few pups are born. In fact, only about 
4-5% of Bsg global knockout mice are born and half of them die prematurely. Among the mice 
that survive to adulthood, they are also more susceptible to develop pneumonia and neurological 
disorders (Naruhashi et al. 1997; Tadahiko Igakura et al. 1996; Muramatsu and Miyauchi 2003). 
Thus, in order to bypass the embryonic lethality caused by global deletion of Bsg, we generated a 
tissue specific Bsg knockout mouse model using the progesterone receptor (PR)-Cre and loxP 
system to study the function of BSG in female reproduction. Therefore, the goals of this study 
were twofold: 1) to generate and validate the Bsg cKO mouse model and 2) to investigate the 
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fertility phenotype in these Bsg cKO mice. Here I demonstrate that the cKO animal model is 
successful as BSG expression is deleted in the PR positive cells such as in the uterus and oviduct, 
but it is still present in the PR negative cells. In addition, cKO of Bsg in the uterus leads to 
subfertility in mice. 
 
Material and Methods 
Animals 
C57/Bl6 mice were housed at the University of Illinois, Urbana-Champaign, at the Institute 
for Genomic Biology Animal Facility in polysulfone cages. Food (Harlan Teklad 8604) and 
filtered water were provided for the mice ad libitum. The room was maintained at a temperature 
of 22 ± 1 °C and on a 12-hour light-dark cycle. All experimental procedures including animal care, 
surgery, euthanasia and tissue collection were approved by the Institutional Animal Care and Use 
Committee at the University of Illinois, Urbana–Champaign. 
Genotyping 
Mice were weaned and sexed at 21 days of age. Upon weaning, mice were ear-tagged and 
tail-clipped. The tail tips were used to extract DNA and genotyped. Briefly, DNA of each tail tip 
was extracted with extraction solution (Sigma E7526) at 55 °C for 3 minutes, with addition of 
neutralization buffer (Sigma N3910). Then 2 µl of DNA solution were added to 10 µl of Red 
Extract-N-Amp PCR Ready Mix buffer (Sigma R4775) and primer sets for a total volume of 20 
µl PCR mix for each sample. The DNA was amplified by PCR using a thermal cycler for 30 cycles. 
After PCR, DNA was loaded on a 1% agarose gel containing 1 µl of ethidium bromide and run by 
electrophoresis at 120V for 60 minutes. A LSM4000 Image Quant system was used to visualize 





A 6-month fertility study was carried out to determine whether the cKO females 
experienced subfertility or infertility. To do this, eight female mice at 2-months of age for each 
genotype were housed individually with one wild type male mouse of proven fertility continuously 
for six months. During this time, mice were checked daily for pregnancy and parturition. Fertility 
outcomes including the number of litters born per female, the number of pups born per litter, the 
pup weight and pup sex were recorded and analyzed. These mice were used only for observation 
of litter size and frequency. 
Tissue Collection and Hormone Level Analysis 
Another set of animals for tissue collection at different days of pregnancy were used. Mice 
of each genotype were placed with wild type males at two months of age. The day of vaginal plug 
was designated as day 1 of pregnancy. Four to eight mice per genotype were euthanized by CO2 
to collect uterine tissue on pregnancy days 1, 4, 5, 6, 9, 12, and 15. Uteri were weighed and 
photographed. One uterine horn was snap-frozen in liquid nitrogen and stored at -80°C for later 
RNA extraction. The other uterine horn was fixed in 10 mL of 10% buffered formalin for 24 hours, 
transferred into 70% ethanol and processed for histology. The uterine tissues were processed with 
a VipTek tissue processor, embedded in paraffin blocks, and then sectioned into 5 µm thick 
sections using a microtome. The slides were dried for at least 24 hours before processed for further 
analysis. Serum samples were collected for hormone measurement on day 4 of pregnancy. Briefly, 
blood was drawn immediately after euthanasia from the posterior vena cava. The blood samples 
were cooled on ice for 30 minutes, then 15 minutes at RT to clot. The samples were centrifuged at 
1000 x g for 10 minutes to remove the clot, and the supernatant liquid component (serum) was 
collected and frozen at -20 °C. The serum was subjected to an Enzyme-linked immunosorbent 
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assay (ELISA) using a commercially available progesterone ELISA kit (DRG EIA1561) for 
progesterone levels. The kit has a sensitivity of 0.0045 ng/ml and detects progesterone ranges from 
0-40 ng/ml. 
RNA isolation and quantitative reverse transcription-PCR (qRT-PCR) 
Total RNA was extracted from uterine tissues of mice on day 4 of pregnancy using the 
Qiagen RNeasy Mini kit (Qiagen #74104) according to the manufacturer’s instructions. The 
concentration of mRNA was determined by a nanodrop and the quality of the mRNA was assessed 
using the Bioanalyzer at the Functional Genomics Center at the University of Illinois, Urbana-
Champaign (https://biotech.illinois.edu/functionalgenomics). One microgram of total RNA was 
reverse transcribed using the First Strand cDNA Synthesis Kit from Roche (#4379012001) 
following the manufacturer’s instructions. After cDNA was synthesized, qRT-PCR was performed 
to assess the mRNA level of Bsg in the uteri of the mice of both genotypes in triplicates using 
Power Sybr Green Master Mix (Life Tech A25742). Briefly, 5 µl of a 1:7 diluted cDNA sample 
was mixed with 10 µl of master mix (7.5 µl of Sybr Green Mix, 0.6 µl primer set and 1.9 µl of 
water) for a total volume of 15 µl per well in a MicroAmp optical 384-well reaction plate. Three 
technical replicates were performed for each sample. qPCR amplification and quantitation were 
performed using a Quant Studio (Applied Biosytem) from the Functional Genomics Center. The 
reaction was run for 40 cycles (95 °C for 15 sec, 60 °C for 1 minute). The comparative CT method 
(ΔΔCT) was used for quantification of gene expression. Relative fold changes in gene expression 
for Bsg were normalized to Peptidylprolyl isomerase A (Ppia) and Ribosomal protein, large, P0 






To assess the protein abundance of BSG in the uteri, oviduct and kidney, 
immunohistochemistry (IHC) was performed on samples collected on day 4 of pregnancy. Briefly, 
uterine, oviduct and kidney sections were deparaffinized using three xylenes, rehydrated through 
a series of decreasing concentration of ethanol, and then subjected to heat-induced antigen retrieval 
with DAKO Target Retrieval Solution at 1:10 dilution (10X pH9) (Dako Denmark A/S, Denmark, 
Part Number: S236784-2, Code: S2367) at 100 ◦C for 30 minutes and allowed to cool to room 
temperature (RT). This was followed by inactivation of endogenous peroxidase activity with 0.3% 
H2O2/methanol for 15 minutes in the dark. The samples were then rinsed with phosphate buffered 
saline containing tween-20 (PBST) and incubated in blocking solution consisting of 5% horse 
serum (Vectastain ABC kit, Vector Laboratories, Inc. Burlingame, CA) diluted in 1%BSA/PBST 
at RT for 60 minutes. Tissue sections were incubated with a primary anti-BSG antibody (R&D 
system AF772) at 1:200 dilution overnight at 4 ◦C. The negative control sections were incubated 
in a non-specific IgG of the same species as the primary antibodies to confirm specificity of the 
primary antibody. On the following day, slides were rinsed with PBST prior to incubation with 
anti-rabbit biotinylated secondary antibody (Vectastain ABC kit, Vector Laboratories, Inc. 
Burlingame, CA) at 1:100 dilution in PBST for 60 minutes at RT. Slides were then rinsed and 
incubated in ABC solution (PBS: A: B=50:1:1) (Vectastain ABC kit, Vector Laboratories, Inc. 
Burlingame, CA) for 30 minutes at RT. For visualization of the immunoreactivity, all slides were 
subjected to chromogen 3’3-diaminobenzidine (DAB) (Vector Laboratories, Inc. Burlingame, CA) 
for 30 seconds. Slides were rinsed in tap water for 10 minutes to stop the DAB reaction. Thereafter, 
the slides were counterstained with hematoxylin (1 g/L) for one minute followed by dehydration 
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in xylenes and cover-slipping. After drying for 24 hours, the slides were cleaned and loaded into 
a Hamamatsu Nanozoomer 2.0 HT for scanning. 
Immunofluorescence Staining 
To assess the protein abundance and localization of BSG in the uteri in an alternative 
method, immunofluorescence (IF) staining for BSG was performed on samples on day4 of 
pregnancy. Briefly, uterine slides were deparaffinized using three xylenes, rehydrated through a 
series of decreasing concentrations of ethanol, and then subjected to heat-induced antigen retrieval 
with DAKO Target Retrieval Solution at 1:10 dilution (10X pH9) (Dako Denmark A/S, Denmark, 
Part Number: S236784-2, Code: S2367) at 100 ◦C for 30 minutes and allowed to cool to RT. The 
slides were then incubated in blocking solution consisting of 5% horse serum (Vectastain ABC 
kit, Vector Laboratories, Inc. Burlingame, CA) diluted in 1%BSA/PBST at RT for 60 minutes. 
The tissue sections were incubated with a primary anti-BSG antibody (R&D systems, AF772) at 
1:200 dilution overnight at 4 ◦C. The negative control sections were incubated in a non-specific 
IgG of the same species as the primary antibodies to confirm specificity of the primary antibody. 
On the following day, slides were rinsed with PBST prior to incubation with anti-goat Alexa488 
conjugated secondary antibody (Jackson Immuno Research # 805-545-180) at 1:200 dilution for 
1 hour at RT. After incubation, slides were rinsed with PBS and covered with a DAPI containing 
mounting medium (Vector Laboratories, H-1200). To visualize the immunoreactivity, all slides 
were imaged using a Zeiss LSM 710 confocal microscope at the Institute for Genomic Biology at 
the University of Illinois, Urbana-Champaign. 
Superovulation 
To assess ovarian response to hormonal stimuli and ovulation of the cKO mice, a 
superovulation experiment was performed. Nine mice of each genotype were injected ip with 6 IU 
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of pregnant mare serum gonadotropin (PMSG, Prospec HOR-272) at 3 pm on day on. The mice 
were rested for 2 days before receiving 6 IU of human chorionic gonadotropin (HCG, Millipore 
#230734) 46 hours later at 1 pm on day 3. After superovulation, the mice were euthanized the next 
day (day 4) at 10 am to collect the oviducts. After transferring to the lab, the oviducts were gently 
pierced at the ampulla region to release a cloud of oocytes in a complex with cumulus cells. The 
oocytes were first incubated in 500 µl of PBS with 20 µl of hyaluronidase (Sigma H4272) for 20 
minutes to remove the excess cumulus cells. The oocytes were then transferred to a new petri dish 
with a drop of PBS and then imaged by a light microscope to count the number. 
Embryo Flushing 
To assess the number of embryos reaching the uterine horn at the time of implantation, 
embryos were flushed on day 4 of pregnancy from both cKO and control mice. To do this, 7 female 
mice of each genotype were individually housed with one wild type male of known fertility. 
Mating behavior was checked daily and the presence of a vaginal plug was designated as day 1 of 
pregnancy. On day 4 of pregnancy, mice were euthanized, and the uterine horns were collected. 
After transferring the uteri back to the lab, a 1 ml syringe with 30-gauge needle was used to flush 
the embryos. Briefly, one end of each uterine horn was held by a pair of forceps over a petri dish, 
the needle was inserted into the opening of the uterine horn to forcefully inject 1 ml of PBS. The 
PBS flushed the uterine horn was collected in a petri dish. This flushing was repeated 3 times to 
ensure flushing of all embryos. The number of embryos was determined using a light microscope 
and photographic images were taken to evaluate the development stages of the embryos.   
Statistical Analysis 
All data were analyzed utilizing GraphPad Prism software 8 (GraphPad Prism, San Diego, 
CA). Data are presented as means ± standard error of the means (SEM).  For normally distributed 
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data, unpaired t tests were used to compare the control group and the experimental group. For non-
normally distributed data, Mann-Whitney tests were used. A statistical significance was assigned 
at p≤0.05. A trending difference was assigned when p value was between 0.05 and 0.1. 
 
Results 
Generation of the Bsg cKO mice 
To generate the Bsg cKO mice, we made a Bsg floxed C57/BL6 mouse where two LoxP 
sites were inserted into the genome, flanking exon 1 of the Bsg gene. We then crossed this mouse 
line with another C57/BL6 line containing a Cre recombinase inserted into the genome under the 
PR promotor region in exon 1. This cross results in a new transgenic mouse where in the PR 
positive cells, the expressing Cre recombinase deleted exon 1 of the Bsg gene. As Figure 3.1 B 
shows, Bsg F/F and PR +/+ female mice were crossed with Bsg F/F and PR cre/+ male mice, to 
generate Bsg F/F and PR cre/+ (conditional Bsg knockout) and Bsg F/F and PR +/+ (littermate 
control) female offspring. Genotypes were determined by PCR and DNA gel electrophoresis, 
where the presence of one band alone at 283 bp indicates a control mouse, while two bands at 283 
and 594 bp indicate a cKO mouse (Figure 3.2). 
Confirmation of loss of BSG expression in the uterus of Bsg cKO mice 
 Knockout of Bsg in the uterus was confirmed by qRT-PCR and histology. Figure 3.3 
shows that the mRNA level of Bsg in whole uteri collected in the cKO on day 4 of pregnancy was 
downregulated by 75%, which was significantly lower than the controls. Figure 3.4 shows the 
IHC results for BSG protein in the kidney, oviducts and uteri in mice of both genotypes on day 1, 
4 and 6 of pregnancy. On day 1 of pregnancy, BSG was expressed mainly in the luminal epithelial 
cells and glandular epithelial cells in the control uterus (B). In the cKO, BSG expression 
76 
 
disappeared in the luminal and glandular epithelial cells (C). On day 4 of pregnancy, BSG was 
expressed abundantly in the stromal cells in the control uterus (E). In the cKO, BSG expression 
was only detected in some scattered endothelial cells and immune cells (F). On day 6 of pregnancy, 
BSG was heavily expressed in the embryo and the secondary decidual zone and undifferentiated 
stromal cells in the control uterus (H). In the cKO, BSG expression level was much reduced, 
mainly in endothelial cells and immune cells in the stroma (I). The non-specific IgG slides of the 
uteri in the control mice on day 1, 4 and 6 showed no immunostaining of BSG (A, D and H). BSG 
was also expressed in the ampulla of the oviduct in the control mouse (K), but not in the cKO 
mouse (L). The kidney is known to express high levels of BSG and served as a positive control. 
The kidney of the cKO female showed extensive BSG expression (J), suggesting that the targeted 
knockout in PR positive cells was specific. Immunofluorescence staining for BSG in uteri on day 
4 of pregnancy also confirmed cell membrane localization of BSG in the stromal cells of the 
controls, but not in the cKO mice (Figure 3.5). 
Deletion of Bsg in uterine cells reduces fertility of female mice. 
A six-month fertility study was carried out to determine the fertility outcomes of the cKO 
female mice, and the results are summarized in Table 3.2. During the six-month period, the eight 
control females produced 40 litters total, which was 5 litters per female on average. However, the 
eight cKO females produced 27 litters total, which was an average of 3.38 litters per female. The 
litter frequency of the cKO females was significantly smaller than the controls (Figure 3.6 B). 
cKO females produced 123 pups total, which was 4.56 per litter, and this was significantly smaller 
than the 309 total pups and 7.73 pups per litter produced by the controls (Figure 3.6 A). Although 
the cKO mice had fewer pups, the number of dead pups at parturition was much higher than the 
controls at a 27:7 ratio. Two of the cKO females died due to dystocia and had to be replaced. In 
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addition to the smaller litter frequency and litter size, the fertility decreased much more severely 
in the cKO females compared to the controls over time. The controls still produced six pups per 
litter at their fifth parity, while the cKO females produced almost no pups at the fifth parity (Figure 
3.6 C). This suggests that BSG may play a role in reproductive aging. There was no difference in 
the pups’ weight at birth between the cKO females and the control females (Figure 3.6 D). The 
sex ratio of the pups was also not different. 
Bsg cKO females have normal ovarian morphology. 
Ovaries are the sources of oocytes and the sites of steroid hormone production, which are 
critical for reproduction (Jamnongjit and Hammes 2006). Ovaries on day 4 of pregnancy were 
collected and stained by hematoxylin and eosin to assess the morphological differences between 
the cKO females and the controls (Figure 3.7). The ovarian morphology appeared similar between 
the two genotypes. The cKO ovary had similar number of follicles at different developmental 
stages as the controls. There were also corpora lutea present in the ovaries of the cKO mice. 
Progesterone levels are normal in the Bsg cKO females. 
Progesterone is key for maintenance of all events of normal pregnancy (Terakawa et al. 
2012). In order to assess progesterone levels, serum was collected on day 4 of pregnancy and 
subjected to progesterone ELISA. The cKO females had 19.12 ng/ml progesterone, which was not 
different from the 19.35 ng/ml levels measured in the controls (Figure 3.8). Thus, the subfertility 
of the cKO females was not due to differences in progesterone levels. 
Response to ovarian superstimulation is not altered in the Bsg cKO females. 
To test ovarian function, including ovulation and response to hormones, a superovulation 
experiment was performed. After stimulating with PMSG and HCG, the cKO females ovulated 
16.44 oocytes, which was comparable to the 20.44 oocytes produced by the controls (Figure 3.9 
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A). The superovulated oocytes were collected and imaged under a light microscope. The 
morphology and size of the oocytes were similar between the cKO and the control mice (Figure 
3.9 B and C). 
Embryo number and developmental stage are normal in the Bsg cKO females. 
Uteri of both genotypes were harvested on the morning of gestational day 4 and the 
embryos were flushed and collected. We retrieved an average of 6.29 embryos per mouse from the 
seven cKO females, which was similar to the 7.86 embryos retrieved from each of the seven control 
mice (Figure 3.10 A). After collection, embryos were imaged under a light microscope to evaluate 
developmental stages. Most of the embryos were at the mature blastocyst stage, or morula stage, 
regardless of the genotypes of the mother (Figure 3.10 B and C). The cKO females had an average 
of 0.71 unfertilized or degenerative eggs, which was similar to the 0.43 unfertilized or degenerative 
eggs observed in the controls. 
Bsg cKO females experience uterine defects at multiple time points of gestation. 
After identifying the cause of subfertility to uterine defects, the timing of the defects was 
assessed. For this purpose, uteri from animals with both genotypes were collected on different days 
of pregnancy. Examples of uteri on days 6, 9, 12 and 15 of gestation for both cKO and control 
mice are shown in Figure 3.11. For each time point checked, the cKO females had some uteri with 
implantation failure. In cKO mice with implantation, some had fewer implantation sites, abnormal 
spacing or crowded implantation sites. On days 12 and 15, there were signs of embryo resorption 
and growth restriction in the cKO females. There were also signs of hemorrhage at implantation 
sites in the cKO mice. This indicates that pregnancy complications occurred at multiple time points 




Bsg cKO females have higher incidence of implantation failure and abnormal pregnancy. 
After carefully checking the pregnancy status of mice at every time point of pregnancy, 
mice were divided into three groups based on observation of the uteri: 1. No implantation; 2. 
Abnormal pregnancy and 3. Normal pregnancy. Only 15.4% of the controls had no implantation 
and 7.7% had abnormal pregnancies, while the majority of controls had normal pregnancies 
(76.9%). On the other hand, 25% of the cKO females had no implantation, and 39.3% had 
abnormal pregnancies. Only 35.7% of the cKO females had normal pregnancies, which was much 




BSG is a highly glycosylated, type-1 transmembrane protein in the immunoglobulin 
superfamily and plays a role in numerous physiological functions (Hahn, Kaushik, and Yong 2015; 
Fossum, Mallett, and Neil Barclay 1991). Global deletion of Bsg is highly embryonic lethal and 
only 4% of global knockout pups are born. Of the few that are born, half of them are small, weak, 
and susceptible to develop interstitial pneumonia and die prematurely. The ones that survive to 
adulthood also exhibit neurological and cognitive disorders such as decreased sensitivity to 
irritating odors and lights, hypersensitivity to electric foot shock and deficits in learning and 
memory (T Igakura et al. 1998; Tadahiko Igakura et al. 1996; Hori et al. 2000; Ochrietor and 
Linser 2004; Naruhashi et al. 1997; Fadool and Linser 1993). Thus, the global Bsg knockout mouse 
model is not amenable to studying the role of BSG in reproduction. 
To bypass this high embryonic lethality of mice lacking Bsg, we utilized the PR-Cre and 
LoxP system to generate a PR positive cell specific Bsg knockout animal model. We produced a 
Bsg floxed mouse where the two LoxP sites flank exon 1 of the Bsg gene. This mouse model was 
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crossed with a PR-Cre knock-in mouse line where a Cre recombinase is inserted in to exon 1 of 
the PR sequence as described by Soyal and colleagues (Soyal et al. 2005). The breeding scheme 
to generate the PR-Cre Bsg cKO mice is illustrated in Figure 2.1. The qRT-PCR results showed 
that the Bsg mRNA level was significantly downregulated in the uteri of the cKO mice. The 
immunostaining results showed that the BSG protein expression was also deleted in the uterine 
luminal epithelial and stromal cells, as well as the ampulla of the oviduct in the cKO mice. Kidney 
is known to express BSG (Fukuoka et al. 2012) and is negative for PR. Because BSG was still 
heavily expressed in the kidney, these data suggest that the knockout of Bsg was successful and 
limited to PR positive cells.  
Following validation of the knockout mouse model, I hypothesized that loss of BSG 
expression in the uterus would lead to infertility or subfertility in female mice. The six-month 
fertility study results showed that the cKO females produced markedly smaller litter numbers and 
litter size compared to the controls, indicating reduced fertility in cKO mice. In addition, there was 
a much higher incidence of neonatal death of the cKO mice. An interesting observation was that 
as the parity increased, the fertility of the cKO mice decreased more severely compared to the 
controls. Normally, the fertility of animals gradually decreases as they age, however, this age-
associated fertility decrease in the cKO mice was accelerated compared to the controls, suggesting 
a possible role of BSG in reproductive aging. Overall, these results demonstrated that loss of BSG 
in the uterus caused subfertility in female mice, instead of complete infertility.  
After demonstrating the subfertility phenotype caused by loss of BSG in the uterine cells, 
it was important to determine where the problems were occurring. Ovaries are critical for 
reproductive functions as they are the sources of the oocytes and the sites of steroid hormone 
production (Jamnongjit and Hammes 2006). However, there were no morphological differences in 
81 
 
the ovarian structures between the two genotypes: both contained follicles at each developmental 
stages and corpora lutea. There was no difference in the number of superovulated oocytes produced 
by the cKO mice compared to the controls, suggesting that the ovaries in the cKO mice responded 
normally to hormonal stimulations. Progesterone is referred to as the “pregnancy hormone” as it 
is essential for maintenance of pregnancy in most mammals studied (Dey et al. 2004). Progesterone 
levels are usually at high levels on day 4 of pregnancy in mice, causes a cessation of the luminal 
epithelial cell proliferation and promotes the stromal cell proliferation. The uterus also enters the 
pre-receptive stage for the incoming blastocyst at this time (Tranguch et al. 2005). The ELISA 
results showed that the progesterone levels on day 4 of pregnancy in the cKO mice were not 
different compared to the controls. These results suggested that the ovarian functions including 
ovulation and progesterone production were comparable between the groups, and thus were not 
the cause of the subfertility in the cKO mice. The fertilized zygote undergoes several rounds of 
cell division to develop into a blastocyst, which will hatch from the zona pellucida before 
implantation can occur (Rossant 2016). A similar number of embryos were retrieved from the uteri 
of both genotypes on day 4 of pregnancy. In both genotypes, most of the embryos were fertilized 
and at the blastocyst stage as they possessed a blastocoel, indicating that the embryonic 
development was not affected in the cKO mice. Collectively, these results suggested that the 
decreased fertility observed in the cKO mice was not likely due to an impairment of the 
hypothalamic-pituitary-ovarian axis. Based on these findings, I determined that the uterine defects 
were the cause of the subfertility in the cKO mice. 
To confirm the hypothesis and determine the time of gestation when the problems occurred, 
I collected the uteri of mice in both genotypes at different gestation times. Results showed that 
only 15.4% and 7.7% of the controls had no implantation or abnormal pregnancy respectively, and 
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76.9% had normal pregnancy. However, in the cKO mice, only 35.7% had normal pregnancy. A 
quarter of the cKO mice did not implant and 39.3% of them had problematic pregnancy. These 
findings suggest that loss of BSG results in complications throughout pregnancy at multiple time 
points. Over the course of pregnancy, BSG may be involved in regulating processes including 
implantation, decidualization and placentation. In addition, parturition could likely be affected by 
the loss of BSG because two cKO mice died due to dystocia and there were more dead pups at 
birth in the cKO mice in the fertility study. These results provide evidence on the possible negative 
effects of loss of BSG in implantation and decidualization and direct me to investigate these 
processes in the future studies. It has been accepted that during the dynamic process of pregnancy, 
any major aberration will terminate pregnancy at the time of insult or perpetuate negative effects 
throughout pregnancy (Cha, Sun, and Dey 2012). Recent studies have proposed the concept of the 
“ripple effect of implantation”, which means the quality of implantation determines the quality of 
the ongoing pregnancy. If the gestation starts with a poor-quality implantation, it is likely to have 
other defects in later course of the pregnancy (Wang et al. 2013). Therefore, it is not surprising 
that if loss of BSG in the uterus causes implantation defects, it will likely lead to other 
complications later on during pregnancy.  
The PR-Cre and LoxP system provides a valuable tool for targeted gene deletion in the 
uterus of mice. Many genes have been conditionally knocked out to study their functions in 
reproduction using this method. For example, Indian Hedgehog (IHH) cKO mice are infertile due 
to failed uterine receptivity and impaired artificial decidualization response (ADR) (Lee et al. 
2007). Similarly, loss of the transcription factor Chicken Ovalbumin Upstream-Promoter 
Transcription Factor II (COUP-TFII) also caused failed embryo attachment, defective decidual 
response in nature or by stimuli, and results in complete infertility of the mice (Kurihara et al. 
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2007). In Bone Morphogenetic Protein 2 (BMP2) cKO mice, the ovarian functions are normal, and 
the embryos are able to attach to the luminal epithelium, but decidualization failed specifically at 
stromal cell proliferation and differentiation steps. This leads to complete infertility of the mice 
(Lee et al. 2007). Interestingly, the Bmp7 cKO mice are subfertile, instead of infertile, due to 
impaired uterine receptivity, decidualization and placentation (Monsivais et al. 2017). Loss of the 
transcription factors Activin-Like Kinases (ALK) 2 and 3 both cause infertility in mice, but the 
mechanisms are different. Alk2 cKO mice experience delayed implantation and compromised 
decidualization, while Alk3 cKO mice failed implantation due defects in the luminal epithelial cell 
functions (Clementi et al. 2013; Monsivais et al. 2016). In addition to complete infertility, loss of 
some genes in the uterus results in subfertility of the mice. For instance, loss of the gap junction 
protein Connexin 43 (CX43) does not alter ovarian functions or implantation, but compromises 
decidualization, decreases angiogenesis and impairs intrauterine embryo growth (Laws et al. 
2008). Forkhead Box Protein A2 (FOXA2) cKO mice have underdeveloped uterine glands, which 
disrupts implantation and causes subfertility (Jeong et al. 2010). The subfertility phenotype caused 
by loss of BSG is very similar to the findings in several gene knockout studies, such as the Bmp7 
and Cx43 cKO mice. 
In summary, the results validated the Bsg cKO mouse model and demonstrated a 
subfertility phenotype of the mice due to the loss of BSG in the uterus. I found that BSG was 
successfully deleted in the PR positive cells in the reproductive tract of the mice such as in the 
uterus and oviduct but remained expression in the PR negative cells such as in the kidney. Loss of 
Bsg in the uteri was also confirmed by qRT-PCR. The fertility study results showed that the cKO 
mice had significantly smaller litter size and litter frequency compared to controls. The cKO mice 
had accelerated reduction in fertility than the controls. The superovulation and progesterone 
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ELISA experiments showed that the ovarian functions including ovulation and steroidogenesis 
were not affected by the loss of BSG. Embryo flushing experiments showed that fertilization and 
early embryo development were similar between the two genotypes. The loss of BSG in the uterus 
led to defects throughout the pregnancy and caused subfertility in mice. Future studies will focus 
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Genes NCBI Gene Reference Left Primer Sequence Right Primer 
Sequence 
Rplp0 NM_007475.5 actggtctaggacccgagaag ctcccaccttgtctccagtc 
Ppia NM_008907.1 ggaccaaacacaaacggttc catgccttctttcaccttcc 
Bsg NM_009768.2 acagcagtggcgttgaca ggtcatctgcgtccactatgt 
Genotype No. of  
animals 
No. of  
Litters 
born 
No. litters  
per animal 
No. of  
pups born 
No. of  
pups per 
litter 





Bsgf/f  8 40 5.0 ± 0.38 309 7.73 ± 0.35 7 1.41 ± 
0.01 
Bsgd/d  8 27 3.38 ± 0.46* 123 4.56 ± 
0.52* 









Figure 3.1 Breeding Schemes. A: a diagram illustrating how the basigin cKOs were generated. 
PR: progesterone receptor. B: a scheme of breeding pairs showing the genotypes of F0 parents to 






Figure 3.2 DNA Gel Electrophoresis Result. An example DNA gel image showing how to 
determine the genotype of the mice. Left lane: DNA standard ladder. C501-C506: 6 mice examined 




Figure 3.3 mRNA Level of Bsg. mRNA levels of Bsg in the uteri of both genotypes on day 4 of 








Figure 3.4 Validation of Bsg knockout in the mouse. Negative control slides of the uteri of a 
control mouse on day 1, 4 and 6 of pregnancy (A, D and G). Bsg expression in the uteri on day 1, 
4 and 6 of pregnancy in control mice (B, E and H) and the cKO mice (C, F, and I). Bsg expression 
in a kidney cross section of a cKO mouse (J). Bsg expression in the oviducts of a control mouse 
(K) and a cKO mouse (L). Em:embryo. LE: luminal epithelium. S: stroma. PDZ: primary decidual 








Figure 3.5 Validation of Bsg knockout in the mouse uterus by immunofluorescence. 
Expression of Bsg in a control mouse (top lane) and a cKO mouse (bottom lane) on day 4 of 










Figure 3.6 Fertility Study Results. A: average litter size of control and cKO mice. B: Average 
litter frequency of the control and cKO mice. C: Litter size of each parity of the control and cKO 







Figure 3.7 Ovarian structure. Hematoxylin stain of the ovary of a control mouse (A) and a cKO 







Figure 3.8 Progesterone levels. Serum progesterone level of the control and cKO mice on day 4 








Figure 3.9 Superovulation results. A: average number of superovulated oocytes from the control 
and cKO mice. Images of oocytes superovulated from the control (B) and the cKO (C) mice. N=9 










Figure 3.10 Embryo flushing results. A: average number of embryos retrieved from flushing of 
the control and cKO mice on day 4 of pregnancy. Images of embryos from the control (B) and the 





Figure 3.11 Pregnancy status at different gestational times in both genotypes. Left: cKO mice. 
Right: control mice. Each lane (from top to bottom): day 6, day 9, day 12 and day 15 of pregnancy. 








Figure 3.12 Post-implantation Pregnancy Success Rate. Pie chart of post-implantation 
pregnancy success rate of the control mice (A) and cKO mice (B). Black: no implantation. Grey: 
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Basigin (BSG) is a transmembrane glycoprotein involved in cell proliferation, angiogenesis and 
tissue remodeling and is essential for male and female reproduction. Due to high embryonic 
lethality of global knockout of BSG, a PR-Cre mediated uterine tissue-specific Bsg knockout 
model was generated to study the role of uterine BSG in reproduction. A fertility study showed 
that the conditional knockout (cKO) females had significantly reduced fertility, and complications 
occurred throughout the course of pregnancy. I hypothesized that BSG is required for normal 
implantation and proper decidualization of uterine stromal cells in mice. To test the hypothesis, 
uteri of day 5 pregnancy mice were collected to assess implantation sites. Based on epithelial 
markers, the luminal epithelium of the cKO mice did not undergo apoptosis and the embryos were 
not able to penetrate the stromal layers. Jones’ silver stain results revealed that the integrity of the 
basement membrane of the cKO mice was not disrupted. To investigate decidualization, an 
artificially induced decidualization response (ADR) experiment was performed. Ovariectomized 
mice of each genotype were given 100 ng estradiol/day for three days, rested for two days, then 
given 10 ng estradiol and 1 mg progesterone/day for three days. One uterine horn was injected 
with 15 µl corn oil as a stimulus while the other horn was an un-injected internal control. Mice 
were supplied with 1 mg progesterone/day for four days before tissue collection and analysis. The 
injected uterine horn weight increased 2.2-fold in cKO mice compared to the un-injected horn, 
which was significantly lower than the 9-fold increase observed in control mice. Histology analysis 
determined that the uterine cross-sections of the decidua were much smaller in the knockout mice. 
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qRT-PCR analysis demonstrated significantly lower expression of the decidualization genes Bmp2 
and Cebpβ in the cKO decidual tissue. Immunohistochemistry showed significantly lower 
expression of the decidualization markers CEBPβ and HAND2 in the decidua of cKO mice. 
Immunofluorescent results on uteri of day 5 pregnant mice showed lower expression levels of 
CEBPβ and HAND2. Protein localization and abundance of the lactate transporter MCT1 were 
altered in the cKO mice compared to the controls. The angiogenic marker CD31 was reduced in 
cKO mice on day 6 of pregnancy, indicating impaired angiogenesis. These results support the 
conclusion that uterine expression of BSG is required for normal implantation and decidualization 
in female mice. 
 
Introduction 
 Embryo implantation is the process where the mature blastocyst attaches to the maternal 
endometrium forming the placenta (Ye 2020). It is a mandatory step for reproduction in 
mammalian species and requires synchronized development of the embryo and the uterus, as well 
as highly organized communication between the two (Cha, Sun, and Dey 2012).  In humans, 
natural conception per cycle is only 30%; about 75% of pregnancy losses are thought to be results 
of implantation failure (Norwitz, Schust, and Fisher 2001). Because of the ethical issues and the 
many conserved mechanisms between mice and humans, mice have been widely used as animal 
models for investigating the embryo implantation process (Aplin and Ruane 2017). In mice, 
implantation occurs at day 4.5. The luminal epithelium is the first maternal cell layer that an 
embryo comes into contact with, and serves as the transient gateway for embryo implantation and 
subsequent embryo development (Ye 2020). After attachment is completed, the embryo must 
penetrate through the luminal epithelium and the basement membrane for a pregnancy to be 
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successful. The luminal epithelial cells at the implantation site undergo specific changes such as 
controlled disassembly of adhesive complexes and apoptosis to assist the invasion of the embryo 
(Parr, Tung, and Parr 1987). When this is completed, the embryo needs to break through the 
basement membrane. The basement membrane is a specialized extracellular scaffold composed of 
type IV collagen, laminin, perlecan, peroxidasin and nidogen (Blankenship and Given 1995; Fisher 
et al. 1985; Jones-Paris et al. 2017). It is a contiguous layer prior to implantation and becomes 
disrupted at the site of implantation. Once the removal of the luminal epithelium and the basement 
membrane has occurred, the trophoblast and the stromal cells come into close contact with each 
other and further development of the pregnancy continues. 
After implantation occurs, the stromal cells surrounding the embryo undergo further 
proliferation and differentiation into large, round, sometimes multinucleated decidual cells. This 
physiological change is known as decidualization and it is a process in rodents and humans during 
early pregnancy (Cha, Dey, and Lim 2014). It is well accepted that proper decidualization is 
essential for successful implantation and normal pregnancy (Singh, Chaudhry, and Asselin 2011). 
The reason is that decidualization has numerous functions, for example providing the implanted 
embryo with growth factors and cytokines, controlling the implantation window and selection of 
embryos, establishing the local immune microenvironment at the fetal-maternal interface, 
maintaining tissue homeostasis during trophoblast invasion, protecting the embryo from 
inflammation and reactive oxygen species, and supporting the angiogenesis processes to nourish 
the growing embryo as well as promoting formation of the placenta (Ramathal et al. 2010; 
Wetendorf and DeMayo 2012; Monsivais et al. 2017; Bhurke, Bagchi, and Bagchi 2016). This 
critical morphological and functional transformation is dependent upon the action of the steroid 
hormone progesterone, epithelial cell secreted factors, cell cycle regulators and transcription 
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factors and immune cells (Conneely, Mulac-Jericevic, and Lydon 2003; Wetendorf and DeMayo 
2012; Das 2009; Croy et al. 2012). Many genes and signaling pathways have been identified to 
play a role in decidualization. For example, progesterone promotes Bone morphogenetic protein 2 
(BMP2), stimulates its downstream target Wingless-related integration site 4 (WNT4) to regulate 
decidualization. Loss of either BMP2 or WNT4 leads to failed decidualization and infertility (Lee 
et al. 2007; Franco et al. n.d.). In addition, BMP2 also regulates the cell cycle transcription factor 
CCAAT enhancer-binding protein beta (CEBPβ), which acts via the Signal transducer and 
activator of transcription 3 (STAT3) pathway to modulate decidualization. Mice with conditional 
deletion of CEBP and STAT3 in the uterus also show decidualization defects (Cheng et al. 2001; 
W. Wang et al. 2012). Development of genetically engineered mouse models has provided a wealth 
of information about the signaling pathways in implantation and decidualization; however, the role 
of BSG involved in implantation and decidualization remains unclear.  
BSG is a highly glycosylated transmembrane protein and is expressed ubiquitously in 
humans and mice (K. Li and Nowak 2019). Studies by our laboratory and others have shown that 
BSG is expressed in the reproductive tissues of both female and male mice, and is important for 
successful pregnancy and spermatogenesis (Braundmeier et al. 2012; Chen et al. 2007; Bi et al. 
2013). BSG was first identified to play a role in reproduction by Igakura and colleagues, who 
demonstrated that both embryonic and maternal expression of BSG is required for normal 
pregnancy in a Bsg null mutant mouse model (Tadahiko Igakura et al. 1998; Kuno et al. 1998). 
However, global deletion of Bsg results in high embryo death and limits our understanding of the 
role of BSG in reproduction. Thus we generated a PR-Cre and lox cKO mouse model to study the 
role of BSG in vivo. The results in the previous chapter validated this animal model and 
demonstrated reduced fertility in the cKO mice. I also targeted the pregnancy complication to 
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uterine defects at a variety of times. It is important to improve our knowledge of how BSG is 
involved in regulating early pregnancy; therefore, I investigated the implantation and 
decidualization processes in this chapter. The goals of this study were: 1) to investigate the luminal 
epithelial cell and basement membrane integrity at the implantation site, 2) to evaluate the status 
of the decidualization process by ADR or natural pregnancy and 3) to investigate post-implantation 
defects such as lactate transporter localization and angiogenesis in the cKO mice in vivo. Here, I 
demonstrate that loss of uterine expression of BSG leads to failures in the breakdown of the luminal 
epithelium and basement membrane at the implantation sites, a compromised decidualization 
response, and reduction in lactate transporter abundance and angiogenesis leading to decreased 
fertility in mice. 
 
Material and Methods 
Animals 
C57/Bl6 mice were housed at the University of Illinois at Urbana-Champaign, the Institute 
for Genomic Biology Animal Facility in polysulfone cages. Food (Harlan Teklad 8604) and 
filtered water were provided for the mice ad libitum. The room was maintained at a temperature 
of 22 ± 1 °C and on a 12 hour light-dark cycle. All experimental procedures including animal care, 
surgery, euthanasia and tissue collection were approved by the Institutional Animal Care and Use 
Committee at the University of Illinois at Urbana–Champaign. 
Tissue Collection and Histological Processing 
Female mice of each genotype were bred with wild type males at two months of age. The 
day of a vaginal plug was designated as day 1 of pregnancy. On pregnancy day 4, day 5 morning, 
day 5 evening and day 6, mice were euthanized by CO2 to collect uterine tissue. Uterine tissues 
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were weighed and photographed. One uterine horn was snap-frozen in liquid nitrogen and stored 
at -80°C for later RNA extraction. The other uterine horn was fixed in 10 mL of 10% buffered 
formalin for 24 hours, transferred into 70% ethanol and processed for histology. The uterine tissues 
were processed in a VipTek tissue processor, embedded with paraffin into 5 mm thick blocks and 
then sectioned into 5 µm thick sections using a microtome. The slides were dried for at least 24 
hours before being processed for further analysis.  
RNA isolation and quantitative reverse transcription-PCR (qRT-PCR) 
Total RNA was extracted from uterine tissues from mice on day 4 and day 5 of pregnancy 
or from ADR decidual tissue using the Qiagen RNeasy Mini kit (Qiagen #74104) according to the 
manufacturer’s instructions. The concentration of mRNA was determined by a nanodrop and the 
quality of the mRNA was assessed using the Bioanalyzer at the Functional Genomics Center at 
the University of Illinois, Urbana-Champaign (https://biotech.illinois.edu/functionalgenomics). 
One microgram of total RNA was reverse transcribed using the First Strand cDNA Synthesis Kit 
from Roche (#4379012001) following the manufacturer’s instructions. After cDNA was 
synthesized, qRT-PCR was performed to assess the mRNA level of decidualization and other gene 
markers in the uteri and decidua of the mice using Power Sybr Green Master Mix (Life Tech 
A25742). Briefly, 5 µl of a 1:7 diluted cDNA sample were mixed with 10 µl of master mix (7.5 µl 
of Sybr Green Mix, 0.6 µl primer sets and 1.9 µl of water) for a total volume of 15 µl per well in 
a MicroAmp optical 384-well reaction plate. Three technical replicates were performed for each 
sample. qRT-PCR amplification and quantitation were performed using a Quant Studio (Applied 
Biosytem) from the Functional Genomics Center. The reaction was run for 40 cycles (95 °C for 
15 seconds, 60 °C for 1 minute). The comparative CT method (ΔΔCT) was used for quantification 
of gene expression. Relative fold changes in gene expression for all tested genes were normalized 
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to Peptidylprolyl isomerase A(Ppia) and Ribosomal protein, large, P0 (Rplp0) endogenous 
housekeeping genes. Genes analyzed include Bsg, Cebpβ, Bmp2, Heart and neural crest 
derivatives-expressed protein 2 (Hand2), Wnt4, Alkaline phosphatase (Alph) and Epiregulin 
encoding gene (Ereg). The primer sequences of these genes are listed in Table 4.1 
Immunohistochemistry 
To assess the abundance of BSG, Monocarboxylate transporter 1 (MCT1), Cluster of 
differentiation 98 (CD98), Cluster of differentiation 31 (CD31), cytokeratin (CK), HAND2 and 
CEBPβ, immunohistochemistry (IHC) was performed on samples collected on day 4, day 5 or day 
6 of pregnancy. Briefly, slides of uterine horns were deparaffinized using three xylenes and 
rehydrated though a series of decreasing concentrations of ethanol, then subjected to heat-induced 
antigen retrieval with DAKO Target Retrieval Solution at 1:10 dilution (10X pH9) (Dako Denmark 
A/S, Denmark, Part Number: S236784-2, Code: S2367) at 100 ◦C for 30 minutes and allowed to 
cool to room temperature (RT). This was followed by inactivation of endogenous peroxidase 
activity with 0.3% H2O2/methanol for 15 minutes in the dark. The samples were then rinsed with 
phosphate buffered saline with Tween-20 (PBST) and incubated in blocking solution consisting of 
5% horse serum (Vectastain ABC kit, Vector Laboratories, Inc. Burlingame, CA) diluted in 
1%BSA/PBST at RT for 60 minutes. The tissue sections were incubated with a primary antibody 
at specific concentrations overnight at 4 ◦C. The primary antibodies used were: BSG (R&D system 
AF772) at 1:200 dilution, MCT1 (LSBio c335287) at 1:100 dilution, CD98 (Santa Cruz Sc9160) 
at 1:200 dilution, CEBPβ (Santa Cruz sc-150) at 1:100 dilution, pan cytokeratin (Sigma c2562) at 
1:200 dilution and CD31 (Abcam, ab28364) at 1:50 dilution. The negative control sections were 
incubated in a non-specific IgG of the same species as the primary antibodies to confirm specificity 
of the primary antibodies. On the following day, slides were rinsed with PBST prior to incubation 
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with anti-rabbit, anti-goat or anti-mouse biotinylated secondary antibody (Vectastain ABC kit, 
Vector Laboratories, Inc. Burlingame, CA) at 1:200 dilution in PBST for 60 minutes at RT. Slides 
were then rinsed and incubated in ABC solution (PBS: A: B=50:1:1) (Vectastain ABC kit, Vector 
Laboratories, Inc. Burlingame, CA) for 30 minutes at RT. For visualization of the 
immunoreactivity, all slides were subjected to chromogen 3’3-diaminobenzidine (DAB) (Vector 
Laboratories, Inc. Burlingame, CA) for 30 seconds. Slides were rinsed in tap water for 10 minutes 
to stop the DAB reaction. Thereafter, the slides were counterstained with hematoxylin for one 
minute followed by dehydration and cover-slipping. After drying for 24 hours, the slides were 
cleaned and loaded into a Hamamatsu Nanozoomer 2.0 HT for scanning. 
Immunofluorescence Staining 
To assess the abundance and localization of BSG, cytokeratin, E-cadherin, HAND2, 
CEBPβ, MCT1 and CD31 in the uteri at the time of implantation and later stages, 
immunofluorescence (IF) staining was performed on samples on day4, day 5 and day 6 of 
pregnancy. Briefly, uterine slides were deparaffinized using three xylenes and rehydrated through 
a series of decreasing concentration of ethanol, and then subjected to heat-induced antigen retrieval 
with DAKO Target Retrieval Solution at 1:10 dilution (10X pH9) (Dako Denmark A/S, Denmark, 
Part Number: S236784-2, Code: S2367) at 100 ◦C for 30 minutes and allowed to cool to RT. The 
slides were then incubated in blocking solution consisting of 5% horse serum (Vectastain ABC 
kit, Vector Laboratories, Inc. Burlingame, CA) diluted in 1%BSA/PBST at RT for 60 minutes. 
The tissue sections were incubated with a primary antibody at specific concentrations overnight at 
4 ◦C. The primary antibodies used were: BSG (R&D system AF772) at 1:200 dilution, MCT1 
(LSBio c335287) at 1:100 dilution, E-cadherin (R&D system af748) at 1:100 dilution, pan 
cytokeratin (Sigma c2562) at 1:200 dilution and CD31 (Abcam, ab28364) at 1:50 dilution. The 
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negative control sections were incubated in a non-specific IgG of the same species as the primary 
antibodies to confirm specificity of the primary antibodies. On the following day, slides were 
rinsed with PBST prior to incubation with either an anti-goat Alexa488 conjugated secondary 
antibody (Jackson Immuno Research # 805-545-180), an anti-rabbit Cy3 conjugated secondary 
antibody (Jackson Immuno Research # 711-165-152) or an anti-mouse Cy5 conjugated secondary 
antibody (Jackson Immuno Research # 715175151) at 1:200 dilution for 1 hour at RT. After 
incubation, slides were rinsed with PBS and covered with a DAPI containing mounting medium 
(Vector Laboratories, H-1200). To detect the immunoreactivity, all slides were imaged using a 
Zeiss LSM 710 confocal microscope at the Institute for Genomic Biology at the University of 
Illinois, Urbana-Champaign. 
Jones’ Silver Stain 
To assess the uterine basement membrane integrity of the cKO females at the time and site of 
implantation, Jones’ silver stain was performed. Briefly, slides of uterine horns on day 5 were 
deparaffinized using three xylenes and rehydrated through a series of decreasing concentrations of 
ethanol, and then oxidized in 0.5% periodic acid solution for 11 minutes. After rinsing thoroughly 
in distilled, deionized water, slides were placed in freshly made methenamine silver solution (3% 
methenamine and 5% silver nitrate) at 70 ◦C for 60 minutes. The slides were checked every 20 
minutes for precipitate formation. Once a medium brown color stain appeared, slides were rinsed 
in distilled deionized water at 70 ◦C. The slides were then placed in 0.2% gold chloride solution 
for 1 minute, rinsed in distilled water and treated with sodium thiosulfate for 1 min. The slides 
were then rinsed in running tap water for 10 minutes before counterstaining. Fast green (Fisher) 
was used for 1 minute as a counterstain. The slides were then dehydrated and covered. After drying 
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for 24 hours, the slides were cleaned and loaded into a Hamamatsu Nanozoomer 2.0 HT for 
scanning. 
Artificial Decidualization Response 
To evaluate the decidualization response of the cKO females, an ADR experiment was 
conducted as illustrated in Figure 4.1. Ten female mice of each genotype were ovariectomized 
and rested for two weeks to eliminate innate circulating steroid hormones. To precisely control the 
level of hormones in the animals, estradiol and progesterone were injected into the animals 
subcutaneously daily for two weeks. First, 100 ng of estradiol was injected for 3 days, then the 
mice were rested for two days before daily injection of 10 ng estradiol and 1 mg progesterone were 
administered for another 3 days. On the third day of estradiol and progesterone injection, the mice 
were anesthetized with 8.7 mg/ml ketamine and 1.5 mg.ml xylazine (provided by the Division of 
Animal Resources at the University of Illinois, Urbana-Champaign). A small incision was made 
on the abdominal side to expose the right uterine horn. Then 15 µl of corn oil (Sigma c8267) were 
injected into the uterine horn from the basal part to serve as a stimulus for decidualization. The 
other uterine horn was not injected as an internal control. The wound was sutured, and the mice 
were allowed to recover. Following the oil injection, the mice were injected with 1 mg 
progesterone every day for another 3 days before tissue collection. One control mouse was lost 
during the surgery, but all the remaining mice were subjected to euthanasia and tissue collection. 
After euthanizing the mice, the uterine horns were weighed separately and photographed. The 
injected uterine horn was cut in half. One half was snap frozen in liquid nitrogen for further RNA 
isolation and qRT-PCR analysis. The other half was fixed in 10% buffered formalin for 24 hours, 
then transferred to 70% ethanol and processed for histological analysis. To measure the size of the 
cross section of the decidua tissue, H&E stained slides were loaded into a Hamamatsu Nanozoomer 
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2.0 HT for scanning. The area, perimeter and diameter of the cross sections were measured and 
recorded for each animal. 
Statistical Analysis 
All data were analyzed utilizing GraphPad Prism software 8 (GraphPad Prism, San Diego, 
CA). Data are presented as means ± standard error of the means (SEM).  For normally distributed 
data, unpaired t tests were used to compare the control group and the experimental group. For non-
normally distributed data, Mann-Whitney tests were used. A statistical significance was assigned 
at p≤0.05. A trending difference was assigned when the p value was between 0.05 and 0.1. 
 
Results 
Luminal epithelial cell integrity is not affected at implantation in the cKO females. 
In order to determine if implantation was impaired in the cKO mice, uterine samples of 
females of both genotypes were collected on day 5 of pregnancy. The uteri slides were stained 
with a pan-cytokeratin antibody by IHC and IF. The IHC results (Figure 4.2) showed that in the 
control animals (top panel), at the embryo implantation site, there was no cytokeratin, indicating a 
disruption of the epithelial layer. However, the embryo in the cKO females (bottom panel) was 
surrounded by a continuous layer of epithelial cells as highlighted by the positive brown color of 
cytokeratin, indicating the embryo was not able to break the epithelium and invade into the stromal 
layers. In the IF results (Figure 4.3), the embryos were marked with green for BSG as they express 
BSG, and the epithelium was marked with red for cytokeratin. In the controls (top panel), at the 
site far away from the embryo, there was continuous expression of cytokeratin, highlighting the 
luminal epithelium, but at the site of implantation, the expression of cytokeratin was disrupted. 
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However, in the cKO (bottom panel), the embryo was clearly restrained in the pocket of epithelial 
layer.  
Immunofluorescence staining of E-cadherin was performed to evaluate the function of the 
luminal epithelium at the implantation site on the evening of day 5 of pregnancy (Figure 4.4). 
There was no E-cadherin at the site of implantation in the control mice (top panel), indicating a 
complete breakdown and apoptosis of the luminal epithelial cells. This suggests the embryo was 
able to penetrate the luminal epithelial barrier and successfully invade into the stromal layer. 
However, in the cKO (bottom panel), the embryo was still surrounded by an intact layer of 
epithelium with intense E-cadherin. The integrity of the epithelium was preserved, indicating 
failed luminal epithelial breakdown and embryo invasion in the cKO mice. This was assessed on 
the evening of day 5, when the embryo should have completed attachment and invasion as the 
control mice showed (Ye 2020). Thus, it suggests that the embryo surrounded by the intact luminal 
epithelium in cKO was not due to delayed implantation, but due to failed implantation.  
Basement membrane is not disrupted at implantation site in the cKO females. 
The penetration and breakdown of the uterine luminal epithelial basement is required for 
successful implantation (Blankenship and Given 1995). To assess the basement membrane status 
of the cKO females, Jones’ silver stain was performed (Figure 4.5) on implantation sites collected 
on day 5 evening of pregnancy. In the controls, the black stain lining the luminal epithelium was 
found away from the embryo, but there was no positive stain at the site of embryo attachment, 
suggesting a breakdown of the basement membrane. In the cKO, the black color positive stain was 
still present at the basal side of the luminal epithelium around the embryo, suggesting an unaltered 




cKO females have an impaired artificial decidualization response. 
Proper decidualization is critical for normal pregnancy (Ramathal et al. 2010). An ADR 
experiment was carried out in both genotypes as Figure 4.1 showed. Uteri were photographed at 
collection and images are shown in Figure 4.6. The results revealed that in the controls, most of 
the animals displayed a robust response to the stimuli (top panel). However, in the cKO mice, there 
was a very modest response or no response at all in most of the animals (bottom panel).  
Each uterine horn was weighed and the ratio of injected horn to uninjected horn weight 
was calculated (Figure 4.7 A). In the controls, on average, the injected uterine horn had a 9.13-
fold increase in weight in response to the stimuli. However, in the cKO mice, there was only a 
modest 2.2-fold increase in the weight of the injected uterine horn, indicating an impaired decidual 
response. The body weight of each mouse was also measured (Figure 4.7 B). The cKO mice 
weighed 22.73 g on average, which was not different compared to the controls at 23.67 g. This 
suggests that the differences in the uterine weights between the genotypes of mice was due to 
different responses to the experimental stimuli, rather than body weight differences.  
ADR-induced decidua size is much smaller in the cKO females. 
To quantify the size of the decidua, cross sections of the decidual tissue were captured and 
measured using the Nanozoomer (Figure 4.8). The size was measured as the area, perimeter and 
diameter of the cross section. The area of the controls was 7.2 mm2, which was significantly higher 
than the area of the cKO at 3.86 mm2. The perimeter of the controls was 10.74 mm, which was 
much higher than the 7.38 mm of the cKO. The diameter of the controls was also significantly 
higher than the cKO, at 3.17 mm to 2.19 mm. These results confirmed that the decidua was much 




Expression of decidualization markers is downregulated in the cKO females. 
I evaluated the expression levels of several genes known to regulate decidualization by 
qRT-PCR and the results are shown in Figure 4.9. Bsg gene expression levels in the cKO were 
downregulated by 86% of the levels in the controls as expected. Cebpβ expression in the cKO was 
significantly downregulated by 75% of the levels in the controls and Bmp2 expression in the cKO 
mice was also significantly downregulated by 88% of the levels in the controls. The expression 
levels of Hand2 and Wnt4 tended to be lower in the cKO, both at 50% of the levels in the controls, 
but not statistically different. Alph and Ereg expression levels were not significantly altered. These 
results confirm that specific decidualization marker genes were downregulated in the cKO, leading 
to the incomplete decidualization response. 
CEBPβ protein abundance is reduced in the cKO females. 
To determine whether the protein expression level was consistent with gene expression 
level for some of the decidualization genes, I chose CEBPβ and HAND2 for immunohistochemical 
analysis. Results shown in Figure 4.10 confirm there was abundant CEBPβ protein expression in 
the decidual tissue in the control mice (A), but there was very little CEBPβ expression in the cKO 
mice (B). This confirmed that the CEBPβ protein abundance level was much reduced in the cKO 
compared to the controls. Similar results were observed in the uteri of mice on the evening of day 
5 pregnancy using IF staining. In Figure 4.12, uterine sections were double stained with BSG and 
CEBPβ. The results in the control animals (top panel) showed abundant CEBPβ expression (orange 
color) present in the primary decidual zone surrounding the embryo. In the cKO females, however, 
the area of CEBPβ positive cells was much smaller (bottom panel). Similarly, in Figure 4.13, 
uterine of day 5 pregnant mice were double stained with E-cadherin (green) and CEBPβ (orange). 
These results showed that the controls lost E-cadherin expression at the implantation site but had 
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a broad region of stromal cells expressing CEBPβ (top panel). In the cKO (bottom panel), the 
embryo was restrained within a circle of intact, E-cadherin positive luminal epithelium, and the 
expression of CEBPβ was limited to a smaller region of stromal cells close to the embryo. 
HAND2 protein abundance is reduced in the cKO females. 
HAND2 protein abundance was also evaluated in the decidual tissue in both the controls 
and the knockouts using IHC. Figure 4.11 showed in the decidual tissue of the controls, HAND2 
was abundant in the stromal cells over a wide area. However, in the cKO mice, HAND2 was 
greatly reduced compared to the controls. Similar results were confirmed in the uteri of day 5 
pregnant mice using IF staining. In Figure 4.14, uterine sections of both genotypes were double 
stained with E-cadherin and HAND2. The top panel illustrated that the controls lost E-cadherin at 
the site of embryo implantation but maintained E-cadherin in the luminal epithelium away from 
the embryo implantation site. HAND2 protein was found in the subepithelial stromal cells 
surrounding the embryo. In the cKO showed in the bottom panel, the luminal epithelium still 
maintained E-cadherin. As a result, the embryo was not able to penetrate through the luminal 
epithelium. There was some HAND2 in the subepithelial stromal cells, but compared to the 
controls, the area of HAND2 positive cells was much smaller. Taken together, these data support 
that HAND2 abundance was reduced in the cKO females. 
CD98 protein localization is not altered in the cKO females. 
CD98 interacts with BSG and is found in the apical surface of endometrial epithelium 
during implantation and is important for adhesion and metabolism (Guo et al. 2015; Domínguez 
et al. 2010). To examine the localization pattern of CD98, IHC for CD98 was performed on 
samples from day 1 and day 4 of pregnancy. There was no difference in the localization of CD98 
on day 1 of pregnancy (top panel) in the controls compared to the cKO, as CD98 was normal in 
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the luminal epithelium. Similarly, CD98 was found the stromal layers on day 4 of pregnancy in 
both the cKO and control uteri (Figure 4.15). This indicates the localization of CD98 was not 
affected by loss of BSG in the cKO females. 
MCT1 protein localization is altered in uterus of the cKO females. 
MCTs are important for lactate transport and metabolic homeostasis, and MCT1 and MCT4 
are shuttled to the membrane by their chaperone protein BSG  (Halestrap 2012; Woodhead et al. 
2000; Gallagher et al. 2007). To assess the abundance and localization of MCT1 in the cKO 
females, I performed IHC and IF on uterine sections at day 4 and day 6 of pregnancy. IHC results 
in Figure 4.16 revealed that, on day 4 of pregnancy, the controls (A) showed MCT1 on the basal 
side of the luminal epithelium, but this localization was not present in the cKO mice (B). On day 
6 of pregnancy, MCT was found in the embryo and in the cell membrane of the stromal cells in 
the deep stromal layer in the controls (C). However, in the cKO females, BSG was only found in 
the embryo, not in the cell membrane of the deep stromal cells (D).  
Immunofluorescence staining showed similar results in Figure 4.17. In the controls, BSG 
was abundant in the deep undifferentiated stromal cells and MCT1 was localized in the same 
region (B and C). In contrast, BSG was found only in some immune cells and endothelial cells in 
a scattered pattern within the stroma of the cKO females on day 6 of pregnancy (F). MCT1 was 
very weak at a low magnification (G), and there was no co-localization of the two proteins (H). 
At a higher magnification focused at the deep stromal layer in Figure 4.18, BSG was abundant in 
the cell membrane (B) in the uteri of the controls. MCT1 was also found in the cell membrane (C) 
and these two co-localized in the merged image (D).  However, in the cKO females, there was no 
such co-localization of BSG and MCT1 in the same area. These results confirm that the localization 
and abundance of MCT1 were altered in the uteri of the cKO females. 
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CD31 protein abundance is reduced in the cKO females. 
To evaluate the status of angiogenesis in the cKO mice, I performed IHC for the angiogenic 
marker CD31 on uterine sections on day 6 of pregnancy. Figure 4.19 shows that, CD31 was 
abundant in the embryo and also in the endothelial cells among deep stromal cells in the controls 
(B). The abundance of CD31 was much lower in the cKO mice (E). A higher magnification of the 
deep stromal layer in Figure 4.20 showed clearly that abundance of CD31 (red) was much higher 
in the control (B) compared to the cKO female (E). To quantify the abundance of CD31, images 
of five fields were randomly selected and measured for their signal intensity. The results showed 
that the signal intensity in sections from the controls was 34.92, which was significantly higher 
than the value of 20.3 in the cKO females (Figure 4.21). These results revealed a markedly 
decreased abundance of CD31 in the uteri of the cKO mice, suggesting reduced angiogenesis at 
the implantation sites in these animals.  
 
Discussion  
 BSG is a transmembrane glycoprotein expressed in many tissue and cell types, including 
the reproductive organs in both humans and mice (Fossum, Mallett, and Neil Barclay 1991; Chen 
et al. 2007). Studies have shown that Bsg null mice were infertile likely due to failed fertilization 
or implantation (Kuno et al. 1998; T Igakura et al. 1998). Implantation is a dynamic event that 
involves a series of physical and physiological interactions between the implanting blastocyst and 
the receptive uterus (H. Wang and Dey 2006). At the time of implantation, the luminal epithelial 
cells at the implantation site undergo apoptosis and the basement membrane is breached for further 
invasion of the embryo (Pampfer and Donnay 1999). Cytokeratin assembles into a flexible 
dynamic network of intermediate filaments and determine the cell shape of epithelial cells (Fuchs 
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and Weber 1994). During peri-implantation period, cytokeratin is downregulated in the 
endometrium of mice, rabbits and cows (Gou et al. 2019; Olson et al. 2002; Haeger et al. 2015). 
The results showed that the luminal epithelial cells at the site of implantation still expressed 
cytokeratin in many cKO mice on the evening of day 5 pregnancy. E-cadherin, a Ca2+-dependent 
transmembrane protein that forms adhesion junctions, is expressed in the luminal epithelium 
(Wesseling, Van Der Valk, and Hilkens 1996). During implantation, expression of E-cadherin is 
downregulated due to cell remodeling to assist blastocyst attachment and invasion in mice, rats 
and rabbits.  (Paria et al. 1999; Q. Li et al. 2002; Gou et al. 2019). Paria and colleague reported 
that E-cadherin is expressed in the luminal epithelium prior to implantation, but it is lost during 
implantation and transiently appears in the stromal cells in mice (Paria et al. 1999). Nallasamy and 
colleague showed that persistent expression of E-cadherin results in implantation failure 
(Nallasamy et al. 2012). The results showed that in the cKO uteri, E-cadherin was expressed 
throughout the uterine luminal epithelium at the time of implantation. Similarly, the activin-like 
kinase (ALK)-3 cKO mice also expressed E-Cadherin in the luminal epithelium at this time and 
had implantation failure and infertility (Monsivais et al. 2016).  
During early pregnancy in rodents and humans, the endometrial stromal cells respond to 
the invasion of the embryo by undergoing proliferation followed by differentiation; this 
morphological and functional transformation is known as decidualization. (Peng et al. 2008). It is 
widely accepted that a fully developed decidua is a prerequisite for successful implantation, and 
abnormal decidualization can result in implantation failure, miscarriages, preeclampsia and 
intrauterine growth restrictions (Ramathal et al. 2010; Kong, Aronow, and Handwerger 2006; 
Singh, Chaudhry, and Asselin 2011). The ADR results showed that most of the cKO females either 
did not have a decidual response or had a modest decidual response, whereas the control females 
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had a robust response. The qRT-PCR results showed that Bmp2 and Cebpβ in the cKO decidual 
tissue have been significantly downregulated compared to the controls. BMP ligands and receptors 
are expressed in the uterus of pregnant mice, and play key roles in regulating implantation 
(Clementi et al. 2013). BMP2 is most studied and loss of BMP2 in the uterus caused infertility of 
mice due to failures in embryo attachment and decidualization. BMP2 acts through its receptor 
ALK2 to regulate decidualization; Alk2 null mice failed to undergo uterine decidualization 
(Monsivais et al. 2016; Clementi et al. 2013). Microarray analysis revealed that CEBPβ is 
downstream of ALK2 and CEBPβ expression is suppressed in ALK2 cKO mice. CEBPβ is a 
transcription factor involved in cell cycle under regulation of steroid hormones, and is expressed 
in the endometrial stromal cells in mice, baboons and humans and (W. Wang et al. 2010; Kannan 
et al. 2010; Bhurke, Bagchi, and Bagchi 2016; Clementi et al. 2013). In mice, its expression is 
rapidly induced at the time of blastocyst attachment, and further increased during decidualization 
in the proliferating and decidualized stromal cells surrounding the blastocyst. Studies have shown 
that CEBPβ is a key regulator of decidualization as CEBPβ-lacking uteri failed to undergo 
decidualization and lacked a response to artificial decidualization stimulation similar to these 
results in this chapter (Bagchi et al. 2006; Mantena et al. 2006). It is also reported that CEBPβ acts 
through its direct downstream target STAT3 to regulate decidual response in human and mice 
(Cheng et al. 2001; W. Wang et al. 2012). Interestingly, BSG is reported to promote STAT3 
activity in cancer cells (L. Li et al. 2013). Together with the downregulation of Bmp2, it suggests 
that loss of BSG in the uterus leads to defective decidualization, likely through BMP-ALK2-
CEBPβ-STAT3 pathway. HAND2 is a transcription factor that is expressed in the uterine stromal 
cells in mice (Q. Li et al. 2011).  Studies have shown that HAND2 mRNA and protein levels 
increase in mouse uterine stromal cells during decidualization and this upregulation is not embryo 
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dependent (DV Huyen 2011). Reduction of HAND2 expression in these cells using RNA knock 
down approaches leads to reduced decidualization in both mouse and human in vitro (DV Huyen 
2011). These results showed that both mRNA and protein abundance of HAND2 were 
downregulated in the decidual tissue from the ADR experiment and the uteri on day 5 of pregnancy 
in the cKO mice compared to the controls. These results indicate that loss of BSG in the uterus 
leads to compromised decidualization through regulating Hand2 expression. 
MCTs are short-chain fatty acids transporters for lactate, pyruvate and ketone bodies and 
play important role in metabolic homeostasis in many tissue types including the uterus (Halestrap 
2012). BSG is a chaperone protein for MCT1 and MCT4 and is responsible for shuttling these 
MCTs to the membrane (Woodhead et al. 2000; Amit-Cohen, Rahat, and Rahat 2013; Gallagher 
et al. 2007). MCT1 and BSG co-localize and form a heterodimer through its transmembrane 
domain and is critical for cells with a high glycolytic rate under hypoxic conditions. The increase 
in glycolytic flux are also seen in physiological processes with rapidly proliferating cells such as 
in embryo implantation (Bougatef et al. 2009; Chen, Belton, and Nowak 2009). The IHC and IF 
results showed that MCT1 abundance and localization were altered in the cKO mice compared to 
the controls on day 4 and day 6 of pregnancy. Studies have shown that BSG regulates MCTs 
abundance and localization, for instance, in the retina of Bsg null mice, MCT1 and MCT4 were 
lost (Philp et al. 2003). Silencing of Bsg in human malignant melanoma cells abrogated the 
expression of MCT1 and downregulated glycolysis (Su, Chen, and Kanekura 2009). Similarly, in 
lung fibroblast cells, knocking down of Bsg suppressed MCT1 and MCT4 expression and reduced 
glycolysis and lactate export of the cells (Le Floch et al. 2011). Therefore, lactate transport in the 
cKO mice needs to be investigated.  
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Angiogenesis during decidualization is crucial for pregnancy establishment and 
maintenance (H. Wang et al. 2013). The differentiating stromal cells form an avascular primary 
decidual zone on day 5 surrounding the embryos, then form a well vascularized secondary decidual 
zone by day 8 (X. Wang et al. 2004). BSG is important in promoting angiogenesis as study shows 
BSG overexpression promotes tumor angiogenesis and growth by inducing vascular endothelial 
growth factors (VEGFs) and matrix metalloproteinases (MMPs) expression in both human and 
mouse (Tang et al. 2005). These results showed that there was a significantly reduction in 
angiogenic marker CD31 in the cKO mice on day 6 of pregnancy. This is very similar to the study 
on the role of gap junction protein connexin 43 (Cx43) in female reproduction. The Cx43 cKO 
mice are subfertile due to failed decidualization by natural mating and ADR. Loss of Cx43 also 
caused strikingly impairment in angiogenesis with reduction in the abundance of CD31 and VEGF 
(Laws et al. 2008). These results indicate loss of BSG leads to a reduced angiogenesis in these 
animals. Future studies on the expression of VEGFs in the cKO mice need to be investigated to 
further support these findings.  
The data results in this chapter clearly demonstrated that loss of uterine BSG results in 
impaired implantation, decidualization and angiogenesis, and eventually causes subfertility in 
mice. The results on the gross morphology of uteri at different gestational days in Chapter 3 
showed 25% cKO mice did not have implantation and about 40% had abnormal pregnancy. In this 
study, I found six out of nine cKO mice had implantation failure and 70% cKO had no response 
or very modest response in the ADR experiment. This reveals that only a subset of the animals 
was negatively affected by lacking BSG in the uteri during pregnancy. There are potentially several 
explanations for their unaffected or partially affected fertility of the cKO mice. First, PR is not 
expressed in all uterine compartment and cell types. Studies have shown that PR is expressed in 
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the luminal and glandular epithelial cells, stromal cells and myometrium of the cycling mice, with 
only PRB in the luminal epithelium, and both PRA and PRB in the stroma and myometrium 
(Binder et al. 2014; Mote et al. 2006). In ovariectomized mice, PR expression is intense in the 
luminal and glandular epithelium, but only approximately 16% and 29% of the myometrial and 
stromal cells express PR respectively. When, treated with estradiol, luminal epithelial expression 
of PR is much downregulated, whereas glandular epithelial expression is the same. Stromal and 
myometrial expression of PR increases to about 60% and 80%. When treated with both estradiol 
and progesterone, PR expression in the epithelium is much downregulated, and stromal and 
myometrial expression remains high at 60% and 70% (Tibbetts et al. 1998). It’s worth noted that 
not all stromal cells express PR. In the report of Soyal et al on characterization of the PR-Cre and 
Lox mouse model, it is clear that some stromal cells did not possess the Cre activity (Soyal et al. 
2005; Ismail et al. 2002). Although it is a powerful tool for genetical modification in vivo, it does 
not guarantee 100% effectiveness of deletion. Indeed, the qRT-PCR results of Bsg mRNA level 
on day 4 and day 5 pregnant mouse uteri and endothelial stromal cells (discussed in Chapter 5) 
showed that about 20%-25% of the cKO samples still expressed comparable levels of Bsg to the 
controls, indicating that not all of the animals or cells have lost BSG in the uteri. The second 
explanation is that the PR negative cells in the uterus still express BSG and this is enough to 
maintain some fertility for the cKO animals. For example, the uterus contain many immune cells 
and blood vessels, which are PR negative (Ismail et al. 2002). However, BSG is expressed in these 
cell populations (Jennifer Nancy Hahn, Kaushik, and Yong 2015; Xin et al. 2016). The IHC and 
IF results on the uteri samples showed that BSG was still expressed in the immune cells and 
endothelial cells as they show intense immunoreactivity in the cKO. These PR negative, BSG 
positive cells could exert BSG function through paracrine activity. In addition, studies have shown 
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that BSG is detected in the microvesicles and can be released through microvesicle shedding (J. 
N. Hahn, Kaushik, and Yong 2015; Nabeshima et al. 2006; Sidhu et al. 2004; Emilova 2012). This 
way, when the luminal epithelial and stromal cells lost BSG expression, other BSG positive cells 
close to the embryo, including the immune cells and endothelial cells, are able to release BSG 
through microvesicles. Thus it is important to investigate whether the microvesicles shed by these 
cells in the cKO mice contain BSG in the future. The third possible explanation is the 
compensatory mechanism of BSG related molecules. Compensation is a common phenomenon in 
complex living organism to maintain biological homeostasis when something goes wrong. For 
instance, in the uterus of mice, COX2 is critical for implantation, but loss of COX2 leads to 
compensatory upregulation of COX1, which rescues the female infertility (H. Wang et al. 2004). 
Similarly, embigin, the founding member of the Ig superfamily, is expressed in the uterus and acts 
as an ancillary protein when BSG is absent (Nakai, Chen, and Nowak 2006). MCT1 and MCT4 
have highest affinity for binding BSG, but when BSG is absent, they can also bind to embigin. 
Furthermore, embigin is required for shuttling MCT2 to the cell surface. MCT2, in turn, can 
compensate for the loss of MCT1 function (Nakai, Chen, and Nowak 2006; Doherty and Cleveland 
2013). Whether the abundance of the other MCTs are altered in the cKO mice should be further 
investigated. Therefore, the effectiveness of the PR knockout, paracrine activity or microvesicle 
shedding by BSG positive cells, as well as compensatory effort by embigin together could explain 
the subfertility caused by loss of uterine BSG using this PR-Cre mouse model.  
In summary, the results in current studies show that the uteri lacking BSG expression failed 
implantation and decidualization in mice. I found that luminal epithelial integrity was not affected 
in the cKO mice at the time of implantation as cytokeratin and E-cadherin were still expressed at 
the implantation site. The basement membrane was also intact in the cKO mice, when it was 
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supposed to be disrupted as in the controls. As a result, embryos in many of the cKO mice were 
not able to attach or break the barrier of luminal epithelium. The ADR experiment showed that the 
cKO mice had a compromised decidualization as they responded less to the artificial stimulus and 
formed smaller decidua. qRT-PCR results on decidualization markers showed that Bmp2 and 
Cebpβ were markedly downregulated in the cKO. IHC and IF results showed that protein levels of 
CEBPβ and HAND2 were downregulated in the cKO mice compared to the controls. The 
localization and abundance of MCT1 were abnormal in the cKO mice, suggesting a possible 
altered lactate transport. This will be investigated in the next chapter. CD31 abundance was 
significantly reduced in the cKO mice, indicating a suppressed angiogenesis in these animals 
compared to the controls. Collectively, these findings suggest that loss of BSG in the uterus led to 
failed implantation, impaired decidualization, altered MCT localization and decreased 
angiogenesis in vivo. Future studies will focus on the role of BSG in decidualization and lactate 
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Table 4.3 ADR Decidua Size  
 
Decidua Size Area Perimeter Diameter 
BSGf/f (n=4) 7.20 10.74 3.17 
BSGd/d(n=4) 3.86* 7.38* 2.19* 
 
  
Genes NCBI Gene Reference Left Primer Sequence Right Primer Sequence 
Rplp0 NM_007475.5 actggtctaggacccgagaag ctcccaccttgtctccagtc 
Ppia NM_008907.1 ggaccaaacacaaacggttc catgccttctttcaccttcc 
Bsg NM_009768.2 acagcagtggcgttgaca ggtcatctgcgtccactatgt 
Cebpβ NM_001287739.1 aagatgcgcaacctggag cagggtgctgagctctcg 
Bmp2 NM_007553.3 agatctgtaccgcaggcact gttcctccacggcttcttc 
Hand2 NM_010402.4 tgagcagcaacgacaagaaa tgctctcctcttcttcactgc 
Wnt4 NM_009523.2 actggactccctccctgtct tgcccttgtcactgcaaa 
Alph NM_007431.3 cggatcctgaccaaaaacc tcatgatgtccgtggtcaat 


















BSGf/f (n=9) 23.667 0.026 0.118 0.144 9.131 0.006 0.005 









Figure 4.1 ADR experiment design and timeline. Mice were ovariectomized and rested for 7 
days. Then 100 ng of E2 was given to each mouse subcutaneously for 3 days, rest for 2 days, then 
10 ng of E2 and 1 mg of P4 were given to each mouse for 3 days. On day 9, 20 µl of corn oil was 
injected into the left uterine horn. 1 mg of P4 was given for 4 more days before the mice were 











Figure 4.2 Luminal epithelial cell integrity at implantation. IHC for cytokeratin on 
implantation sites of control females (A and B) and cKO females (C and D) on day 5 evening of 












Figure 4.3 Luminal epithelial cell integrity at implantation. Immunofluorescent stain against 
bsg (green), cytokeratin (red) on implantation sites of control females (top lane) and cKO females 












Figure 4.4 Luminal epithelial cell integrity at implantation. Immunofluorescent stain against 
e-cadherin (green) on implantation sites of control females (top lane) and cKO females (bottom 









Figure 4.5 Basement membrane integrity at implantation. Jones’ silver stain of uterine cross-
sections at the implantation site on day 5 evening of a control (A) and a cKO (B) mouse. Black 









Figure 4.6 Artificial decidualization response images. Photos of uteri undergone ADR 








Figure 4.7 Artificial decidualization response results. A: Injected to uninjected uterine weight 








Figure 4.8 ADR cross section size. A: H&E stain on cross sections of decidua from a control 
female (left) and cKO female (right). B: quantitation of decidua size measured by area (left), 









Figure 4.9 Decidualization gene expression results on RNA extracted from decidua of both 
genotypes. Bsg, Bmp2, and Cebpβ were significantly downregulated in the cKO decidual tissues 
compared to the controls (p<0.05). Hand2 and Wnt4 expression levels were lower in the cKO 








Figure 4.10 Cebpβ localization. IHC for decidualization marker CEBPβ in the decidua from a 






Figure 4.11 HAND2 localization. IHC for decidualization marker HAND2 in the decidua from a 






Figure 4.12 CEBPβ and BSG localization in the uteri of day 5 pregnant mice. IF stain for BSG 
(green) and CEBPβ (orange) on uterine sections of cKO mice (A-D) and control mice (E-H) on 
day 5 of pregnancy. Images were taken at 10X magnification. 
 
Figure 4.13 CEBPβ and E-CAD in the uteri of day 5 pregnant mice. IF stain for BSG (green) 
and E-CAD (orange) on uterine sections of cKO mice (A-D) and control mice (E-H) on day 5 of 






Figure 4.14 HAND2 and E-CAD in the uteri of day 5 pregnant mice. IF stain for E-CAD 
(green) and HAND2 (orange) on uterine sections of cKO mice (A-D) and control mice (E-H) on 












Figure 4.15 CD98 localization. IHC for CD98 on uterine cross sections of control mice (A, C) 









Figure 4.16 MCT localization. IHC for MCT1 on uterine sections of control mice (A, C) and 






Figure 4.17 MCT1 localization at low magnification. IF stain for MCT1 (red) and BSG (green) 
on uterine sections of cKO mice (A-D) and control mice (E-H) on day 6 of pregnancy. Images 
were taken at 5X magnification. 
 
 
Figure 4.18 MCT1 localization at high magnification. IF stain for MCT1 (red) and BSG (green) 
on uterine sections of cKO mice (A-D) and control mice (E-H) on day 6 of pregnancy. Images 







Figure 4.19 CD31 localization at low magnification. IF stain for CD31 (red) on uterine sections 










Figure 4.20 CD31 localization at high magnification. IF stain for CD31 (red) on uterine sections 









Figure 4.21 Quantification of CD31 abundance. Quantification of CD31 signal intensity in the 
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Loss of Basigin in the Mouse Endometrial Stromal Cells Leads to Impaired Decidualization 
and Lactate Transport in vitro 
 
Abstract 
Basigin (BSG) is a member of the Ig superfamily and plays a role in cell proliferation, induction 
of MMPs for tissue remodeling and promoting angiogenesis. BSG is expressed in many tissues 
including the male and female reproductive tracts and is important for fertility. The previous 
studies showed that conditional knockout (cKO) of BSG in the uterus led to subfertility in mice 
due to impaired implantation, compromised decidualization, and altered abundance of the lactate 
transporters in vivo. Here I hypothesized that BSG is required for proper decidualization and 
normal lactate transport in the endometrial stromal cells cultured in vitro. To test this hypothesis, 
we used a primary cell culture system to isolate and culture mouse endometrial stromal cells 
(MESC). The aims of this study were 1) to investigate in vitro decidualization and 2) to investigate 
lactate transport in the cKO MESC. The results showed that proliferation of the cKO MESCs was 
not different compared to the controls at 24 hour and 48 hours of culture, indicating that the loss 
of BSG does not affect cell proliferation in the MESCs. Decidualization was suppressed in the 
cKO MESCs as expression of the decidualization markers Prl8a2, Cebpβ, Bmp2 and Hand2 were 
downregulated at some point during the four-day cell culture period. Protein levels of CEBPβ were 
not affected in the cKO MESCs. MMP9 immunofluorescent staining revealed there was no 
difference in the localization and abundance of MMP9 in the MESCs of the two genotypes. The 
concentrations of lactate secreted by the stromal cells were significantly reduced in the cell culture 
medium of the cKO MESCs compared to the controls on day 2 and day 4 of culture. MESCs were 
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also cultured under hypoxic conditions to investigate decidualization and lactate concentrations. 
These results showed that gene expression levels of decidualization markers were similar in the 
cKO MESCs compared to the controls under hypoxic condition. In agreement with the results from 
normoxia, lactate concentrations in the medium were significantly lower in the cKO MESCs 
compared to the controls when cultured under hypoxia. Collectively, these results suggest that the 
loss of BSG suppressed in vitro decidualization and reduced the concentration of lactate secreted 
by the MESCs. 
 
Introduction 
Pregnancy is a complex process that consists of discrete events such as implantation, 
decidualization, placentation and parturition (Cha, Sun, and Dey 2012). Implantation is the process 
where the blastocyst makes the first physical and physiological interaction with the maternal 
endometrium, and this event requires synchronization between the embryo and the receptive 
endometrium (H. Wang et al. 2013). After implantation, the uterine endometrium undergoes a 
unique transformation in mice and humans, known as decidualization, where the fibroblast-like 
endometrial stromal cells proliferate and terminally differentiate into large, round polyploid 
decidual cells (W. Wang et al. 2012; Kong, Aronow, and Handwerger 2006). This process is 
delicately controlled by steroid hormones, epithelial cell secreted factors, cell cycle regulators and 
immune cells (Conneely, Mulac-Jericevic, and Lydon 2003; Wetendorf and DeMayo 2012; Das 
2009; Croy et al. 2012). Normal decidualization is a prerequisite for successful pregnancy because 
it is involved in many important functions, including regulating trophoblast growth and 
invasiveness, providing nutrition to the developing blastocyst, establishing maternal-fetal 
immune-microenvironment, synthesizing hormones and promoting angiogenesis prior to the 
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formation of a functional placenta (Peng et al. 2008; X. Wang et al. 2004; Welsh and Enders 1987; 
Bombail et al. 2010). 
 During implantation and decidualization, the maternal microenvironment is under a 
hypoxic condition as the concentration of oxygen within the lumen of the uterus has been reported 
to be in the range of 1.5% to 5% depending on the species (Fischer and Bavister 1993). With 
limited levels of oxygen available, the embryos increase glucose consumption. This low oxygen 
environment and upregulation of glucose consumption are associated with high levels of lactate 
formation (Gardner 2015). Studies have shown that in the implanting embryo, 90% of the 
consumed glucose is converted to lactate (Clough and Whittingham 1983). The metabolism of the 
endometrial stromal cells at the time of implantation and decidualization is not clear, but it is 
reported that glucose metabolism is also important for decidualization of the endometrial stromal 
cells in humans and mice (Tsai et al. 2014). Lactate transport is facilitated by the monocarboxylate 
transporters (MCT). There are four MCTs in mice and their transmembrane localization requires 
the chaperone proteins BSG and embigin (Le Floch et al. 2011; Nagai et al. 2010; Kirk et al. 2000). 
BSG, also known as CD147 and EMMPRIN in humans; OX-47, MC31 and CE9 in rats; 
and HT7 in chickens, is a highly glycosylated protein with two immunoglobulin-like domains (K. 
Li and Nowak 2019). BSG plays multiple roles in both physiological and pathological processes 
including tumorigenesis, inflammation, tissue remodeling and neurological functions (Grass and 
Bryan 2016; Tang et al. 2005; Guindolet and Gabison Eric 2019; Weidle et al. 2010). BSG is also 
expressed in the reproductive tissues and is important for male and female reproduction (Chen et 
al. 2010; Bi et al. 2013). The previous chapters demonstrated, using a PR-Cre cKO model, that the 
loss of BSG led to subfertility in female mice. This is due to defective implantation and 
decidualization in vivo. The goals of this study were: 1) to investigate whether in vitro 
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decidualization is compromised in the MESCs of cKO mice and 2) to determine whether the lactate 
concentrations secreted into the culture medium by the MESCs from the cKO mice were different 
compared to the controls under normal oxygen levels and hypoxic conditions. Here I demonstrate 
that lack of BSG in the MESCs of the cKO mice led to compromised decidualization, as well as a 
reduction in the amount of lactate transported out of the cells into the medium under normal and 
hypoxic conditions.  
 
Material and Methods 
Animals 
C57/Bl6 mice were housed at the University of Illinois, Urbana-Champaign, at the Institute 
for Genomic Biology Animal Facility in polysulfone cages. Food (Harlan Teklad 8604) and 
filtered water were provided for the mice ad libitum. The room was maintained at a temperature 
of 22 ± 1 °C and on a 12 hour light-dark cycle. All experimental procedures including animal care, 
surgery, euthanasia and tissue collection were approved by the Institutional Animal Care and Use 
Committee at the University of Illinois, Urbana–Champaign. 
Animal mating 
To collect mouse endometrial stromal cells (MESC), two-month-old female mice of each 
genotype were mated naturally with one wild type male of proven fertility. One female and one 
male were housed together. The presence of a vaginal plug indicated successful mating behavior 
and the morning of the plug detection was designated as day 1 of pregnancy.  
Isolation of MESCs 
 Female mice were euthanized on day 4 of pregnancy, and the uteri were collected and 
transferred back to the laboratory in cold HBSS supplemented with 1% penicillin-streptomycin 
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(Fisher). The uterine horns were cut open longitudinally to expose the uterine lumen and placed in 
a Petri dish with fresh HBSS. The digestion mix pancreatin solution was made by dissolving 0.25 
g pancreatin (Sigma) in 10 ml 0.25% trypsin (Fisher) and then warmed in a 37 °C water bath for 
at least 1 hour prior to tissue isolation. The uteri were transferred into the pancreatin digestion mix 
and incubated horizontally for 60 minutes at 4 °C on an orbital shaker, then horizontally for 45 
minutes at room temperature (RT) without shaking and finally horizontally for 15 minutes at 37 
°C without shaking. After this two-hour incubation, the supernatant solution was poured away, 
and the uteri were transferred into a Petri dish containing cold medium containing 10% serum to 
inactivate trypsin activity for 5 minutes. The uteri were transferred to a 15 ml tube containing 3 ml 
of cold HBSS and vortexed for 10 seconds to release the epithelial sheets, then rinsed in a clean 
Petri dish with 3 ml HBSS. This vortexing and rinsing step was repeated two more times to remove 
the epithelial cells. The uteri were then transferred to digestion solution I and incubated for 30 
minutes at RT. For each animal, digestion solution I was made consisting of 30 mg dispase II 
(Sigma), 125 mg pancreatin (Sigma), 1% penicillin-streptomycin (Fisher) in 5 ml HBSS. 
Following 30 minutes of incubation, the same volume of stop solution (consisting of 10% FBS 
and 1% penicillin-streptomycin in HBSS) was added to the digestion solution. The supernatant 
was discarded, and the uterine tissues were washed twice in HBSS before transferring into 
digestion solution II to incubate for 45 minutes at 37 °C. Digestion solution II was made by diluting 
2.5 mg collagenase IA (Sigma) and 1% penicillin-streptomycin in 5 ml HBSS for each uterine 
sample. After completion of this incubation, the same volume of stop solution was added and the 
tube was vortexed for 10 seconds. The stromal cells were collected by passing the solution through 
a 40 µm nylon mesh filter (Fisher) into a new 50 ml tube. The cell-containing suspension was then 
centrifuged at 450 g for 6 minutes. The supernatant was discarded, and the cells were resuspended 
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with 10 ml of HBSS. After another centrifugation at 450 g for 6 minutes, the supernatant was 
aspirated, and the cells were resuspended and plated in DMEM/F12 medium. The DMEM/F12 
medium contained 10% FBS, 10 nM estradiol, 1 µM progesterone and 1% penicillin-streptomycin. 
Mouse endometrial stromal cell culture 
Following isolation of the MESCs, cell culture studies were performed under either normal 
or hypoxic conditions. For the normoxic conditions (20% O2), the cells from each animal 
(minimum five animals per genotype) were plated into two 75 cm2 culture flasks. The cells were 
incubated for 3-5 days, and the medium was changed every two days. For flask 1, on day 2, serum 
free medium was added to the flask. On day 3, the cells were trypsinized and collected for RNA 
extraction. Ten ml of the serum free medium were collected and stored in -80 ◦C for future analysis. 
For flask 2, regular medium was changed on day 2, then the serum free medium was added on day 
4. On day 5, cells were trypsinized and collected for future RNA extraction. Ten ml of the serum 
free medium were collected and stored at -80 ◦C for further analysis. For hypoxic conditions (1% 
O2), the cells were plated in two 75 cm
2 culture flasks and incubated in a regular incubator 
overnight before transferring to a Biospherix hypoxia incubator for 3-5 days. For flask 1, on day 
3, the medium was collected for lactate assay and the cells were trypsinized and collected for RNA 
extraction. For flask 2, the medium was changed on day 3. On day 5, the medium was collected 
for lactate assay and the cells were trypsinized and collected for RNA extraction.  
MESCS proliferation assay  
MESCs of both genotypes were seeded at a density of 105 cell/dish in 35 mm Petri dishes 
and were cultured in DMEM/F12 medium for 48 hours. At 24 hours and 48 hours, the cells were 
photographed, then trypsinized and harvested. The numbers of cells were counted using a 
Hemocytometer. Four dishes of cells were counted at each time point for each genotype. 
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RNA isolation and quantitative reverse transcription-PCR (qRT-PCR) 
Total RNA was extracted from the MESCs on day 0 (cells collected immediately after 
isolation on day 4 of pregnancy), 2, and 4 from normoxia incubation and on day 3 from hypoxia 
incubation using the Qiagen RNeasy Mini kit (Qiagen #74104) according to the manufacturer’s 
instructions. The concentration of the mRNA was determined by Nanodrop and the quality of the 
mRNA was assessed using the Bioanalyzer at the Functional Genomics Center at the University 
of Illinois, Urbana-Champaign (https://biotech.illinois.edu/functionalgenomics). One microgram 
of total RNA was reverse transcribed using the First Strand cDNA Synthesis Kit from Roche 
(#4379012001) following the manufacturer’s instructions. After the cDNA was synthesized, qRT-
PCR was performed to assess the mRNA levels of the decidualization markers in the stromal cells 
of the mice using the Power Sybr Green Master Mix (Life Tech #A25742). Briefly, 5 µl of a 1:7 
diluted cDNA sample were mixed with 10 µl of master mix (7.5 µl of Sybr Green Mix, 0.6 µl of 
primer set and 1.9 µl of water) for a total volume of 15 µl per well in a MicroAmp optical 384-
well reaction plate. Three technical replicates were performed for each sample. qRT-PCR 
amplification and quantitation were performed using a Quant Studio (Applied Biosytem) from the 
Functional Genomics Center. The reaction was run for 40 cycles (95 °C for 15 seconds, 60 °C for 
1 minute). The comparative CT method (ΔΔCT) was used for quantification of gene expression. 
Relative fold changes in gene expression for all tested genes were normalized to Peptidylprolyl 
isomerase A (Ppia) and Ribosomal protein, large, P0 (Rplp0) endogenous housekeeping genes. 
Genes analyzed include Bsg, Decidual prolactin-related protein family 8, subfamily a, member 2 
(Prl8a2), CCAAT enhancer-binding protein beta (Cebpβ), Bone morphogenetic protein 2 (Bmp2), 
Heart and neural crest derivatives-expressed protein 2 (Hand2) and Wingless-related integration 




To assess the protein abundance and localization of BSG, CEBPβ and MMP-9 in the 
MESCs, immunofluorescence (IF) staining was performed on cells incubated for two or four days 
after collection on day 4 of pregnancy. Briefly, the MESCs were plated in six-well plates with 
coverslips coated with poly L-lysine (Sigma Aldrich) and incubated for two days. Then the MESCs 
were fixed with freshly made 4% paraformaldehyde (Fisher) for 30 minutes at RT (RT). After 
washing cells with PBS three times, 1 ml of 0.5% Triton 100 (Sigma) was added to each well to 
permeabilize the cells for 15 minutes at RT.  The cells were washed with PBS before blocking 
with 5% horse serum (Vectastain ABC kit, Vector Laboratories, Inc. Burlingame, CA) diluted in 
1%BSA/PBST at RT for 60 minutes. The cells were incubated with primary antibodies at specific 
concentrations overnight at 4 ◦C. The primary antibodies used were: BSG (R&D System AF772) 
at 1:200 dilution, CEBPβ (Santa Cruz sc-150) at 1:100 dilution and MMP-9 (Abcam Ab38898) at 
1:100 dilution. The negative control cells were incubated with a non-specific IgG of the same 
species as the primary antibodies to confirm specificity of the primary antibodies. On the following 
day, the cells were rinsed with PBST prior to incubation with either an anti-goat Alexa488 
conjugated secondary antibody (Jackson Immuno Research # 805-545-180), or an anti-rabbit Cy3 
conjugated secondary antibody (Jackson Immuno Research # 711-165-152) at 1:200 dilution for 
1 hour at RT. After incubation, the cells were rinsed with PBS and covered with a DAPI containing 
mounting medium (Vector Laboratories, H-1200). To visualize the immunoreactivity, all slides 
were imaged using a Zeiss LSM 710 confocal microscope at the Institute for Genomic Biology at 






To determine the amount of lactate secreted by the cells under both normoxic and hypoxic 
conditions, a colorimetric assay was performed using a Lactate Assay kit (Millipore Sigma 
#MAK064) according to manufacturer’s instructions. Medium from cultured cells collected at 
each time point and stored in -80 ◦C was thawed on ice. The lactate standard was made by adding 
0, 2, 4, 6, 8 and 10 µl of the standard solution to each well of a 96-well plate to generate 0, 2, 3, 4, 
8 and 10 nM/well standards. 10 µl of cell culture medium were added to each well and the assay 
was run in duplicate. For each well, 50 µl of the master reaction mix (46 µl of lactate assay buffer, 
2 µl of lactate enzyme mix and 2 µl of lactate probe) were added to each well along with 40 µl of 
the assay buffer  and the 10 µl samples for a total volume of 100 µl. The plate was incubated for 
30 minutes at RT, then read at the 670 nm wavelength for absorbance in a plate reader. A standard 
curve was generated with the standard samples and the best fit line was calculated. The lactate 
concentrations were calculated by plotting the readings into the standard curve. 
Statistical Analysis 
All data were analyzed utilizing GraphPad Prism software 8 (GraphPad Prism, San Diego, 
CA). Data are presented as means ± standard error of the means (SEM).  For normally distributed 
data, unpaired t tests were used to compare the control group to the experimental group. For non-
normally distributed data, Mann-Whitney tests were used. Statistical significance was assigned at 
p≤0.05. Trending difference was assigned when the p value was between 0.05 and 0.1. 
 
Results 
Cell proliferation is not different in the cKO MESCs compared to the controls. 
 The MESCs were isolated from uteri of both control and Bsg cKO mice to set up the 
primary cell cultures. The numbers of cells were counted at 24 hours and 48 hours to quantify cell 
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proliferation (Figure 5.1 A). After 24 hours, there were 1.52 x 105 cells on average in the control 
MESCs and 1.55 x 105 cells in the cKO MESCs. After 48 hours, there were 5.64 x 105 cells in the 
control MESCs on average and 4.68 x 105 cells in the cKO MESCs. There were no significant 
differences between the two genotypes at either time point. Microscopic images of the cells taken 
at 48 hours (Figure 5.1 B and C) showed that both the cell populations appeared healthy and 
similar in cell morphology. These data suggest that the loss of BSG did not affect cell proliferation 
in the MESCs. 
Expression of decidualization genes is altered in the MESCs of cKO cultured in vitro. 
 The mRNA expression levels of Bsg and of specific decidualization markers (Prl8a2, 
Cebpβ, Bmp2, Hand2 and Wnt4) were analyzed in MESCs on day 0, 2 and 4 of culture (Figure 
5.2). The results showed that Bsg mRNA in the cKO MESCS was markedly lower compared to 
the controls at every time point as expected. Prl8a2 was not detected in MESCs on day 0 for either 
genotype and increased dramatically from day 2 to day 4 by 7-fold. However, in the cKO MESCs, 
Prl8a2 mRNA remained at the same low level at days 2 and 4 of culture and was downregulated 
by over 80% compared to the controls. The level of Cebpβ mRNA in the controls also increased 
over time. The Cebpβ level in the cKO MESCs was downregulated by approximately 60% on day 
0, then increased to a comparable level on day 2, then showed lower expression by about 50% on 
day 4 compared to the controls. The levels of Bmp2, Hand2 and Wnt4 in the control MESCs all 
decreased slowly overtime, but levels of expression in the cKO MESCs were different. The level 
of Bmp2 mRNA in the cKO cells on day 0 was significantly downregulated by 80% as compared 
to the controls. Later on, there was a slight upregulation on day 2 and then a slight downregulation 
on day 4 in the cKO cells, which was not significantly different from the controls. Expression of 
Hand2 in the cKO cells continued to decline over time. On day 2, Hand2 was decreased by 25%, 
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and on day 4, the level was significantly downregulated to half of the levels seen in controls. 
Surprisingly, the Wnt4 level in the cKO MESCs was comparable to the controls on day 0, but 
significantly increased by two-fold on day 2 and then decreased again to levels similar to the 
controls on day 4. 
CEBPβ protein localization is similar in the cKO and control MESCs. 
 The protein localization of CEBPβ in the MESCs of the cKO mice and control mice was 
evaluated by performing IF double staining for BSG and CEBPβ after 2 days in culture (Figure 
5.3). These results showed that BSG in the cKO cells was successfully downregulated, with only 
a few cells expressing BSG, compared to the control cells, where most cells expressed abundant 
BSG (B and F). However, the CEBPβ localization appeared to be the same in the cKO MESCs as 
compared to the controls, since most of the cell showed positive immunoreactivity for CEBPβ in 
the cells of both genotypes (C and G). There was no difference in the protein localization of 
CEBPβ in the cKO cells compared to the controls in this short time experiment.  
MESCs of the cKO mice secreted lower levels of lactate into the medium. 
 The previous studies showed that MCT1 abundance and localization were altered in the 
uterine cells of cKO mice in vivo, and MCT1 is important for transporting lactate out of these cells. 
In order to determine the amount of lactate secreted out of the cell by the MESCs of the cKO mice, 
I carried out lactate assays. The lactate assay results (Figure 5.4) showed that on both day 2 and 
day 4 of culture, the cKO MESCs secreted less lactate into the medium compared to the control 
MESCs. On day 2, the medium of cKO MESCs contained 97.74 ng/µl lactate, which was markedly 
lower than the concentration of lactate at 106.2 ng/µl in the medium from control MESCs. 
Similarly, on day 4, there was, on average, 32.66 ng/µl lactate in the medium from cKO MESCs, 
significantly lower than the 76 ng/µl concentration in the medium from control MESCs. These 
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data suggest that the loss of BSG in the cells inhibited the ability of cells to transport lactate out of 
the cell into the cell culture medium. 
MMP9 protein abundance and localization are not different in the cKO MESCs compared 
to the controls. 
 Secretion of MMPs and VEGFs are increased in early pregnancy and are important for 
tissue remodeling and angiogenesis (Sharkey and Smith 2003). To examine MMP9 protein levels 
in the MESCs, I performed an IF staining for MMP9 in cultured cells of both genotypes (Figure 
5.5). The results showed that there did not appear to be any difference in the abundance or 
localization of MMP9 in the cKO MESCs compared to the controls. There was no apparent 
difference in the two groups of cells at either the lower or higher magnification (A and B). The 
higher magnification did show some accumulated localization of MMP9 on the edges of the cells 
of both genotypes (C and D). These results suggest that the MMP9 was not altered in the MESCs 
of the cKO mice. 
Decidualization marker expression levels were similar in the cKO and control MESCs under 
hypoxic conditions. 
 Implantation occurs in a hypoxic environment in humans and mice and this low oxygen 
favors embryo survival (Shahbazi et al. 2016). To better mimic the cell response in vivo, I cultured 
the MESCs of both genotypes under hypoxic conditions to evaluate the decidualization response. 
The results in Figure 5.6 show that the expression of decidualization markers was not altered in 
the cKO MESCs compared to the controls, although the Bsg level was much lower in the cKO 
MESCs. Expression of all the genes analyzed, Prl8a2, Bmp2, Wnt4 and Cebpβ was not statistically 




MESCs of the cKO mice secrete lower level of lactate under hypoxic conditions. 
 I also measured the lactate concentrations in the medium of the MESCs of both genotypes 
under hypoxic conditions using the lactate assay. Similar to the results for the cells under normoxic 
conditions, the cKO MESCs secreted much less lactate into the medium compared to the controls 
when cultured for 48 hours under hypoxic conditions at day 3 of culture (Figure 5.7). The medium 
from cKO MESCs contained 23.62 ng/µl lactate, which was significantly lower than the 
concentration in the control medium at 46.67 ng/µl. These results support the hypothesis that the 




The immunoglobulin superfamily member BSG is expressed in diverse tissues and play 
important roles in lymphocyte migration, tissue remodeling, stimulation of angiogenesis, lactate 
transport and energy metabolism (K. Li and Nowak 2019). The expression of BSG in the uterus 
during early pregnancy has been characterized and null mutant mice are profoundly infertile (Chen 
et al. 2007; Chen, Belton, and Nowak 2009; Igakura et al. 1998). To overcome the high embryonic 
lethality of global deletion of Bsg, our laboratory generated and validated a PR-Cre Bsg cKO 
model. The previous results showed that loss of BSG caused impaired implantation and 
decidualization in vivo, eventually lead to a reduction of fertility in mice. In this study, I examined 
the role of BSG in decidualization and lactate transport in vitro using a primary MESC culture 
system. 
Decidualization of the endometrium is a crucial step for the uterus to become receptive for 
embryos and further events in pregnancy. During decidualization, the endometrial stromal cells 
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undergo extensive proliferation first, then terminal differentiation to become the decidualized 
stromal cells (Zhu et al. 2014). Bagchi et al have reported that insufficient proliferation of the 
stromal cells leads to failed differentiation in mice (Bagchi et al. 2006). Studies have shown that 
BSG promotes cell proliferation in tumor cells in humans (Sidhu et al. 2010; Knutti, Kuepper, and 
Friedrich 2015; Hasaneen et al. 2016). These results showed that the number of cells at 24 hours 
or 48 hours of incubation were not different between the two genotypes. This agrees with the KI67 
results of the uteri of mice on day 4 pregnancy in vivo, that there was no difference in the number 
of proliferating stromal cells in the cKO mice compared to the controls. Interestingly, this is 
contrary to the findings in human endometrial stromal cells (HESC), where knocking down of Bsg 
by siRNA inhibits stromal cell proliferation after 72 hours (Bi 2013). However, this result is 
consistent with the results from MESCs of Bsg null mice study, which showed BSG does not affect 
stromal cell proliferation in vitro (Chen 2006). This indicates that BSG might play different roles 
in stromal cell proliferation in the humans than in the mice, or culturing for 48 hours was not long 
enough to see the effects.  
A set of decidualization marker genes was analyzed for mRNA levels in the MESCs on 
day 0, 2 and 4 of culture to determine their changes over time. These results showed that in the 
control MESCs, Prl8a2 and Cebpβ were upregulated over time, but Bmp2, Hand2 and Wnt4 were 
downregulated over time. For the cKO MESCs, Prl8a2, Cebpβ, Bmp2 and Hand2 were all 
downregulated compared to the controls at some point. This is consistent with the results on 
decidualization marker expression levels in vivo, where Bmp2, Cebpβ and Hand2 were 
downregulated in the decidua of cKO females. Similarly, in HESC, siRNA knocking down of Bsg 
leads to impaired decidualization with downregulated mRNA levels of decidual markers Igfbp1 
and Prolactin (Bi 2013). In the HESC study microarray results, knocking down of Bsg leads to 
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downregulation of Wnt family members, indicating involvement of BSG in Wnt4/β-catenin 
pathway (Bi 2013). In these results, however, Wnt4 mRNA level was upregulated and then 
downregulated to the same level as the controls. This indicates that it is different than in the 
humans, BSG may regulate decidualization in mice through mechanisms other than the BSG-
Wnt4/β-catenin pathway. Studies have shown that BMP2 acts through its downstream target 
activin-like kinases 2 (ALK2) and CEBPβ, then via CEBPβ’s downstream target signal transducer 
and activator of transcription 3 (STAT3) to regulate decidualization (Monsivais et al. 2016; 
Clementi et al. 2013; Kannan et al. 2010; Cheng et al. 2001). BSG has also been shown to promote 
the STAT3 activity in the pancreatic cancer cells (L. Li et al. 2013). Therefore, it is possible that 
BSG is involved in a BMP-ALK2-CEBPβ-STAT3 pathway to regulate decidualization in mice. 
Further studies are needed to explore the direct relationships between BSG and ALK2 and STAT3 
in the endometrial stromal cells. 
MMPs are a family of proteolytic enzymes, including collagenases (MMP1, 8, 13), 
stromelysins (MMP3, 7, 10) and gelatinases (MMP2, 9) (Davidson et al. 2003). Studies have 
shown that MMP2 and MMP9 are produced by the endometrial stromal cells and the decidual 
cells, and their main function is to degrade and reorganize the extracellular matrix during 
decidualization (Gellersen et al. 2010; Guo et al. 2011). Studies on BSG also reported that it 
mediates the expression and activity of MMP1, 2, 3 and 9 (Sun and Hemler 2001; Weidle et al. 
2010; Xiong, Edwards, and Zhou 2014; Nabeshima et al. 2006; Braundmeier et al. 2006; Chen, 
Belton, and Nowak 2009). In this study, MMP9 protein abundance and localization were not 
different in the MESCS of the cKO or the control mice. Chen reported a rapid and marked decrease 
in mRNA levels of MMP3 and MMP9 during in vitro decidualization, which could be upregulated 
once treated with recombinant BSG protein (Chen, Belton, and Nowak 2009). MMP2, MMP3 and 
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MMP9 mRNA levels were not different in the BSG null mice decidual tissues (Chen 2006). These 
results showed that MMP9, at least at the protein abundance level, was not reduced in the MESC 
cells lacking BSG. This may be because that other factors, such as interleukin-1 (IL-1) and 
Transforming growth factor beta (TNFβ), also regulate MMP9 productions (Anumba et al. 2010) 
and promote expression of MMPs in compensation to loss of BSG. Since MMPs are secreted 
proteins, it would be important to examine the amount of MMPs secreted into the culture medium 
by the stromal cells by immunoblotting and ELISA in the future. 
Under hypoxic conditions at the time of implantation, cells produce a large amount of 
lactate (Gardner 2015). MCTs are important in lactate transport and maintaining the metabolic 
homeostasis in a variety of cell types (Halestrap 2012). BSG is a chaperone protein for MCT1 and 
MCT4, and is responsible for translocating them to the cell membrane (Marchiq et al. 2015). In 
the previous chapter, I demonstrated that the loss of BSG altered the abundance and localization 
of MCT1 in vivo. The lactate assay results under normoxic conditions showed the medium of the 
cKO MESCs contained significantly lower concentration of lactate compared to the controls at 
both time points. Unfortunately, I was only able to collect the cells and the culture medium on day 
3 of incubation under hypoxic conditions (48 hours under hypoxia) due to contaminations and 
equipment problems. These results showed that although the level of Bsg was markedly lower in 
the cKO MESCs compared to the controls, expression of other decidualization marker was not 
different. This could indicate that either none of the two MESCs decidualized, or the cKO MESCs 
were able to decidualize to the same extend as the control MESCs under hypoxic conditions. 
Regardless, this experiment should be repeated with longer periods of incubation to characterize 
the change of decidualization marker gene expression over time. The lactate results showed that 
the cKO MESCs secreted significantly lower concentration of lactate into the medium compared 
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to the control MESCs under hypoxic conditions, which is consistent with the lactate assay results 
under normal oxygen level. This indicates that the loss of BSG in the MESCs decreases the 
concentration of lactate transported by the cells into the medium. The concentrations of lactate 
secreted by both MESCs were lower in the hypoxic conditions compared to the normoxic 
conditions. This might be because that the total number of cells under hypoxic conditions were 
lower than the normoxic conditions for both genotypes. The number of cells in the hypoxic 
conditions were not quantified because a large portion of cells did not detach from the culture 
flasks even hours after trypsin treatment, preventing an accurate quantification. In the future, the 
number of cells under hypoxic conditions need to be quantified using alternative methods.  
In summary, the results in this study showed that loss of BSG in the MESCs, without 
altering cell proliferation, suppressed decidualization and reduced lactate secretion into the 
medium in vitro. I discovered that most decidualization marker genes analyzed, including Prl8a2, 
Cebpβ, BMP2 and Hand2, were downregulated at a point during in vitro decidualization. The 
MMP9 protein abundance was not different in the cKO MESCs compared to the controls. The 
lactate assay results showed that the lactate concentrations secreted into the medium of the cKO 
MESCs were markedly lower than the controls on day 2 and day 4 of culture under nomoxic 
conditions. Under hypoxic conditions, the decidualization marker expression levels were similar 
in the cKO MESCs compared to the controls, but lactate concentrations secreted into the medium 
was significantly lower in the cKO MESCs. These findings suggest that the loss of BSG in the 
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Genes NCBI Gene Reference Left Primer Sequence Right Primer Sequence 
Rplp0 NM_007475.5 actggtctaggacccgagaag ctcccaccttgtctccagtc 
Ppia NM_008907.1 ggaccaaacacaaacggttc catgccttctttcaccttcc 
Bsg NM_009768.2 acagcagtggcgttgaca ggtcatctgcgtccactatgt 
Prl8a2 NM_010088.2 gctggacaatttgaaacacttg tgggtttgtgacattagagtgg 
Cebpβ NM_001287739.1 aagatgcgcaacctggag cagggtgctgagctctcg 
Bmp2 NM_007553.3 agatctgtaccgcaggcact gttcctccacggcttcttc 
Hand2 NM_010402.4 tgagcagcaacgacaagaaa tgctctcctcttcttcactgc 







Figure 5.1 MESCs proliferation. A: number of MESCs at 24 hours and 48 hours of incubation. 
B and C: representative images of MESC of a control mouse (left) and a cKO mouse (right) on 






Figure 5.2 Decidualization marker expression levels in the MESCs from D0-D4. qRT-PCR 
gene expression levels of Bsg (A), Prl8a2  (B), Cebpβ (C), Bmp2 (D), Hand2 (E) and Wnt4 (F) in 
the MESCs from the control mice (white bars) and the cKO mice (grey bars) from cell culture day 







Figure 5.3 CEBPβ localization in MESCs. Localization of BSG (green) and CEBPβ in MESCs 






Figure 5.4 MESCs lactate production on day 2 and day 4. Lactate concentrations in the medium 
of the MESCs from the control mice (white) and the cKO mice (grey) on day 2 (A) and day 4 (B) 





Figure 5.5 MMP9 protein localization in the MESCs. MMP9 protein abundance in the MESCs. 
MMP9 (orange) abundance in the MESCs of a control mouse (A and C) and a cKO mouse (B and 






Figure 5.6 Decidualization marker expression levels under hypoxic condition in the MESCs. 
qRT-PCR gene expression levels of Bsg, Prl8a2, Cebpβ, Bmp2, Wn4 and Hand2 in the MESCs 
from the control mice (white) and the cKO mice (grey) on day 3 of culture under hypoxic 








Figure 5.7 Lactate production under hypoxic condition. The lactate concentrations produced 
by the MESCs from the control mice (white bar) and the cKO mice (grey bar) on day 3 under 
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Summary and Future Directions 
 
Summary 
 The overall goal of this doctoral dissertation work was to investigate the role of uterine 
basigin (BSG) in early reproduction in female mice. Implantation is the process where the 
blastocyst attaches to the maternal endometrium. It is a complex event delicately orchestrated by 
steroid hormones, cytokines, adhesion molecules, developmental transcription factors and cell 
cycle regulators. Proper implantation is a prerequisite for successful pregnancy and a poor-quality 
implantation causes adverse ripple effects in the later course of pregnancy. BSG is a cell membrane 
glycoprotein expressed in many tissues, including the reproductive organs, and is important for 
fertility in both males and females. However, studies on BSG have been complicated due to the 
high embryonic lethality in the Bsg global knockout mouse model. Therefore, in this dissertation, 
we generated a tissue specific Bsg knockout mouse model to study the role of BSG in female 
reproduction in mice. Using this improved animal model, I was able to investigate the hypotheses 
and aims. This doctoral dissertation work provided insights into the role of BSG in early pregnancy 
in mice to further advance our understanding of the mechanisms of implantation. Collectively, 
these studies show that loss of uterine BSG leads to subfertility and BSG is required for normal 
implantation and decidualization in mice. 
In Chapter Three, I generated and validated the Bsg cKO mouse model. I was able to 
generate the cKO mouse model by using the progesterone receptor (PR)-Cre and lox method to 
delete Bsg in the PR positive cells. I crossed the BSG FF and PR Cre +/- male mice with the BSG 
FF and PR +/+ female mice to produce pups. The genotype of the pups was determined by PCR. 
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The BSG FF and PR Cre +/- mice are the cKO mice and the BSG FF and PR +/+ mice are the 
littermate controls. The successful ablation of BSG in the reproductive tissues was confirmed by 
quantitative real time PCR (qRT-PCR) and histology. The qRT-PCR results showed that the 
mRNA level of Bsg in the uteri of the cKO mice was significantly decreased compared to the 
controls. The histology results also confirmed that BSG was no longer in the PR positive cells in 
the uteri and oviduct of the cKO mice. In addition, the cKO mice still expressed BSG in the kidney, 
indicating the knockout was indeed PR positive cell specific. 
I also undertook investigation of the fertility phenotype of the cKO mice in Chapter Three. 
I hypothesized that loss of BSG in the uterus would lead to infertility or subfertility in the mice. 
The six-month breeding study results showed that the cKO females had significantly reduced 
fertility compared to the controls. The cKO mice had much smaller litter size and litter frequency. 
There were more dead pups at parturition and higher incidence of dystocia in the cKO females. 
The fertility of the cKO mice decreased more severely as they aged compared to the controls. 
There was no difference in the weight or sex ratio of the pups between the two genotypes. 
After demonstrating the subfertility caused by knocking out uterine BSG, I wanted to 
determine when and where the problems were occurring in the cKO mice. In Chapter Three, I 
eliminated the possibility of ovarian failures and identified uterine defects as the cause of 
subfertility in the cKO mice. Histology of the ovarian morphology revealed similar structures 
between the two genotypes. The superovulation results showed there was no difference in the 
number of oocytes ovulated by the females of both genotypes. They also produced the same levels 
of progesterone on day 4 of pregnancy. Therefore, the cKO mice had normal ovulation and 
steroidogenesis. The uterine horns of both genotypes were flushed to collect embryos on day 4 of 
pregnancy, and the results showed no difference in the number of embryos retrieved from the 
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control or cKO mice. Most of the embryos were fertilized and at the blastocyst stage, indicating 
fertilization and early embryo development were not affected in the cKO females. These results 
together suggested that the subfertility originated from a uterine defect. To determine the timing 
of the problems, I euthanized mice at different times of gestation from day 4 to day 15 and 
discovered pregnancy defects throughout gestation in the uteri of the cKO mice. Some females 
had no implantations; some had abnormal implantation such as fewer implantation sites, crowded 
implantation sites or smaller implantation chambers. At later stages of pregnancy, at days 12 and 
15, the cKO females showed increased embryo resorption, intrauterine growth restriction and 
hemorrhage in the uteri on day 12 and day15 of pregnancy. The pregnancy status results showed 
that many more of the cKO females had implantation failure or abnormal pregnancy compared to 
the controls.  
In Chapter Four, I examined the luminal epithelial cell integrity in the cKO females in vivo 
after identifying the uterus as the origin of the fertility problem. I hypothesized that BSG is 
required for normal implantation in mice. The immunohistochemistry (IHC) and 
immunofluorescence (IF) results showed that in many of the cKO mice, the embryos were not able 
to breach the luminal epithelium in the uteri on day 5 of pregnancy. There was still strong 
abundance of E-cadherin at the site of implantation in the cKO uteri, compared to the loss of E-
cadherin in the control uteri. Similar results were observed in cytokeratin abundance in the luminal 
epithelial cells. These suggest that the embryos in the cKO females were restricted in the uterine 
lumen, and not able to penetrate through the luminal epithelium. Subsequently, I investigated the 
integrity of the basement membrane in the cKO mice using Jones’ silver stain. The results showed 
that, in some of the cKO mice, the basement membrane was still intact, indicating the embryos in 
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the cKO mice were not able to penetrate the basement membrane and invade into the endometrial 
stromal cells. These results showed about 70% of mice examined had implantation failures. 
In Chapter Four, I also investigated the role of BSG in decidualization in vivo and 
formulated the hypothesis that BSG is necessary for proper decidualization in mice. To test my 
hypothesis, I conducted an artificially induced decidualization response (ADR) experiment by 
ovariectomizing the mice, supplementing them with hormones and then stimulating the decidual 
response by injection of corn oil into one of the uterine horns. The results showed that while the 
controls had a robust decidual response, the cKO mice only had a modest response or no response 
to the stimuli. The total uterine weight was also significantly lower in the cKO females. There was 
no difference in the body weight between the two genotypes, indicating the decreased uterine 
weight and injected uterine weight in the cKO mice were due to an impaired decidual response. 
Histology analysis showed that the cross-sections of the decidua were much smaller in the cKO 
mice. qRT-PCR results on the expression levels of several decidualization marker genes showed 
that Cebpβ and Bmp2 were significantly downregulated in the cKO mice compared to the controls. 
IHC results also showed that CEBPβ and HAND2 protein levels were markedly lower in the cKO 
mice compared to the controls. This indicates that BSG is possibly involved in the Bmp2-Alk2-
Cebpβ-Stat3 pathway to regulate decidualization in mice. 
In addition, I investigated additional post-implantation defects in angiogenesis and lactate 
transport in the cKO females. To achieve this, I examined the localization of a few proteins that 
are known to interact with BSG and play a role in metabolism and angiogenesis. CD98 is found 
on the apical side of the luminal epithelium at the time of implantation, and it interacts with BSG 
to form amino acid transporters to function in energy metabolism. The IHC results for CD98 on 
the uteri of day 1 and day 4 of pregnancy showed no difference in the protein abundance and 
182 
 
localization of CD98 in the cKO mice compared to the controls. BSG is a chaperon protein for 
MCT1/4 and is required for shuttling these MCTs to the cell membrane, where they function as 
lactate transporters. MCT1 protein was decreased in the cKO mouse uteri on day 4 and 6 of 
pregnancy compared to the controls, possibly leading to a difference in lactate transport in the cKO 
mice. To investigate the effect of loss of BSG on angiogenesis, I immunostained uterine cross-
sections of day 6 pregnant mice for the angiogenic marker CD31. The results showed greatly 
reduced CD31 abundance in the endothelial cells in the secondary decidual zone and the 
undifferentiated stromal layer in the cKO mice compared the controls. Quantification of the CD31 
signal intensity confirmed significantly lower CD31 levels in the cKO, indicating loss of uterine 
BSG leads to reduced angiogenesis in mice. 
In Chapter Five, I examined the role of BSG in decidualization using an in vitro system. I 
hypothesized that BSG is required for normal decidualization in vitro. To test my hypothesis, I 
isolated the endometrial stromal cells (MESCs) from mice of both genotypes and set up a primary 
cell culture system. Decidualization involves extensive proliferation and then terminal 
differentiation. I first determined whether BSG played a role in cell proliferation in these MESCs 
by culturing the cells for 48 hours. The cell numbers were the same between the cKO MESCs and 
control MESCs at 24 and 48 hours of culture, indicating BSG does not affect cell proliferation 
over this time period in vitro. The mRNA was extracted from cultured cells to determine the 
expression levels of several decidualization markers over a four-day cell culture period. The qRT-
PCR results showed that Bsg level was significantly lower in the cKO MESCs, as expected. In the 
controls, Prl8a2 and Cebpβ levels increased over time, while Bmp2 and Hand2 levels decreased 
over the four days. In the cKO MESCs, the levels of Prl8a2, Cebpβ, Bmp2 and Hand2 were all 
significantly downregulated at some point compared to the controls. These results agree with the 
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in vivo decidualization results. MMP9 protein abundance and localization did not appear to be 
affected in the cKO MESCs. These findings indicate that the loss of BSG in the MESCs leads to 
suppression in decidualization in vitro. 
I also investigated whether BSG plays a role in regulating lactate transport in vitro in 
Chapter Five and hypothesized that loss of BSG would lead to altered lactate secretion by the 
MESCs. To investigate my hypothesis, I cultured the MESCs of both genotypes for four days and 
collected the cell medium to measure the lactate concentrations in the medium. The results showed 
that on both day 2 and day 4, the lactate concentrations in the medium of the cKO MESCs were 
markedly lower compared to the controls. In addition, I also incubated the cells under the hypoxic 
conditions for three days to mimic the low oxygen environment in the uterus during implantation. 
The results showed that the expression levels of the decidualization markers did not differ in either 
genotype, but the lactate concentrations in the medium of cKO MESCs were significantly lower 
than the control MESCs. These findings suggest that BSG is required for normal lactate secretion 
in the MESCs. 
Based on the studies demonstrated in this dissertation, I propose a model for the potential 
roles of BSG in early pregnancy in mice in Figure 6.1. BSG is involved in normal events during 
implantation such as the luminal epithelium breakdown and basement membrane degradation. 
BSG regulates Bmp2 and Cebpβ and may act through the Bmp2-Alk2-Cebpβ-Stat3 pathway to 
promote decidualization in mice. BSG also controls Hand2 expression in regulating 
decidualization. In addition, BSG appears to regulate angiogenesis at the implantation sites and 
MCT1 for lactate transport post-implantation. The loss of BSG dysregulates the early events of 
implantation and decidualization, causing adverse ripple effects that leads to increased incidence 
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of complications in later stages of pregnancy, such as hemorrhage, embryo resorption and dystocia, 
and eventually results in subfertility in mice. 
 
Future Directions 
 Despite the findings presented in this dissertation; many additional questions need to be 
investigated to better elucidate the comprehensive role of BSG in regulating implantation and 
pregnancy. I would propose a few questions for future directions. First, additional novel genes and 
signaling pathways need to be examined for understanding the functions of BSG in implantation 
and decidualization. For example, the gene expression levels of Alk2 and Stat3 should be evaluated 
to confirm that BSG indeed act through this pathway to regulate decidualization. Further, it is 
important to determine whether BSG regulates early differentiation or late phase of 
decidualization. The ADR and in vitro MESC decidualization experiments could be repeated with 
longer experimental period and more collection time points. More marker genes of either early or 
late decidualization should be examined. The mechanisms underlying the problems with the 
breaching of the luminal epithelium in the cKO mice at the time of implantation remains unclear. 
Whether BSG is involved in facilitating apoptosis in these luminal epithelial cells needs to be 
studied. The degradation of the basement membrane is mediated by MMPs, which can be induced 
by BSG. Although I did not observe any differences in the abundance of MMP9 in the cKO mice, 
it is important to better quantify the abundance of MMP9 and other MMPs, such as MMP2 and 
MMP3. Immunoblotting and ELISA are recommended because MMPs are secreted proteins. 
Second, BSG has been found in microvesicles and exosomes and can transmit signals through 
microvesicle shedding. Thus, it would be important to collect the serum free medium of MESCs 
and isolate the extracellular vesicles. Determining whether the microvesicles from stromal or 
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epithelial cells of cKO mice contain BSG by immunoblotting would provide useful information. 
Third, it is worth repeating the hypoxic cell culture experiments with more time points and 
replicates because it is helpful to better understand the impact of hypoxic conditions on 
decidualization and lactate production. Fourth, BSG is found in the placental trophoblast cells and 
the endothelial cells in humans and mice. Lower abundance of BSG in the placenta is associated 
with preeclampsia in humans and the underlying mechanisms remain unknown. Thus, further 
investigations on the role of BSG in placenta development and later stages of pregnancy would be 
valuable.  
 There are limitations using this PR-Cre model to study the role of BSG in the uterus. First, 
PR-Cre did not show very high efficiency of recombination. Secondly PR-Cre deletes Bsg in the 
epithelium, stroma and myometrium of the uterus, thus making it difficult to determine the cell 
type-specific function of Bsg. Other Cre mouse lines may be useful to distinguish the function of 
Bsg in a specific cell type. For example, Wnt7a-Cre deletes gens in the epithelial cells and Amhr2-
Cre deletes genes in the mesenchymal cells. However, like the PR-Cre mouse, these genes are 
expressed in other tissues, and the recombination occurs prior to sexual maturity of the animals, 
which could affect the development of the uterus. Lactoferrin (Ltf)-iCre mouse only deletes genes 
in the uterine luminal epithelium of adult mice, thus could be used to study the luminal epithelial-
specific function of BSG in the adult mice. More animal models with cell type (e.g. stromal cells) 
specific deletions need to be developed to study the role of BSG in a specific uterine compartment.  
 In conclusion, my doctoral dissertation work shows that loss of BSG in the reproductive 
tract leads to subfertility in mice. The subfertility is due to uterine defects throughout the courses 
of pregnancy. Specifically, deletion of BSG in the uterine cells results in impaired implantation 
and decidualization in vitro and in vivo, as well as reduction in angiogenesis and lactate transport. 
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These findings provide important new information on the role of BSG in early pregnancy and 
contributes to our knowledge on the mechanisms of implantation. Understanding the role of BSG 
in female reproduction helps to explain the implantation and decidualization associated 











Figure 6.1 A schematic diagram highlighting the role of BSG in pregnancy in mice. BSG is 
required for the luminal epithelium breakdown and the basement membrane degradation during 
implantation. BSG regulates Bmp2, Cebpβ and Hand2 to stimulate decidualization. BSG regulate 
CD31 and MCT1 for angiogenesis and lactate transport. Loss of BSG impairs implantation and 








Acronyms and Abbreviations 
 
Adm  adrenomedullin  
ADR  Artificially-induced decidualization response 
ALK2  Activin-like kinases 2 
ALPH  Alkaline phosphatase  
AM  Antimesometrial 
BCL2  B cell lymphoma 2 
Bl  Blastocyst 
Bmp  Bone morphogenetic protein  
BSA  Bovine serum albumin 
BSG  Basigin 
BTEB1 basic transcription element-binding protein 1 
CEBPβ CCAAT enhancer-binding protein beta 
CD31  Cluster of differentiation 31 
CD98  Cluster of differentiation 98 
CD147  Cluster of differentiation 147 
CFTR  Cystic fibrosis transmembrane conductance regulator  
COUP TFII Chicken ovalbumin upstream promoter transcription factor 2 
COX  Cycloocygenase 
Cre  Cyclization recombinase 
Cyp-A  Cyclophilin A 
Cyp-B  Cyclophilin B 
DAB  3,3’-Diaminobenzidine 
DEDD  Death effector domain-containing protein 
DMEM/F12 Dulbecco’s modified eagle medium/nutrient mixture F-12 
DNA  Deoxyribonucleic acid 
E2  Estradiol  
EC  Extracellular 
ECM  Extracellular matix 
ELISA  Enzyme linked immunosorbent assay 
Em  Embryo 
EMMPRIN Extracellular matrix metalloproteinase inducer 
ENaC  Epithelial Na+ channel 
ER  Estrogen receptor  
Ereg  Epiregulin encoding gene 
ERK  Extracellular signal-regulated kinases 
EV  Extracellular vesicle  
FAK  Focal adhesion kinase 
Fkbp52 FK506 binding protein 4 
Foxa2  Forkhead box protein A2 
FSH  Follicle stimulating hormone 
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Gal  Galectins 
GE  Glandular epithelium  
Gp130  Glycoprotein 130 
GSK3β Glycogen synthase kinase 3 beta 
Hand2  Heart and neural crest derivatives-expressed protein 2 
HBSS  Hank’s balanced salt solution 
HCG  Human chorionic gonadotropin 
H&E  Hematoxylin and eosin 
HESC  Human endometrial stromal cells 
Hoxa  Homeobox A gene 
Hurp   Hepatoma upregulated protein 
HUVEC Human umbilical vein endothelial cell  
IFN-β  Interferon beta 
Ig  Immunoglobulin 
IF  Immunofluorescent 
IGF1  Insulin-like growth factor 1 
IHC  Immunohistochemistry 
Ihh  Indian hedgehog 
IL  Interleukin  
IVF  in vitro fertilization 
JAK  Janus Kinase 
KLF5  Kruppel-like factor 5 
KO  Knockout 
KS  Kaposi’s sarcoma 
LAT1  Large neutral amino acid transporter 1 
LE  Luminal epithelium 
LH  Leutinizing hormone 
LIF  Leukemia inhibitory factor 
LoxP  locus of cross-over of P1 
M  mesometrial 
MAPK  Mitogen-activated protein kinases 
MCF7  Michigan Cancer Foundation-7 
MCT1  Monocarboxylate transporter 1 
MESC  Mouse endometrial stromal cells 
MMP   Matrix metalloproteinase 
mRNA  messenger RNA 
MSH  Muscle segment homeobox gene 
Msx  Msh homeobox gene 
NCAM Neural cell adhesion molecule 
NFκB  Nuclear factor kappa-light-chain-enhancer of activated B cells 
P4  Progesterone 
PBS  Phosphate buffered saline 
PBST  Phosphate buffered saline with tween-20 
PC6  Proprotein convertase 6  
PCR  Polymerase chain reaction 
PDL1  Programmed death ligand 1 
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PDZ  Primary decidual zone 
PI3K  Phosphoinositide 3 kinases 
PMSG  Pregnant mare serum gonadotropin 
PPIA  peptidylprolyl isomerase A 
PR  Progesterone receptor 
Prl8a2  Decidual prolactin-related protein family 8, subfamily a, member 2 
PTCH1 Protein patched homolog 1 
Ptgs2  Postaglandin-endoperoxide synthase 2 
qPCR  Quantitative polymerase chain reaction 
RGD  Arginine-glycine-aspartic acid 
RNA  Ribonucleic acid 
RPLP0  Ribosomal protein, large, P0 
RT  Room temperature 
S  Stroma 
SDZ  Secondary decidual zone 
SEM  Standard error of the means 
Sgk1  Serum and glucocorticoid-regulated kinase 1   
shRNA Short hairpin RNA 
siRNA  Small interfering RNA 
STAT3 Signal transducer and activator of transcription 3 
TCSF   Tumor cell collagenase-stimulatory factor 
TGFβ  Transforming growth factor beta 
TNF  Tumor necrosis factor 
TRAF2 TNF receptor-associated factor 2 
Trp53  Transformation related protein 53 
VEGF  Vascular endothelial growth factor 













Figure A1. BSG expression in kidney. A cKO kidney cross section stained for nonspecific IgG 
(A) and BSG (B) 
 
 
Figure A2. CD98 expression in the uterus on day 4 of pregnancy. Top panel: a control mouse 
uterus stained for nonspecific IgG (A) and CD98 (B). Bottom panel: a cKO mouse uterus stained 





Figure A3. CEBPβ expression in the ADR decidual tissues. Top panel: a control mouse decidual 
cross section stained for nonspecific IgG (A) and CEBPβ (B). Bottom panel: a cKO mouse 







Figure A4. HAND2 expression in the ADR decidual tissues. Top panel: a control mouse 
decidual cross section stained for nonspecific IgG (A) and HAND2 (B). Bottom panel: a cKO 








Figure A5. MCT1 expression in the uterus on day 4 of pregnancy. Top panel: a control mouse 
uterus stained for nonspecific IgG (A) and MCT1 (B). Bottom panel: a cKO mouse uterus stained 






Figure A6. MCT1 expression in the control uterus on day 6 of pregnancy. Top panel: a control 
mouse uterus stained for nonspecific IgG (A) and MCT1 (B) at the implantation site. Bottom panel: 







Figure A7. MCT1 expression in the cKO uterus on day 6 of pregnancy. Top panel: a cKO 
mouse uterus stained for nonspecific IgG (A) and MCT1 (B) at the implantation site. Bottom panel: 









Name Supplier Cat. # Host Species reactivity Application Other 





R&D systems AF772 Goat M IHC:  
Basigin/EMMPRIN/CD1
47 
R&D systems AF972 Goat H IHC:  
Wnt-4 (C-14) Santa cruz Sc-5214 Goat H, (M) WB: 1/1000 
IHC: 1/50-500 
 




WB loading control 







Millipore 05-665 Mouse H, M, R WB: 1/500-5000  
KI67 Abcam Ab 16667 Rabbit M, R, H, IHC:1/100-200 
WB: 1/1000 
 




Cytokeratin 19 Abcam 52625 Rabbit M, H IHC1/400-800 
WB:1/5000 
 
Placental lactogen 1 (c-
12) 
Santa cruz 376436 Mouse M, r, h Ihc: 1/50-500 
Wb: 1/1000 
Trophoblast cell 
CD98 (H300) Santa cruz Sc-9160 Rabbit M, H, R IHC1/50-500 
WB:1/1000 
 
MCT-1/SLC16A1 LSBio Ls-c335287 Rabbit H, M Ihc: 1/50-200 
WB:1/1000 
good 
MCT-1/SLC16A1 Novusbio 59656H Rabbit H, M Experiment Not good 
C/EBPβ (c-19) Santa curz Sc-150 Rabbit M, R, H IHC: 1/50-500 
WB: 1/1000 
 
CD31/PECAM1 Abcam Ab28364 Rabbit M, H, Pg IHC:1/50 
WB:1/500 
 
VEGF (A-20) Santa cruz Sc-152 Rabbit M, R, H IHC:1/50-500 
WB:1/1000 
 
LIF (N-18) Santa cruz Sc-1336 Goat M, R H IHC: 1/50-500 
WB:1/1000 
 
EMMPRIN (C-19) Santa cruz Sc-9754 Goat H WB:1/1000  
EMMPRIN (N-19) Santa cruz Sc-9752 Goat H WB:1/1000  
GPR30 (K-19)-R Santa cruz Sc-48524-R Rabbit H, M, R WB:1/1000 
IHC:1/50-500 
 
Chromogranin A Abcam Ab15160 Rabbit M, H, Mk IHC:1/400 
WB: 1/100 
 
Von Willebrand Factor Dako A008229-5 Rabbit M, R, H, Ch IHC:1/400  
Actin muscle (Huc1-1) ThermoFisher MA511874 Mouse H M R IHC:1/200  
Actin smooth muscle Thermo Fisher PA5-16697 Rabbit H M R Fe IHC 1/200  
Hand2 ABCAM Ab200040 Rabbit M, R, H IHC Good one 
Hand Santa cruz Sc398167 Mouse   NOT GOOD 
MMP-9 Abcam Ab38898 Rabbit H,M, Rat IF 1:100 
IHC 
 
Pan cytokeratin Sigma C2562 Mouse H,M, IHC, IF 1:200 Good 
E-cadherin R&D system AF748 Goat H;M 1:200 good 
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Genes NCBI Gene Reference Left Primer Sequence Right Primer Sequence 
Alph NM_007431.3 cggatcctgaccaaaaacc tcatgatgtccgtggtcaat 
Angpt1 NM_001286062.1 ggaagatggaagcctggat accagagggattcccaaaac 
Angptl1 NM_028333.2 gatggctctgtcaatttcttca caatgtttccaaaccctttctt 
Angpt2 NM_007426.4 ccaccagtggcatctacaca acccacgtccatgtcacag 
Angpt4 NM_009641.2 cgcctggtacggattgtag tggaacactggcttaggtgtc 
Bmp2 NM_007553.3 agatctgtaccgcaggcact gttcctccacggcttcttc 
Bmp5 NM_007555.4 ccgcaataaatccaactctca tgcaggcttgtttttgttca 
Bmp7 NM_007557.3 cgagaccttccagatcacagt cagcaagaagaggtccgact 
Bsg NM_009768.2 acagcagtggcgttgaca ggtcatctgcgtccactatgt 
Ccnd1 NM_007631.2 catccatgcggaaaatcg gcgggaagacctcctctt 
Cd31 NM_001032378.2 cggtgttcagcgagatcc actcgacaggatggaaatcac 
Cebpβ NM_001287739.1 aagatgcgcaacctggag cagggtgctgagctctcg 
E-cadherin NM_009864.3 gctctcatcatcgccacag gatgggagcgttgtcattg 
Ereg NM_007950.2 ttgacgctgctttgtctagg ggatcacggttgtgctgat 
Esr1 NM_001302532.1 caactgggcaaagagagtgc ccagacgagaccaatcatca 
Esr2 NM_207707.1 gaccctcactggcacgtt aatcccttccacgcacttc 
Hand2 NM_010402.4 tgagcagcaacgacaagaaa tgctctcctcttcttcactgc 
Hoxa10 NM_008263.3 ccttcagaaaacagtaaagcttcg aagggcagcgtttcttcc 
Itgav NM_008402.3 ggtgtggatcgagctgtctt caaggccagcatttacagtg 
Itgb1 NM_010578.2 caaccacaacagctgcttctaa tcagccctcttgaattttaatgt 
Mct1 NM_009196.4 gaatgctgccctgtcctc ccacaagcccagtacgtgtat 
Mct4 NM_001310705.1 gtcatcactccgtttctctgc acgtcccaagaatggaggta 
Mmp2 NM_008610.3 gtgggacaagaaccagatcac gcatcatccacggtttcag 
Mmp3 NM_010809.2 tgcagctctactttgttctttga agagatttgcgccaaaagtg 
Mmp9 NM_013599.4 cagaggtaacccacgtcagc gggatccaccttctgagactt 
Mmp14 NM_008608.4 gagaacttcgtgttgcctga ctttgtgggtgaccctgact 
Pcna NM_011045.2 ctagccatgggcgtgaac gaatactagtgctaaggtgtctgcatt 
Pgr NM_008829.2 tgcacctgatctaatcctaaatga ggtaaggcacagcgagtagaa 
Ppia NM_008907.1 ggaccaaacacaaacggttc catgccttctttcaccttcc 
Prl8a2 NM_010088.2 gctggacaatttgaaacacttg tgggtttgtgacattagagtgg 
Rplp0 NM_007475.5 actggtctaggacccgagaag ctcccaccttgtctccagtc 
Vegfa NM_001025250.3 aaaaacgaaagcgcaagaaa tttctccgctctgaacaagg 
Vegfb NM_011697.3 gctcaacccagacacctgtag aggaggttcgcctgtgct 
Vegfc NM_009506.2 cagacaagttcattcaattattagacg catgtcttgttagctgcctga 
Vegfd NM_001308489.1 gcaactttctatgacactgaaacac tctctctagggctgcattgg 
Vimentin NM_011701.4 ccaaccttttcttccctgaac ttgagtgggtgtcaaccaga 




Hematoxylin & Eosin staining 
 
Once you start staining, do not allow sections to dry throughout the procedure.  
 Solution Time   
Deparaffinization Xylene I (Dirty) 5 min Xylene can interact with gloves. Be 
careful  
 Xylene II (Dirty) 5 min  
 Xylene III (Clean)  5 min  
Rehydration 100% EtOH I 1 min Number of ethanol dilutions can be 
increased or decreased as needed. 
 100% EtOH II  1 min 
 70% EtOH  1 min 
Wash  DI water 1 min  
Nuclear Staining Hematoxylin 1-2 min Mayer’s Hematoxylin (Sigma) 
Wash Running TAP water 5-15 min Not DI water. Check the color (Blue to 
purple)  
Cytoplasmic Stain 1% Eosin 1 min May need to increase or decrease time 
depending on fixatives, tissue types, 
etc… 
Dehydration 70% EtOH 1 min No need to wash. The Eosin will stain 
the ethanol solutions which then need 
to be discarded in the ethanol+eosin 
waste so as not to interfere with 
subsequent experiments. 
 80% EtOH 1 min 
 90% EtOH 1 min 
 100% EtOH I 1 min 
 100% EtOH II 1 min 
 100% EtOH III 1 min 
Clearing  Xylene I (Dirty) 1 min  
 Xylene II (Dirty) 1 min  
 Xylene III (Clean) 1 min Remove each slide from xylene to 
mount the coverslip. Leave remaining 
slides in xylene while doing so. 
Cover slip Permount/Clear Mount  Do not dry sections before covering.  
Results  
    Nuclei: Blue 
    Erythocytes: Red 




Periodic Acid Optimized Schiff’s Stain (PAS) 





______ 5 min Xylene 
______ 5 min Xylene 
______ 10-12 dips in 100% Ethanol 
______ 10-12 dips in 100% Ethanol 
______ 10-12 dips in 100% Ethanol 
______ 10-12 dips in 95% Ethanol 
______ 10-12 dips in 95% Ethanol 
______ 10-12 dips in 70% Ethanol 
______ 1 minute in running tap water 
______ 10-12 dips in DI water 
______ 7 minutes in 0.5% Periodic Acid 
______ 2-3 dips in DI water  
______ 15 minutes in Optimized Schiff’s Solution 
______ 5 minutes in running tap water 
______ 2 minutes in Modified Mayer’s Hematoxylin 
______ 3 minutes in running tap water 
______ 2-5 dips in Light Green Stain 
 
 
Dehydration and Cover  
______ 10-12 dips in 70% Ethanol 
______ 10-12 dips in 95% Ethanol 
______ 10-12 dips in 95% Ethanol 
______ 10-12 dips in 100% Ethanol 
______ 10-12 dips in 100% Ethanol 
______ 10-12 dips in 100% Ethanol 
______ 10-12 dips in Xylene 
______ 10-12 dips in Xylene 
______ 10-12 dips in Xylene 





Jones’ silver staining 




Deparaffinization and rehydration Xylene 1: 5 min  
Xylene 2: 5 min 5 min 
Xylene 3 (clean) 5 min 
100% Ethanol 5 min 
100% Ethanol 5 min 
90% Ethanol 5 min 
80% Ethanol 5 min 
70% Ethanol 5 min 
Oxidation 0.5% Periodic acid 11 min 
Wash Distilled deionized water  
Methenamine silver solution 3% methenamine and 5% nitrate, freshly 
made 
60 min at 70 °C 
Check every 20 mins Check for precipitate formation, a medium 
brown color stain 
 
Wash Distilled deionized water 5 min at 70 °C 
Gold chloride solution 0.2% gold chloride solution 1 min 
Wash Distilled water treated with sodium thiosulfate 1 min 
Wash Running tap water 10 min 
Counter stain Fast green (Fisher) 1 min 
Dehydration and cover 70% Ethanol 1 min 
80% Ethanol 1 min 
90% Ethanol 1 min 
100% Ethanol 1 min 
100% Ethanol 1 min 
Xylene 1 1 min 
Xylene 2 1 min 





Immunohistochemical staining (IHC) 
 
• For ABC method      Keep antibody solutions on ice. 
• Do not allow sections to dry once you start staining. Incubation must be performed in a moist 
chamber. 
Day Procedure Time 
1 Deparaffinization and rehydration  
Wash in tap water  5 min 
Antigen retrieval in 0.01M citrate buffer or 1X Dako 
(make new citrate buffer each time/change Dako weekly) 
Boil for 20 
min 
Cool down to room temperature  
Wash in 1X PBST on shaker 5 min 
Inactivation of endogenous peroxidase in 0.3% H2O2/Methanol 
(make new solution each time) 
15 min 
Wash in 1X PBST on shaker  5 min *3 
Encircle section with a PAP pen wihle rinsing in PBST 
(make sure draw big circles far from sections to prevent oil blocking) 
 
Blocking of non-specific binding in 5% normal serum and 1% BSA 
(never let sections dry out) 
60 min RT 
Incubation in the primary antibody diluted in 1%BSA/PBST Overnight 
at 4°C 
2 Rinse in PBST on shaker 5 min * 3  
Incubation in biotinylated secondary antibody in 1%BSA/PBST 60 min RT 
Prepare ABC solution in 1%BSA/PBST 30 min before use 
(PBS:A:B=50:1:1) 
 
Rinse in PBST on shaker 5 min * 3 
Incubation in ABC solution at RT  30 min 
Rinse in PBST on shaker 5 min * 3 
DAB reaction (watch under scope for time needed to change color, time varies 
to different AB) 
~  30 sec 
Stop DAB reaction in tap water 10 min 
Counterstaining in hematoxylin (filter hematoxylin) 2 min 
Wash in tap water (only tap water, not DI water) >10 min 
Dehydration, clearing and cover with permount. (do not use excess permount)  
 
Deparaffinzation and rehydration: Dehydration and clearing 
Xylene 1: 5 min 70% Ethanol: 1 min 
Xylene 2: 5 min 80% Ethanol: 1 min 
Xylene 3 (clean): 5 min 90% Ethanol: 1 min 
100% Ethanol: 5 min 100% Ethanol: 1 min 
100% Ethanol: 5 min 100% Ethanol: 1 min 
90% Ethanol: 5 min Xylene 1: 1 min 
80% Ethanol: 5 min Xylene 2: 1 min 




Immunofluorescence staining (IF) 
 
• All procedures are performed at room temperature unless specified 
• Keep antibody solutions on ice. 





Deparaffinzation and rehydration: 
Xylene 1: 5 min 
Xylene 2: 5 min 
Xylene 3 (clean): 5 min 
100% Ethanol: 5 min 
100% Ethanol: 5 min 
90% Ethanol: 5 min 
80% Ethanol: 5 min 
70% Ethanol: 5 min 
 
  
Day Procedure Time 
1 Deparaffinization and rehydration  
Wash in tap water  5 min 
Antigen retrieval in 0.01M citrate buffer or 1X Dako 
(make new citrate buffer each time/change Dako weekly) 
Boil for 20 
min 
Cool down to room temperature  
Wash in 1X PBST on shaker 5 min 
Encircle section with a PAP pen wihle rinsing in PBST 
(make sure draw big circles far from sections to prevent oil blocking) 
 
Blocking of non-specific binding in 5% normal serum and 1% BSA 
(never let sections dry out) 
60 min RT 
Incubation in the primary antibody diluted in 1%BSA/PBST  Overnight at 
4°C 
   
2 Rinse in PBST on shaker 5 min * 3  
Incubation in biotinylated secondary antibody in 1%BSA/PBST in dark 60 min RT 
Rinse in PBST on shaker 5 min * 3 
Coverslip with DAPI containing mounting medium  
Store in 4 °C fridge or image using LSM710 confocal  
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Isolation of Mouse Endometrial Stromal Cells (MESC) 
 





- digestion mix Pancreatin (may be referred to as MESC digestion mix): 
     0.25 g pancreatin (Sigma – cat# P3292) 
     10 ml trypsin 0.25% 
Make it in 50 ml conical tube, mix well and let the solution for 1 hour at 37oC in the water bath. 
 
- DIGESTION SOLUTION I – DISPASE 
     120 mg dispase  ---- 4 Jia jia’s aliquots or Sigma (cat# D4693-1G Dispase II) 
     500 mg pancreatin 
     20 ml HBSS 
     0.2 ml penstrep (1%) 
Make 5 ml of solution per animal. This recipe is for 4 animals = 20 ml. 
 
- STOP SOLUTION (10% FBS in HBSS) 
     17.8 ml HBSS 
     0.2 ml pentrep 
     2 ml FBS 
Make the same volume as the Digestion solution I. In this case, 20 ml = 4 animals. Make this solution twice, 
2 tubes with 20 ml each. 
 
- DIGESTION SOLUTION II – COLLAGENASE 
     10 mg Collagenase IA (glass bottle – Sigma cat# 2674) 
     17.8 ml HBSS 
     0.2 ml penstrep (1%) 
Optional: you can make 500 mL of Hank's Balanced Salt Solution (HBBS) 1x complemented with 100 
U/mL penicillin and 100 µg/mL streptomycin (further referred to as HBSS+) and use it to make those 
solutions. 
- ESTRADIOL STOCK 100X (Sigma cat# E8875-1G) 
     0.00272 g dissolved in 10 ml ethanol 100% - shake vigorously 
    
   From this solution make estradiol 1X by diluting 10 µl of the 100X stock into 990 µl ethanol 100%. We 
used this 1X solution for making the medium. Aliquots made on 12/01/2017 are stored in -20oC. 
 
- PROGESTERONE STOCK 100X (Sigma cat# P8783-1G) 
     0.0393 g dissolved in 1.25 ml ethanol 100%  
 
   From this solution make progesterone 1X by diluting 10 µl of the 100X stock into 990 µl ethanol 100%. 
We used this 1X solution for making the medium. Aliquots made on 12/01/2017 are stored in -20oC. 
- MEDIUM FOR CELLS CULTURE 
     > For washing steps (200 ml): 
        178 ml DMEM/F12 
        20 ml FBS (10%) 
        2 ml penstrep (1%)  
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     > For seeding and culturing (100 ml): 
        88.8 ml DMEM/F12  
        10 ml FBS (10%) 
        100 µl estradiol 1X (10 nM) ---- check that info! 
        100 µl progesterone 1X (1 µM) ---- check that info! 
        1 ml penstrep (1%) 
 
NOTES: You might want to use exosome-depleted FBS in the culture medium. If so, check when to start 
using this medium during the protocol. 
~ It might be interesting to use or not hormones, depending on your goals. These concentrations will likely 
make the stromal cells decidualize. 
~ For more information, check Ramona’s lab notebook. 
 
Procedures 
1. Isolation of uteri 
• In the IGB mouse room, euthanize the animals using an appropriate method such as cervical 
dislocation or CO2-induced narcosis. 
• Spray the carcasses with 70% ethanol in order to generate a sterile environment. 
• Grab the uterine horn at the most distal end under the fallopian tube. Dissect the uterine horns from 
the fallopian tube and remove adipose and connective tissue. Cut out the horn at the distal end 
above the uterine body and place it in a 15 ml conical tube with 3 mL of HBSS+. 
• Repeat this step for the other horn and for the other animals until all uterine horns are collected. 
• Back to the laboratory, place the uterine horn in Petri dishes and clean the uterine horn (in HBSS+) 
further and remove all residual adipose or connective tissue, as well as the cervix. 
• Cut the uterine horns open longitudinally to expose the uterine lumen and replace the horn in a new 
Petri dish with fresh HBSS+. 
2. Isolation and Culture of Mouse Endometrial Stromal Cells (MESC):  
1. Transfer all uterine horns to the 15 mL tube containing Digestion Mix Pancreatin (pancreatin and 
trypsin). 
2. Incubate horizontally for 60 min at 4 °C on an orbital shaker (50 rpm) – Dr. Bahr’s cold room. 
3. Incubate horizontally for 45 min at 23 °C (Room Temperature), without shaking. 
4. Incubate horizontally for 15 min at 37 °C (water bath), without shaking. 
5. NOTE: From now on, further isolation steps are performed in a sterile environment under a laminar 
flow cabinet. 
6. After those 2 h of incubation, carefully pour away the supernatant solution. 
7. Transfer the uteri into a Petri dish containing cold medium and incubate for 5 min in order to 
inactivate trypsin activity. 
8. Transfer the uteri to a 15 mL tube containing 3 mL of cold HBSS+ and vortex for 10 s to release 
the epithelial sheets. (1) 
9. Rinse the uteri in a clean Petri dish with 3 mL HBSS+. 
10. Transfer the uteri to a new 15 mL tube containing 3 mL of cold HBSS+ and vortex for 10 s to 
release the epithelial sheets. (2) 
11. Rinse the uteri in a new clean Petri dish with 3 mL HBSS+. 
12. Transfer the uteri to a new 15 mL tube containing 3 mL of cold HBSS+ and vortex for 10 s to 
release the epithelial sheets. (3) 
13. Rinse the uteri in a clean Petri dish with 3 mL HBSS+. 
14. Transfer the uteri tissue to Digestion solution I (containing Dispase and Pancreatin) and incubate 
that for 30 minutes at room temperature. 
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15. After the 30 minutes incubation in Digestion Solution I (containing Dispase and Pancreatin) add 
the Stop Solution in the conical tube and mix well – use the same amount as digestion solution, in 
this case, 20 ml. 
16. Remove and discard the supernatant. 
17. Pick the tissue and wash in 5 ml of HBSS+ in a Petri dish, twice. 
18. Place tissue in Digestion solution II – Collagenase for 45 minutes at 37oC (water bath). 
19. After that, add Stop Solution to the tube and mix by vortexing for 10 seconds – use the same amount 
as digestion solution, in this case, 20 ml. 
20. Collect the stromal cells by passing this solution through a 40 µm nylon mesh strainer into a new 
50 ml conical tube. I used 2 tubes and 2 strainers because they clogged. 
21. Centrifuge the cell suspension at 450 g for 6 min. 
22. Discard supernatant and resuspend the pellet in 10 ml HBSS+. 
23. Centrifuge again at 450 g for 6 minutes. 
24. Aspirate supernatant, resuspend pellet and plate stromal cells in DMEM/F12 medium at the desired 




RNA Extraction from animal tissue using Qiagen RNeasy Mini Kit 
 
 
*RNA later stabilized samples *Using QIAshredder homogenizer *Add 10 ul b-Mercaptoethanol (bME) 
per 1 ml RLT buffer. 
1. Excise the tissue sample from the animal or remove it from storage. Remove RNAlater stabilized tissues 
from the reagent using forceps. Determine the amount of tissue. Do not use more than 30 mg. Note: If the 
tissues were stored in RNAlater Reagent at –20°C, be sure to remove any crystals that may have formed. 
2. Disruption using a mortar and pestle followed by homogenization using a QIAshredder homogenizer: 
Immediately place the weighed (fresh, frozen, or RNAlater stabilized) tissue in liquid nitrogen, and grind 
thoroughly with a mortar and pestle. Decant tissue powder and liquid nitrogen into an RNase-free, liquid-
nitrogen–cooled, 2 ml microcentrifuge tube. Allow the liquid nitrogen to evaporate, but do not allow the 
tissue to thaw.  
3. Add the 600 ul of Buffer RLT (with BME). Pipet the lysate directly into a QIAshredder spin column 
placed in a 2 ml collection tube.  
4. Centrifuge the lysate for 3 min at full speed. Carefully remove the supernatant by pipetting, and transfer 
it to a new microcentrifuge tube. Use only this supernatant (lysate) in subsequent steps. 
In some preparations, very small amounts of insoluble material will be present after the 3 min 
centrifugation, making the pellet invisible. 
5. Add 600 ul of 70% ethanol to the cleared lysate, and mix immediately by pipetting. Do not centrifuge. 
Proceed immediately to step 6. Note: The volume of lysate may be less than 350 µl or 600 µl due to loss 
during homogenization and centrifugation. Note: Precipitates may be visible after addition of ethanol. This 
does not affect the procedure. 
6. Transfer up to 700 µl of the sample, including any precipitate that may have formed, to an RNeasy spin 
column placed in a 2 ml collection tube (supplied). Close the lid gently, and centrifuge for 15 s at ≥8000 x 
g (≥10,000 rpm). Discard the flow-through. If the sample volume exceeds 700 µl, centrifuge successive 
aliquots in the same RNeasy spin column. Discard the flow-through after each centrifugation.  
7. Add 350 µl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge for 15 s at 
≥8000 x g (≥10,000 rpm) to wash the spin column membrane. Discard the flow-through. 
8. Add 10 µl DNase I stock solution (in -20) to 70 µl Buffer RDD (in RNase-Free DNase Set in fridge). 
Mix by gently inverting the tube, and centrifuge briefly to collect residual liquid from the sides of the tube. 
Note: DNase I is especially sensitive to physical denaturation. Mixing should only be carried out by gently 
inverting the tube. Do not vortex.  
9. Add the DNase I incubation mix (80 µl) directly to the RNeasy spin column membrane, and place on 
the benchtop (20–30°C) for 15 min. Note: Be sure to add the DNase I incubation mix directly to the RNeasy 
spin column membrane. DNase digestion will be incomplete if part of the mix sticks to the walls or the O-
ring of the spin column. 
10. Add 350 µl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge for 15 s at 
≥8000 x g (≥10,000 rpm). Discard the flow-through. 
11. Add 500 µl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge for 15 s at 
≥8000 x g (≥10,000 rpm) to wash the spin column membrane. Discard the flow-through.  
12. Add 500 µl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge for 2 min at 
≥8000 x g (≥10,000 rpm) to wash the spin column membrane. The long centrifugation dries the spin column 
membrane, ensuring that no ethanol is carried over during RNA elution. Residual ethanol may interfere 
with downstream reactions. Note: After centrifugation, carefully remove the RNeasy spin column from the 
collection tube so that the column does not contact the flow-through. Otherwise, carryover of ethanol will 
occur. 
13. Place the RNeasy spin column in a new 1.5 ml collection tube (supplied). Add 50 µl RNase-free water 
directly to the spin column membrane. Close the lid gently, and centrifuge for 2 min at ≥8000 x g (≥10,000 
rpm) to elute the RNA. 
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If the expected RNA yield is >30 µg, repeat step 11 using another 30–50 µl RNasefree water, or using the 
eluate from step 11 (if high RNA concentration is required).  




Protocol for RNA Purification 
 
 
1.) Add  - 0.5 volume Ammonium Acetate 7.5 M (4C) or 0.3 M Sodium Acetate (3M stock) 
- 2.5 volume 100% EtOH (-20C) 
- 1 mg/ml Glycogen about 10 ul for 500 ul RNA  
2.) Place in -80 overnight 
3.) Spin 4C for 20-30 min (12,000 x8) 
4.) Pour off supernatant 
5.) Wash with 1 ml 70% EtOH (-20C)  
6.) Pour off and pipette out the residual EtOH  
7.) Air dry 10 min (don’t invert; cover with Kimwipe, place in hood)  
8.) Resuspend with sterile DEPC water 25-50ul 
9.) Heat at 55C for 15 min if won’t dissolve 
10.) Quantify on the Nanodrop  
 
*Better procedure when 260/280 is good and 260/230 is bad; as this will pull down salts as well & purity 







HWM DNA Isolation 
 
(Isolate DNA from Myo and Fib tissue) 
 
 
PROTOCOL – Tissue Lysis 
1. Remove tissues from liquid nitrogen tank and allow to sit on ice for 1 hour. 
2. Cut off a small chunk of tissue. 
3. Measure out a chunk of tissue up to 25mg and put it into a 2mL tube. 
4. Add 220 uL buffer ATL. 
5. Add 20 uL Proteinase K and vortex for 10 seconds. 
6. Incubate overnight (16 hours) on a Thermomixer at 56C, 900 rpm. 
PROTOCOL – DNA Isolation 
1. Spin the tube down to get the liquid to the bottom of the tube. 
2. Transfer 200 uL of liquid to a new 2 mL tube. 
3. Add 4 uL RNase A and pulse-vortex for 10 seconds. 
4. Incubate at RT for 2 minutes. 
5. Add 150 uL buffer ATL and pipette up and down several times. 
6. Add 280 uL buffer MB. 
7. Vortex Suspension G for 3 minutes. 
8. Add 40 uL Suspension G to the sample. 
9. Incubate on the Thermomixer at 25C, 1400 rpm for 3 minutes. 
10. Place tubes on the magnetic base for 1 minute. 
11. Still on the magnet, remove all supernatant. 
12. Remove tubes from magnet and add 700 uL buffer MW1. 
13. Incubate on the Thermomixer at 25C, 1400 rpm for 2 minutes. 
14. Place tubes on the magnetic base for 1 minute. 
15. Still on the magnet, remove all supernatant. 
16. Remove tubes from magnet and add 700 uL buffer MW1. 
17. Incubate on Thermomixer at 25C, 1400 rpm for 2 minutes. 
18. Place tubes on the magnetic base for 1 minute. 
19. Still on the magnet, remove all supernatant. 
20. Remove tubes from magnet and add 700 uL buffer PE. 
21. Incubate on Thermomixer at 25C, 1400 rpm for 2 minutes. 
22. Place tubes on magnetic base for 1 minute. 
23. Still on the magnet, remove all supernatant. 
24. Remove tubes from magnet and add 700 uL buffer PE. 
25. Incubate on the Thermomixer at 25C, 1400 rpm for 2 minutes. 
26. Place tubes on the magnetic base for 1 minute. 
27. Still on the magnet, remove all supernatant. 
28. Still on the magnet, rinse pellet with 700 uL distilled water. 
a. Rinse against the side of the tube away from the pellet! 
29. Incubate at RT for 1 minute. 
30. Still on magnet, remove all supernatant. 
31. Still on magnet, rinse pellet with 700 uL distilled water. 
32. Incubate at RT for 1 minute 
33. Still on magnet, remove all supernatant 
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34. Remove tubes from magnet and add 100 uL buffer AE. 
35. Incubate on thermomixer at 25C, 1400 rpm for 3 minutes. 
36. Place tubes on the magnetic base for 1 minute. 
37. Still on magnetic base, transfer 100 uL supernatant (DNA we want) to a new tube. 
38. Transfer 5 ul of sample to a new tube and label for Quibit → put on ice. (ERML356+sample 
form) 
39. Transfer 5 ul of sample to a new tube for agarose gel (1%) 





Fibroid/Myometrium Cell Culture Protocol 
 
 
Cell Culture Medium Recipe  
DMEM 1X (Corning cellgro REF 10-013-cv) 
10% FBS (use 10% for plating cells, after cells attach, switch to 5%) 
1% Pen-Strep 
1% L-Glutamine 
Freezing Medium: 90% FBS + 10% DMSO 
 
Tissue Digestion and Cell Culture Protocol: 
(Day 1)  
1. Chop up Fibroid/Myometrium into small pieces 
2. Transfer tissue pieces into tube containing medium with 10% collagenase II (200 U/ml)  
(Stock Conc.: 2000U/ml, Working conc.:200 U/ml) 
3. Place tube on shaker in incubator at 37 for overnight. (about 16 hours) 
(Day 2) 
4. Spin down cells at 600-1000 RPM for 5 min at RT. 
5. Aspirate supernatant. 
6. Re-suspend cells with small amount of medium. 
7. Evenly distribute into multiple plates.  
8. Incubate at 37°, 5% CO2. Let cells settle for 48 hours before checking or changing medium. 




1. Check cell confluency first. 
2. Add 3 ml of 0.25% Trypsin EDTA (Corning REF 25-053-ci) to rinse the plate 
3. Aspirate the Trypsin and add 3 ml more of 0.25% Trypsin. 
4. Incubate at 37°, 5% CO2 for 10 min. Then check every 3 min for cell detachment. (usually 
takes about 10-15 min) 
5. Transfer cells into a tube with 7 ml of medium. 
6. Spin down cells at 600 – 1000 RPM for 5 min at RT. 
7. Aspirate supernatant. 
8. Re-suspend cells with freezing medium. (Freezing medium: 90% FBS+ 10% DMSO) 
9. Transfer cells into cryovials and label the vials. 
10. Place vials on ice for 30 min. 
11. Place vials in -80° freezer for 24 hours. 
(Day 2) 




Mouse Genotyping Protocol 
 
DNA Extraction 
o Add 2mL TP (tissue prep) to 8mL E 9(extraction buffer) 
o Add 125 microliters E (extraction buffer) to each tube 
o Heat for 10 min at 55 degrees C to activate 
o Heat for 3 min at 95 degrees C to stop reaction 
o Add 100 microliters of N (neutralizing buffer) 
o DNA ready   
 
Making PCR mix: 
Components vary based on target gene 
Take out components and let thaw. Aliquots are located inside -20 in lab. 




Cre(_______ + 1) x 1.1 = 
 
 TAQ                 10 microliters                                         TAQ _____ microliters 
 P1 (PR cre f1) 0.4 microliters                                          P1    _____ microliters 
 P2 (PR cre f2) 0.4 microliters       x  _______                 P2    _____ microliters 
 P3 (PR cre r)   0.4 microliters                                          P3    _____ microliters               
 H2O                 6.8 microliters                                         H2O  _____ microliters 
 = 18 microliters 
 
Lox(________ + 1) x 1.1 
 
 TAQ          10 microliters                                               TAQ _____ microliters 
 P1 (Lox 1)   2 microliters                                               P1     _____ microliters 
 P2 (Lox 2)   2 microliters           x ________                 P2     _____ microliters 
 H2O             3 microliters                                               H2O  _____ microliters 
 = 17 microliters 
 
DDR 
(__________ + 1) x 1.1 
 
 TAQ                   10 microliters                                      TAQ _____ microliters 
 P1 (DDR neo II)   2 microliters                                      P1    _____ microliters 
 P2 (Nul 5-2)         2 microliters         x ________          P2     _____ microliters 
 P3 (Nul 5-6)         2 microliters                                      P3     _____ microliters 
 H2O                      3 microliters                                      H2O  _____ microliters 
 = 17 microliters 
PCR 
Ensure tubes are closed. 
Use microcentrifuge to spin tubes, only for a few seconds to ensure contents are at bottom of tubes. 
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Carefully load into Thermal Cycler machine 
Go to Nowak Lab, choose protocol (DDR runs separate from other types) 
After a run is complete, machine will infinitely keep samples at 4 degreees C until you return. 
 
Preparing for electrophoresis: 
 
Making Running Solution 
Use 1% TBE is a solution for the making of the gel and during the electrophoresis 
 
10% x TBE 
Weigh and combine in a beaker: 
o 108g Tris Base 
o 55g Boric Acid 
o 9.3 EDTA 
Add DI water until you have 1L total solution 
Using pH meter, test pH and make adjustments as needed. The 
solution should have a pH of 8.3. Adding acid may be necessary to 
decrease the pH. 
 
To make 1% x TBE, add 100 mL TBE to 900 DI water. 
 
Making Gel 
Tape the sides of your box before/while making gel. Make sure to cover open sides and allow for 
extra tape to prevent leakage from the bottom as well as the sides. 
 
Choose recipe from the following: (Fore cre, etc use 1% gel. For DDR use 1.5%. If you are running 
both, can use 1% gel for DDR as well) 
 
1% agarose gel with ethidium bromide 
Place 1 gram agarose in beaker with 100mL 1x TBE 
Heat in microwave for about 40 seconds, swirl beaker, then microwave for another 30 
seconds. 
Let stand to cool until you can touch the bottom of the beaker (not too much, or the solution 
may start to gel). Now is a perfect time to tape your box’s edges. 
Add 5 microliters of ethidium bromide to the beaker, swirl to mix. Ready to pour into box. 
 
Pour gel into box. Pop any bubbles or push them away from center. Place your combs into gel 
right after pouring. Use the thicker teeth for a larger well. To avoid unnecessary waste, most gels 
you can use 2 combs and therefore run double samples. Make sure to adjust running time as 
needed. 
 




Load your samples into gel carefully, pipetting the full 20 microliters into each well. 
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Add 5 microliters of DNA standard 
Note placement of samples, order matters! 
 
Set a constant voltage 120V. Your amp is calculated by the machine. Select the amount of time to 
run your samples, 1 hour. 
 
Reading your gel 
Photographing: 
Make sure the machine isn’t in use! 
Select a clear glass tray with the “tissue paper” cover. You may have to rinse the tray/cover. Dry 
off the tray/cover and place it back onto tray. 
Carefully peel your gel out of its box and place onto the paper on the tray. You may now place the 
tray into the machine 
Open the Image Quant LAS program 
Adjust your focus first, make sure you can also adjust brightness and contrast as needed. 
Use position 4 initially, this should give you a shot of the entire gel. Positions 3, 2, and 1 will bring 
the gel/tray closer to the lens. 
For a standard DNA pcr, we want to use fluorescence (which allows us to visualize the ethidium 
bromide) and trans UV light 
Select the exposure type, set this to position. Exposure time should be manually selected. 1/8 or 
1/15 seconds should be sufficient. 
Once you have captured an image you would like to save, save it in a folder with the date the gel 
was run and information such as the sample numbers and what genes you are testing for. 
 
Ideally, you get a picture of the whole gel, one of the top half, and then the bottom half. 
 
Visualizing: 
Lox     size (bp)          genotype 
• 370                     F/F 
• 370 + 302           F/+ 
• 302                     +/+ 
Cre 
• 594 + 283          cre/+ 
• 283                     +/+ 
DDR 
• 240                      wt 
• 360/240               +/- 
BSG (global) 
• 250                    Wt 
• 1250/250           +/- 










o Lox 1 
o Lox 2 
• PR cre 
o PRcre f1 
o PRcre f2 
o PRcre r 
DDR1 
• DDR Neo II 
• Nul 5-2 




















Artificial Decidualization Response (ADR) Timeline and Procedure 








!!! D-10 ovariectomy D -10 
  D-9 Recovery   
  D-8 Recovery   
  D-7 Recovery   
  D-6 Recovery   
  D-5 Recovery   
  D-4 Recovery   
  D-3 Recovery   
  D-2 Recovery   
  D-1 Recovery   
! D1 100 ng E2 in 0.1 ml corn oil 9am D1 
  D2 100 ng E2 in 0.1 ml corn oil 9am D2  
  D3 100 ng E2 in 0.1 ml corn oil 9am D3 
  D4 Rest D4 
  D5 Rest D5  
 !!! D6  10 ng E2 + 1 mg P4 in 0.1 ml oil 9am D6   request drugs 




10 ng E2 + 1 mg P4 in 0.1 ml oil 9am 
D8 Oil injection 15 ul corn oil 
into right horn 11a-1p. use 30G 
needle 
  D9  1 mg P4 in 0.1 ml oil 9am D9 24 hr 
  D10 r 1 mg P4 in 0.1 ml oil 9am D10 48 hr 
  D11  1 mg P4 in 0.1 ml oil 9am D11 72 hr 
  D12  
1 mg P4 in 0.1 ml oil 9am 




Mouse tail vein injection of blue dye  
 
Implantation sites in mice can be detected as early as late at night on day 4 (2200–2300 h) and onward, 
considering the presence of a copulatory plug as day 1 of pregnancy. This is achieved by intravenous 




1. Fill a 1-mL syringe attached to a 27-gauge needle with 1% blue dye solution (Chicago Blue B, Evans 
blue, or pontamine blue) avoiding any air bubbles inside the syringe.  
2. After a mouse is anesthetized, dilate the tail veins by the application of a paper towel soaked in warm 
water.  
3. Locate one of the two lateral veins in the tail (veins are located on both sides of the central artery) and 
place the mouse on that side.  
4. Hold the tail gently between the thumb and forefinger and keep the tail parallel to the body of the mouse 
(Fig. 5).  
5. Align the needle (bevel side up) with the plane of the vein. Insert the needle into the vein and slowly 
inject the desired amount of dye (0.1 mL/mouse, 0.25 mL/ rat). As a result of increased capillary 
permeability in the endometrial bed at the sites of implantation, the dye bound with the serum proteins 
accumulates in the interstitial space at the sites of blastocysts, showing distinct blue bands (Fig. 6). Chicago 
Blue B dye has been used for many years to identify implantation sites (see Note 4).  
6. Animals are sacrificed 3–5 min after dye injection to identify blue bands in the uterus. Identification of 
uterine implantation sites from day 6 onward does not require blue-dye injection. Visual observation of 




Lactate Assay Procedure 
(Lactate Assay Kit, Millipore Sigma #MAK064) 
 
 
Lactate Standards for Colorimetric Detection: 
• Dilute 10 µL of the 100 nmole/µL Lactate standard with 990 µL of Lactate Assay Buffer to generate 
a 1 nmole/µL standard solution.  
• Add 0, 2, 4, 6, 8, and 10 µL of the 1 nmole/µL Lactate standard into a 96 well plate, generating 0 
(blank), 2, 4, 6, 8, and 10 nmole/well standards.  
• Add Lactate Assay Buffer to each well to bring the volume to 50 µL.  
Sample Preparation:   
• Assay requires 50 µL of sample for each reaction (well).  
• Serum samples/medium (0.5–10 µL/assay) can be assayed directly by adding in duplicate to 96 
well plate.  
• Bring samples to final volume of 50 µL/well with Lactate Assay Buffer. 
• For unknown samples, it is suggested to test several sample volumes to make sure the readings are 
within the standard curve range.  
Assay Reaction  
1. Set up the Master Reaction Mix according to the scheme in Table 1. 50 µL of the Master Reaction 
Mix is required for each reaction (well).  
Reagent Master Reaction Mix 
Lactate Assay Buffer  46 µL 
Lactate Enzyme Mix  2 µL 
Lactate Probe  2 µL 
 
2. Add 50 µL of the Master Reaction Mix to each of the wells. Mix well using a horizontal shaker or 
by pipetting, and incubate the reaction for 30 minutes at room temperature. Protect the plate from 
light during the incubation.  
3. For colorometric assays, measure the absorbance at 570 nm (A570). For fluorometric assays, 
measure fluorescence intensity (λ= 535/ λ = 587 nm). 
Concentration of Lactate  
Sa/Sv = C 
Sa = Amount of lactate acid in unknown sample (nmole) from standard curve  
Sv = Sample volume (µL) added into the wells.  
C = Concentration of lactate acid in sample  
Lactate molecular weight: 89.07 g/mole  
Sample Calculation  
• Amount of Lactate (Sa) = 5.07 nmole (e.g.) 
• Sample volume (Sv) = 50 µL  
• Concentration of lactate in sample: 
o 5.07 nmole/50 µL = 0.101 nmole/µL  
o 0.101 nmole/µL ´ 89.07 ng/nmole= 9.0 ng/µL  
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Protocol for Western Blotting 
 
 
1) Switch on the heat block set at 95oC. Thaw samples and 4X LSB on ice. Always check whether the 
protein needs to be run in a reducing or non-reducing condition. Check the primary antibody 
product sheet or pertinent references for this information. Accordingly use LSB with or without 
betamercaptoethanol in it. 
2) Prepare samples (3 parts) with 4X LSB (1 part). Load maximum of 20ug of sample in each well 
for the mini gels. Samples should be loaded in equal quantities (ug of total protein or volume; as 
needed by specific experimental setup). The total volume of sample+LSB should not exceed 25ul 
for the 15 well gels and 40ul for the 10 well gels. Always check the gel product sheet specifications 
for this information.  
3) Prepare the Running Buffer: 1 packet per 500 mL of DI H2O. Running Buffer is BupH Tris-HEPES-
SDS Running Buffer (Thermo Scientific Prod #28398) for the gels we use. Always check the type 
of running buffer needed for the specific type of gel being used). Add the running buffer powder 
to the DI water in the fume hood, cover and mix on the magnetic stirrer. (The powder contains SDS 
which should not be inhaled).  
4) Need precast gels to be at room temperature prior to use. Type of gel needed is dependent on the 
molecular weight of the protein being analyzed. Higher molecular weight proteins need a lower 
percent/concentration of gel and vice versa. Check product sheet and pertinent references for this 
information. As soon as your gels are ready (at room temperature), take your gels out of their wrap 
and put them into the gel boxes. 
i. Stack the gels with the shorter plates INWARDS (facing one another) into the gel box 
inside one of the beige gel holders. Once both gels are in (and facing each other), push 
them down with one hand while closing the clear doors with other hand.  
ii. Pour your Running buffer into the center between the two gels first. Check for leaks. If 
there are no leaks, continue to add Running buffer until you reach the outer lip of the gel 
box. Make sure the gels are covered and continue. (Don’t fill too much it will leak from 
the sides)  
5) Place all the tubes with your samples on the 95oC heat block for 5-6 minutes. Check to make sure 
the samples have mixed thoroughly with the LSB.  
6) Make sure the wells in the gel are devoid of air bubbles or the gel preservative buffer by pipetting 
in small volumes of running buffer into each well before loading your samples. 
7) Get a protein ladder aliquot from the -20oC. Each aliquot is 12ul. Load 6-12ul per gel. Position of 
the ladder in the gel may be decided depending on whether the membrane will be used as a whole 
(well#1) or cut into sections and incubated under different conditions (any of the central wells).  
8) Load 20ul of 1xLSB (with dye) in all of the wells that will remain empty i.e. spaces between your 
samples according to how you planned your gel. This is done to balance the gel & keep the samples 
from running crooked down the gel. 
9) Once done with the heat block, quickly spin down the samples in the table-top microfuge. Load all 
of your samples as soon as they are done from the centrifuge. Load your positive control first and 
then proceed with the samples.  
10) Once you have loaded all of your samples on both gels (or on one gel, depends how many samples 
you have), place the green cover on the top of the gel box making sure that the red-red and black-
black pins match. Make sure of this as it will affect how the gel runs when plugged into the voltage 
machine.  
11) Use a piece of tape (colored) on the front of the gel box to make sure you know which side is the 
front (so you can tell the gels apart).  
12) Once you have plugged in your gel box (red-red and black-black) you can turn on the power switch 
on the side.  If this is plugged in incorrectly, you’ll end up running your samples off the gel… and 
that’s no fun.  
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13) The gel can be run with different voltage and time parameters. Lower voltage makes the proteins 
move slowly down the gel and hence needs a longer run time and vice versa. Voltage may be set 
between 80-120V and run for 45 -95 minutes depending on specific experimental set up. Then start 
the machine (running man symbol) and check for bubbles. The bubbles need to move up from the 
bottom of the gel box and the samples need to slowly run downward.  
14) While it is running, you want to check the separation of your protein ladder bands. Do not let the 
samples run off the gel. Stop the machine once the blue sample “line” reaches below the green 
mark/line on the gel box. 
15) In this time you can prepare for the Transfer process. For this- 
i. You need two sponges, 2 filter papers, 1 membrane per gel. Type of membrane can be 
nitrocellulose membrane (Thermo Scientific Prod #88018) or PVDF membrane (Millipore 
Prod#IPVH00010). If using the PVDF membrane remember to immerse in methanol for at 
least 15 seconds so as to activate it before use.  
ii. You need to wet all of these things in Transfer buffer before assembling your sandwich.  
Transfer buffer:  
Glycine 11.6 g 
Tris (base) 23.2 g 
SDS 1.48g  
Methanol 800mL  
Total volume (DI water) 4 L  
16) In this time, you can also make TBST pH=8 (WASH buffer).  
  TBST pH=8: (Good for two weeks, store covered at 4oC)  
   For 2L:   For 1L:   For 500mL (for one memb) 
  17.5g NaCL  8.75g   4.375g 
  12.1g Tris base  6.05g   3.025g 
  2mL Tween-20 1mL   .5g 
17) Once the gel is run with complete separation of protein ladder, stop the machine, and take the green 
cover off. Drain off the running buffer in the sink.  
18) Pull the beige tray out and remove the gels out one at a time, so that you know which one is which. 
Make sure you remember which one came from the front. 
19) Using the green gel snapper, slide it between the plastic pieces holding the gel and pull the pieces 
apart. You want to make sure that you know which side is up on your gel so that you can lay it 
down correctly. The best way to tell is to make sure the ladder in on the LEFT.  
20) Assemble the sandwich using forceps. Keep all components submerged in transfer buffer during 
assembly. The order of the sandwich is as follows- On the clear side/piece assemble:   
 a. Sponge 
 b. Filter Paper 
 c. Nitrocellulose/PVDF membrane 
d. Gel (With the ladder on the LEFT side) 
  e. Filter Paper  
  f. Sponge 
Make sure no air bubbles are trapped between the layers. This can be done by constantly pouring 
transfer buffer (use the sponge) on each layer as you assemble the sandwich. Make sure to mark on 
the membrane (with pencil) the wells and the gel ID. Then close the sandwich. The current moves 
from negative to positive (black to red). Always make sure the gel is closest to the black side/piece 
of the plastic assembly. This ensures the proteins move from the gel to the membrane.  
21) In the big plastic box, place a stir bar, and the black and red transfer tray and the ice tray.  
22) Once you have assembled your sandwiches, carefully slide them into the black and red transfer tray 
and fill up the box with transfer buffer. Again check that the black side of the sandwich is closest 
to the black side of the transfer tray. 
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23) Add the green cover again on the top of the box (match the red-red and black-black pins). Turn ON 
the spin plate (check to see that the stir bar is spinning gently), and plug the box back into the 
machine (red-red and black-black). Once it is plugged in, turn the power on.  
24) Proteins can be transferred either overnight (slow transfer) or in one hour (fast transfer). Usually a 
fast transfer works well. For this set voltage at 100V and run transfer for 60 minutes. 
25) During this time prepare the buffer to be used as blocking buffer and for the primary and secondary 
antibody incubation. This can be a 5% solution of skimmed milk powder in TBST or 5% solution 
of BSA powder in TBST or a mix of the two. Check the primary antibody product sheet for 
specfications.  
26) Once the transfer is complete, remove the membrane carefully from the assembly and wash once 
with DI water for 2-3 minutes. The transfer buffer may be re-used as long as it is clear in color (not 
yellow). Preferably use only 3-4 times as each use tends to concentrate the buffer and a change in 
the concentration can cause excess heating of the buffer during the run and lack or incorrect transfer.  
27) Always make sure the surface of the membrane with the protein ladder is on the top so that it comes 
in maximum contact with the buffers. Protein transfer can be evaluated using Ponceau S stain. 
Immerse the membrane in the stain for 5 minutes; keep it on the plate shaker (belly dancer). Remove 
the stain, wash once (quickly) with TBST and check for protein bands on membrane. Once the 
transfer is confirmed, wash the membrane with TBST at least 3 times to remove all of the Ponceau 
S. 
28) Drain the TBST and add the Blocking solution. Place the lid on the plastic container and set to rock 
for 60 min.  
29) Once blocking is done, wash quickly twice with TBST and discard in the sink. 
30) In a conical tube add appropriate volume of buffer (milk or BSA) and primary antibody. Check the 
product sheet for antibody dilution specifications. Incubate the membrane in the primary antibody 
overnight at 4oC on the shaker in the cold room in Dr. Bahr’s Lab. 
31) Always check the specifics for the blocking and primary as well as secondary antibody incubation 
time and temperature before starting the experiment. These may vary depending on the type of 
protein being evaluated and/or the experimental set-up. 
32) Once the primary antibody incubation is completed, wash the membrane 3 times for 5 minutes each 
with TBST buffer.  
33) During the last wash prepare your secondary antibody solution. Check the product sheet for 
specifics. Usually the secondary antibody is used at a 1:5000 - 1:10,000 dilution. Leave it on the 
shaker in the secondary antibody mixture for 1 hour or as specified in the product sheet/references.  
34) Once the secondary antibody incubation is done, wash the membrane 6 times for 5 minutes each 
with TBST.   
35) During the last wash prepare the chemiluminescence solution by mixing equal parts of both 
solutions in the kit. Be careful that separate pipettes are used for each solution to avoid cross 
contamination; as this will render the solutions useless for subsequent experiments. Mix well.  
36) Prepare a platform laying a clean sheet of Parafilm on the bench top. Once the washes are done, 
remove the membrane using forceps, drain off excess liquid by touching a tip of the membrane to 
a paper towel or Kimwipe and place the membrane on the Parafilm platform. Add the 
chemiluminescence solution on to the membrane making sure the entire membrane is covered 
(about 1 ml of solution is enough for one membrane). Incubate the membrane in this solution for 
at least 6 minutes.  
37) During this time, go to Dr. Miller’s lab and log onto the computer attached to the Image Quant 
machine. Start the program and set the machine to cool down.   
38) Once the 6 minute incubation is done, pick up the membrane with forceps; drain off excess liquid 
by touching an edge or tip of the membrane to a paper towel/Kimwipe. Place the membrane right 
side up in a sheet protector packet. Make sure to avoid air bubbles. Label each packet with Gel ID. 
Keep all such packets with membranes protected from light in the X-ray cassette. 
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39) Take these to Dr. Miller’s lab and image using the Image Quant machine. Set the program to auto 
exposure as the machine can evaluate the best exposure time for us. Make sure each membrane is 
set to the same exposure parameters especially when comparison between membranes is required 










                       Start up ImageQuant LAS 4000 Control Software 
 
1 – Menu Bar 
2 – Exposure Type [Choose Precision, Increment*, Repetition* or Program*] 
3 – Exposure Time [Auto or Manual in seconds, minutes, hours] 
4 – Sensitivity/Resolution [Choose one, High Resolution and Std are normally used]  
See manual for more options 
5 – Digitization Image will be exposed simultaneously with chemiluminescence image if checked. 
6 –  CCD temperature setting displayed.  Will display Ready or Not Ready. 
7 – The (IDX) Intelligent dark box display 
8 – Method/Tray position [Readable area vairies with tray position] 
   ►Small gels use position 1 (closest to camera), biggest gels use position 4. 
   ► Use Epi (Black tray for Chemiluminescence & Fluorescence Epi illumination)  
   ► Use White Trans tray for exposing fluorescent samples with Ethidium Bromide (312nm) 
9 – Focusing allows focusing, brightness and adjustment. 
10 – Start button 
        * For Increment, Repetition or Program exposures see manual pgs 59- 69  
   
Placing the Sample: (insert trays with holes facing outwards toward door) 
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1) For Chemiluminescence & Fluorescence (Epi illuminatiuon) samples place sample directly on Epi 
(Black) tray. 
 
2) For Gels stained with Coomassie or silver stains use White trans tray.  Place a gel sheet (slightly 
larger than sample) on the tray then place gel on top of sheet. 
 
3) Choose exposure size and tray position 
Position 1 = sample size 105mm x 70mm  Position 2 = 122mm x 96mm 
Position 3 = sample size 180mm x 120mm  Position 4 = 210mm x 140mm 
 
4) Exposing Chemiluminescent samples 
a.  With sample placed on Epi (black) tray 
b.  Click Method/Tray position button 
c.   Select CHEMILUMINESCENCE for Method 
d.   Select TRAY POSITION according to sample size 
e.   Click OK button 
f.    Click FOCUSING button [check sample position and focus as needed] 
g.    Select PRECISION for EXPOSURE TYPE 
h.    Select AUTO or MANUAL for EXPOSURE TIME 
i.     Select SENSITIVITY/RESOLUTION 
[if unsure select Help:Sensitivity/Resolution to see relation between the two] 
j.    Click START button 
k. Adjust gradations of exposed image, save. 
l.  Click COMPLETE button 
m. Display will return to main screen.   
 
5) Exposing Fluorescence (Epi illumination) 
a. Place sample on Epi (black) tray 
b. Select FLOURESCENCE [choose marker and light source from pull down menus. 
Appropriate filters are automatically selected] 
c. Select TRAY POSITION 
d. Click OK button 
e. Click FOCUSING button 
f. Click RETURN 
g. Select PRECISION for EXPOSURE TYPE 
h. Select AUTO or MANUAL EXPOSURE TIME 
i. Select SENSITIVITY/RESOLUTION 
j. Click START button 
k. View image, adjust gradations as desired, then save. 
l. Click COMPLETE button 
 
6) Exposing dye stained samples and films (White Epi light) 
a. Place sample on White Trans tray.  
b. Select DIGITIZATION:TRANS-ILLUMINATION for Method 
c. Select TRAY POSITION 
d. Click OK button 
e. Click FOCUSING button. 
f. Confirm the sample position and the focus 
g. Click RETURN button. 
h. Select PRECISION for EXPOSURE TYPE 
i. Select EXPOSURE TIME 
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j. Select SENSITIVITY 
k. Click START button 









Instructions for using ImageQuant with ethidium bromide stained gel: 
 
 
ATTENTION IMAGEQUANT USERS!!! 
PLEASE REMOVE AT LEAST ONE GLOVE PRIOR TO TOUCHING THE PC 




1. Remove at least one glove to do the following:  
a. Log on PC using your password, launch ImageQuant application, and turn on 
ImageQuant machine. 
b. Using one hand without glove, open the ImageQuant door and place the clear tray with 
the white paper inside the ImageQuant. 
c. Using the other hand with glove, place the gel onto the clear tray with the white paper 
(NOTE: To position the gel correctly under the camera, use one hand without glove to 
open the ImageQuant door and use the other hand with glove to ONLY move the gel or 
to move the white paper under the gel). 
d. Once the gel imaging is done, use one hand without glove to open ImageQuant door. Use 
the other hand with glove to remove the gel.  
e. Using one hand without glove, take the clear tray with the white paper to the sink and 
briefly rinse with running water. 








1. Clean and dry slides for 24 hours before scan. 
2. 210 slides can be scanned in one batch. 
3. Log-in to the IGB system on the Nanozoomer computer. 
4. Put in the slides in the slide holders starting from the first slot. Do not leave any slot empty. 
5. Open door of the slide holder by pushing on the door (do not use the button). 
6. Open NDP.scan2.5.85 (double click). 
7. Go into settings → output path – my computer – data part D – users – choose your file – click 
“apply” then OK. 
8. Threshold 5.1-94.9% 
9. Choose batch mode when running multiple slides. 
10. Profile – choose previous profile set up for you by Donna Epps. 
11. Slide Reference – name the order of slides put in the holder. 
12. Start batch. 
13. Set up scan area → manual – semiautomatic - Choose scan area by click dragging the edge of the 
box created around your section….bring it as close to the edge of your section as possible so the 
machine doesn’t spend time on unnecessary areas of the slide. For selection of specific points on 
scan area – right click on various parts of your tissue section which will produce yellow colored 












Sample Preparation for SEM 
 




1. For each sample, use a 1-in-long piece of glass cut from a clean microscope slide. 
 
2. On each piece of clean glass put a drop (ca. 20 microliters) of concentrated microvesicles in liquid, 
as prepared. 
 
3. To each drop add the same volume of 2.0% E.M.-grade formaldehyde and 2.5% E.M.-grade 
glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. 
 
4. Use a diamond stylus to scratch a circle around each (now larger) drop, and put each piece of slide 
with its drop of microvesicles/fixative into the refrigerator for 60 to 75 minutes. 
 
5. Put each piece of slide into a small plastic Petri dish and add 0.1 M sodium cacodylate buffer, pH 
7.4. Put each small Petri dish on a slowly moving shaker table. The 0.1 M sodium cacodylate buffer 
is used to rinse the fixative away; change it after a few minutes, for completely new buffer. Never 
leave the slide exposed to air for long; always have the next change of solution ready when you 
take the old solution away. 
 
6. After 10 minutes, change the buffer for 37% ethanol (10 minutes), then 67% ethanol (10 minutes), 
then 95% ethanol (10 minutes), and then three changes of 100% ethanol (10 minutes each). 
 
7. After that, in 100% ethanol, critical-point-dry the samples using the Tousimis PVT-3D critical point 
dryer, one at a time to avoid cross-contamination.  Then mount the samples on a stub and coat them 
with about 6 nm of gold-palladium. Paint Flash-Dry silver paint onto an edge of each piece of slide 
while the piece of slide is in the fume hood so the solvent in the paint will not affect the samples. 





Protocol for using the Ultra-centrifuge machine (Dr. Bahr’s lab) 




1. Cool down takes about 20 minutes so start the machine in advance (won’t start if not cool). Vacuum 
will be at <20 when cool enough. 
2. Check and set up parameters for speed, time, temperature and vacuum before starting. 
3. Acceleration and deceleration at maximum. 
4. When at 4oC press vacuum so you can open the machine. 
5. Rotor should be stored at 4oC (cold room Bahr Lab). It has a laser on the bottom so be very careful 
while fixing it in place in the machine or even while placing it on any surface.  
6. Fix rotor in place, spin by hand to check that it is not wobbly. Put in samples and tighten lid well. 
7. Press “speed-enter-time-enter-temp-enter” in fast succession and then press start very quickly. 
8. Vacuum starts automatically. 
9. Once done press vacuum to release pressure and open. 
10. Take your samples out of rotor and keep on ice.  
11. Mark on the tube the position of the micro-vesicle pellet (usually towards outer side) as it soon 
becomes clear and not visible to the eye. 
12. Remove rotor from machine carefully and place in the cold room again. Don’t fix the lid on too 
tight. 
13. Write down the revolution counter details at the end of the run. 






Cell Culture Etiquette 
 
 
Laminar Flow Biosafety Hood  
1.) Air Flow: the air flow needs to be turned on for at least 15 min before working in the hood to 
establish sterile conditions.  
2.) UV light: the UV light offers protection from the growth of material (bacterial/fungal/cells) 
that may be displaced during use of the hood. The UV light needs to be turned on every night 
at the closing of the lab and turned off every morning prior to working in near the biosafety 
hood.  
3.) Aspiration: there is a vacuum trap located inside the hood that is connected to a collection trap 
by plastic tubing. This vacuum is used to aspirate media from cells and therefore needs to be 
treated with bleach to eliminate the growth of cells in the collection trap. It is important that 
the trap is never overfilled because the backflow of the fluid into the vacuum line will result in 
major repair bills. The collection trap should be treated by bleach after every use by EACH lab 
member. When the trap is 3/4th full it should be emptied down the lab drain with running cold 
water for at least 15 min.  
4.) Maintenance: The biosafety hood needs to be sprayed with 70% ethanol and wiped with a Kim 
wipe prior and after each use. All spills need to be cleaned up immediately. General cleaning 
should be done 2X/year with mild soap and warm water. NEVER use toxic/halogenic 
chemicals in the flow hood. This is not a fume hood so please do not treat it as such. All 
chemicals or toxic substances need to be used in the fume hood. This includes TRIZOL.  
 
CO2 Incubators 
1.) Relative Humidity: Cell lines utilized in the Nowak lab require 99% relative humidity. To 
create this humidity the incubator is set at 85% relative humidity and we have a pan of DI water 
in the bottom of the incubator. This pan needs to be checked and filled at least once a week. 
Only DI water should be used in this incubator; add few drops of the antifungal solution to this 
DI water in the pan. The incubator also has a water jacket surrounding the cell chamber. The 
indicator on the incubator will alert us when this water lever is low and needs to be filled.  
2.) CO2 levels: The level of CO2 in our cell culture is set for 5%. The CO2 supply tanks are located 
next to the laminar flow hood (main lab) or next to the door (small cell culture room). The 
registers on the supply tanks will indicate the level of CO2 being supplied to the incubator. The 
pressure of CO2 supplied to the incubators should be at 15mmHg, anything higher will offset 
the monitor of the incubator. When the tanks get low it is the responsibility of each lab member 
to change the tanks and notify the correct personnel of the number of empty tanks so that they 
can order new tanks. The level of CO2 within the incubator can be determined by using our 
FYRITE gauge. This will be checked every week and necessary calibrations will be performed 
by a specific lab member.  
3.) Temperature: Unless otherwise stated the temperature of the incubators should always be set 
at 37oC. An internal thermometer should be read with the door is shut to determine the actual 
internal temperature. The temperature should be calibrated once a week. Chicken cells in 
culture need a higher temperature of 39oC. 
4.) Cell containers: All cell culture dishes, flasks, plates, etc. should be contained in an autoclaved 
tray. Cell culture plastic ware should never be placed directly on shelves. This will help prevent 
spilling of cell culture media and also keep the incubators clean. Once your experiments are 
complete you can place the tray on the dirty dish cart and it will be cleaned and autoclaved for 




5.) Maintenance: If we should encounter a contamination, the shelves and water pan need to be 
removed from the incubator and cleaned/autoclaved. Then the walls of the incubator should be 
cleaned with warm water and mild soap followed by a 70% ethanol wipe.  
6.) General Notes: DO NOT leave the inner door open while using the incubator. DO NOT go into 
the incubator without first cleaning your gloves with 70% ethanol. If the incubator is alarming 
DO NOT ignore the alarm or silence the alarm without first taking action to fix the reason for 
the alarm indication.  
 
Inverted Microscope  
1.) Imaging cells: Cell dishes/flasks may be placed on the stage for imaging. Please be sure to 
clean up the stage after imaging cells, especially if media has been spilled. 
2.) Confluency: One of the main reasons for imaging cells is to determine cell growth/confluency. 
Cell confluency is expressed as a percentage and it is a very subjective measurement of cell 
growth. Develop your own style and stick with it.  
3.) Cell Counts: To determine the number of cells that are in a dish/flask for seeding we perform 
cell counts using a very special/costly slide called a hemacytometer slide. This slide has a grid 
etched into the glass slide which you can use to count your cells.  
 
Water Bath  
 There is a water bath located on the bench by the laminar hood in the main lab. The temperature 
on this water bath is set to 37oC and should remain at this temperature. It is important that the water bath 
always have a constant level of water, therefore if you see the water level low then please use DI water 
ONLY to refill the water bath. The water bath is used to warm media/reagents and also to thaw cells 
therefore it is critical that the water bath stay clean and free of fungus and bacteria. To clean the water bath 
please empty all the water and use mild soap and warm water. Following cleaning please spray with 70% 
ethanol prior to refilling the water bath with DI water. Add antifungal solution to the DI water in the water 
bath.  
1.) Warming up media/reagents: Please make sure that all media/reagent bottles are secured in the 
water bath. They tend to float so use the weights provided near the water bath to anchor the 
media bottles. You do not want to use a bottle that has tipped over in the water bath, it is 
considered contaminated.  
2.) Thawing cells: When cells are thawed they need to have a quick thaw. This allows the cells to 
remain viable by quickly removing the cryoprotectant from inside the cell. Place your cells in 
a tube flotation device with their caps above water level. Only allow cells to sit in the water 
bath until halfway thawed, NO LONGER.  
3.) When items are removed from the water bath they need to be dried and wiped with 70% ethanol. 
Please make sure that everything is wiped prior to placing in the hood.  
 
RULES FOR STERILITY 
1.) Never open anything that needs to be used for cell culture unless it is in the laminar flow hood. 
This includes the lids of your dishes/plates/flasks/media.  
2.) All media should be made in the hood. All aliquots of cell culture supplies should be prepared 
in the hood. 
3.) For small pipetting only use barrier tips. These tip boxes are located in the hood. These boxes 
are individually wrapped and should not be used except for RNA/DNA or cell culture work.  
4.) For aspirating media use the glass pipettes. The container for these pipettes should be opened 
in the hood and closed after use by each person. Never leave this open if the blower is not on!!!  
5.) For large pipetting use the serological pipettes. These should only be opened in the hood.  
6.) When placing items in the hood that are not usually left in the hood… always first wipe the 
bottom surface with 70% ethanol. This is easily done by spraying Kimwipe with ethanol and 
then wiping the surface of the container/pipet/pipetaid/rack/etc. 
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7.) Gloves and a lab coat should be worn at all times when working in the hood/incubator/handling 
cell dishes. We work in a BSL2 lab and handle human cells. You shouldn’t have exposed skin 
beyond the air barrier in the cell culture hood. This is for your protection as well as to eliminate 
any disruption of the sterile field. Also as a side note, hair should be worn up or kept out of the 
face. You don’t want to have to brush your hair out of your eyes with your gloved hand or have 
it bothering you while working at the hood. Do not touch anything (hair, face, mobile phone, 
ear phone etc.) with your gloved hand.  
8.) Do not do any work over the air barrier. As a rule try to keep your elbows on the air barrier so 
that forces you to do all your work beyond the air barrier. Anything that crosses the air barrier 
is no longer considered sterile.  
9.) Clean up spills immediately so that they don’t cause contamination.  
10.) Do not let media bottles sit for too long in the water bath. Also do not let media bottles turn 
over in the water bath.  
 
How to deal with a contamination: 
1.) First notify everyone that there is a contamination either in the incubator/water bath/ hood.  
2.) Remove all of the contaminated plates and dispose of properly in the biological waste container. 
This includes aspirating out the contaminated media in the vacuum trap and bleaching the trap.  
3.) Remove all trays/shelves/water pans from the incubator and clean with soap and water. Then 
sterilize equipment by autoclaving in wrapped bags.  
4.) Wipe down walls of the incubator with soapy water using a soft sponge or cloth.  
5.) Finally spray incubator walls with 70% ethanol to remove any leftover contamination.  
6.) Change the HEPA filter according to incubator guidelines.  
7.) Allow 48 hours to cycle air and then notify lab personnel that incubator can be used again.  
 
Defined media and supplements  
 pH 
Most cells grow well at pH 7.4 Phenol red is the indicator that is used in most of our cell media. At 
pH 7.4, phenol red is red, at 7.0 orange, at 6.5 lemon yellow, at 7.6 pink and at 7.8 purple. 
 
CO2 and bicarbonate  
Carbon dioxide interacts with HCO3 and lowers the pH of the media. For this reason bicarbonates 
(NaHCO3 or HEPES) are added to the media to stabilize the pH. Without CO2 cells will not grow. 
If you have Na pyruvate in your media your cells are less dependent on CO2 and therefore should 
be added if cells are to be transported.  
 
Oxygen 
Cultured cells often rely on glycolysis for energy production. In many cells this is anaerobic 
glycolysis instead of respiration. In most incubators the level of oxygen is atmospheric 21%. 
However, cells can be cultured in normoxic 6% or hypoxic conditions 0.5-2% and still survive. The 
level of oxygen used for cell culture is highly dependent on oxygen diffusion. For this reason the 




Cells should be cultured in media within the osmolarity range of 260-320 mosmol/kg.  Once an 
osmolarity is reached it should not deviate more than 10 mosmol/kg. In this lab we typically use 
balanced salt solutions that are pre-made to maintain osmolarity.  
 
Amino Acids  
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Glutamine is an amino acid that is required by most cells for growth and function. In this lab we 
buy media containing L-glutamine or we add it exogenously. Please note what concentration of 
glutamine is needed for your particular cell type.  
 
Antibiotics 
Antibiotics penicillin and streptomycin are added to all culture media to prevent contamination. 
We typically use 6mls of Pen/Strep at 10,000IU/ml Pen and 10,000ug/ml Strep for 500 ml bottle 
of media. Some cell culture experiments (i.e. Transfection of cells) will not use antibiotics in the 
serum. Please take extra precautions when working with this type of media.  
 
Serum 
Serum contains growth factors that are vital to cell growth. In this lab we use Fetal Bovine Serum 
(FBS), Newborn Calf Serum (NCS), Bovine Calf Serum (BCS), Chicken serum for our serum 
types. Be sure to know which type and what concentration of serum your cell line needs to grow 
efficiently.  
 
Depending on the cell line you are working with it may be necessary to add additional components 
to the media such as, vitamins, mineral, hormones, growth factors, etc. It is important to realize that 
your cell line can be as individual as you or I so they each have a little variation in how they like 
to grow. Understanding the needs of your cell type prior to experimental assay will save you a lot 
of time and effort in the long run.   
 
Please be sure that when you are done working in the hood all of these items are checked! 
1.) Laminar hood restocked for  
a. Pipette tips, serological pipettes, dishes, flasks, glass pipettes.  
2.) Vacuum flask bleached and if necessary emptied.  
3.) Hood sprayed with 70% ethanol 
4.) Media put away in appropriate fridge 
5.) Pipettes replaced to holder and pipette man plugged in  
6.) Glass pipette lid replaced 
7.) If the last one to leave then please turn on the UV light and turn off the blower 






Wear Gloves at all times 
Be as gentle and careful as possible throughout the procedure  
 
1.) Place 10% serum containing medium in the water bath.  
2.) Remove cryovial containing frozen cells from the liquid Nitrogen tank 
3.) Place cryovial in the water bath and observe for thawing. Remove them as soon as they are 
halfway thawed. (Never leave them in for too long; the DMSO will kill the cells) 
4.) Add 5 mL of medium to sterile 15 mL conical tube.  
5.) Use P1000 pipette to transfer the thawed cells from the cryovial into the conical tubes. Use the 
resuspension method to insure that all of the cells are removed. 
6.) Spin the cell suspension for 5 minutes at 50-100RCF. 
7.) Aspirate out the supernatant and add an appropriate volume of fresh medium to resuspend the 
cell pellet (depending on number of dishes). 
8.) Prepare appropriate number of culture dishes and label them (Cell ID, Passage number, Initials, 
Date) 









1.) Trypsinize cells as done for passaging and collect cell suspension in conical tube.  
2.) Centrifuge the cell suspension at 50-100RCF for 5 mins. BE SURE to balance the centrifuge. 
3.) During this time place freezing media (located in the freezer of the cell culture freezer on the 
door rack far left) in the 37deg water bath.  
4.) After spinning the 15 ml conical – take the conical and look for a cell pellet. Remove the 
supernatant without disturbing the pellet.  
5.) Resuspend pellet in 1.5 ml of freezing media. Mix carefully. 
6.) Label a 2 ml cryovial with cell information (cell ID, passage #, date and your initials). 
7.) Place cells that are resuspended in the freezing media into the 2ml cryovial and place on ice for 
30 mins.  
8.) After the 30 minutes place cells/cryovials in the -80 freezer.  
9.) Transfer the cryovials from the -80C freezer to the liquid Nitrogen tank after 24 hours. Make a 





Protocol for Passaging Cells in Culture 
 
 
1.) Aspirate out the old media 
2.) Add appropriate volume (3-5 ml) of Trypsin EDTA or sterile PBS depending on culture dish 
and wash over cells 
3.) Aspirate out   
4.) Add an appropriate volume (3-5 ml) of Trypsin EDTA to the cells  
5.) Incubate for 5-6 minutes in the incubator   
6.) Check the culture dish under the microscope for detachment of cells. Incubate for longer if 
needed. 
7.) Add 7-10 ml of serum containing culture medium to the culture dish to neutralize the effect of 
the Trypsin EDTA 
8.) Collect this cell suspension in conical tubes and centrifuge at 50-100RCF for 5 minutes (speed 
depends on cell type) 
9.) Aspirate the supernatant and resuspend the cell pellet in an appropriate volume of fresh culture 
medium depending on number of dishes to be used for expansion of cells (1 ml per dish)  
10.) Add 1 ml of cell suspension to each culture dish and an additional appropriate volume of fresh 
medium depending on type of culture dish being used  
11.) Move the culture dish to spread out the cell suspension and place these new dishes into the 
incubator 
12.) Check periodically for cell growth 
 
Reminder 
 -Use the standard 10% serum containing medium or as needed for specific study 
- Place the Trypsin EDTA and medium into the water bath for about 10-15 min prior to passaging  
-Make sure all culture dishes are properly labeled with cell ID, passage number, initials, and date 
of passage   










1.) Trypsinize cells as done for passaging and collect cell suspension in conical tube.  
2.) Centrifuge the cell suspension at 50-100RCF for 5 mins. BE SURE to balance the centrifuge. 
3.) Aspirate the supernatant while leaving pellet.  
4.) Depending on the size of the cell pellet, add fresh medium and resuspend pellet thoroughly but 
carefully. 
5.) Clean the hemacytometer and coverslip with DI water and then 70% EtOH before and after 
each use. Dry the counting chamber completely before use. 
6.) Place the coverslip on the counting chamber. Add 10ul of the above prepared cell suspension 
to each side of the hemacytometer under the cover slip. 
7.) Place the slide on the microscope stage and focus on to the counting grid using the 10x lens on 
the inverted microsocope. Both grids on the slide can thus be counted. 
8.) Count the number of cells in the 4 corner squares thus counting a total of 16 smaller squares. 
Make sure the cell suspension is dilute enough to provide a uniform single cell suspension and 
the cells do not appear too crowded within the grid. 
9.) When counting, count only those cells on the lines of two sides of the square to avoid counting 
cells twice. Decide on which two sides will be included and stick to it throughout the counting 
process.   
10.) The area of each big square is 1mm x 1mm  = 1mm2 and the depth of each square below the 
coverslip is 0.1mm. Since 1cm3 is equivalent to 1ml, the final volume of each square is 0.1mm3 
= 0.0001ml.   
11.) Divide the total number of cells counted in four large squares by 4 to obtain average count  
12.) Cells per ml = average count per big square x 104 
13.) Total cell count = cells per ml x original volume of media used to resuspend cell pellet 
 
 







10X TBE Buffer Recipe (pH 8.3) 
 
108g Tris Base 
55g Boric Acid 
9.3g EDTA 
Add to 800ml MilliQ water. Make up to 1L after everything dissolves. 
Add 9L MilliQ water to make 1X solution that we need. 
 
 
10X PBS (pH 7.4) 
 
80g Sodium Chloride 
2g Potassium Chloride 
21.6g Sodium Phosphate dibasic heptahydrate (Na2HPO4.7H2o) 
2.4g Potassium dihydrogen Phosphate (KH2PO4) 
Dissolve in 1L MilliQ water. 
 
 
 
 
 
